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CHAPTER 1   
General Introduction






Between 1966 and 1970, Barnett Newman (1905 -1970) completed Who’s Afraid of Red, 
Yellow and Blue?, a series of four large-scale paintings solely combining the three primary 
colours. Newman’s work has been described as an attempt “to come closer to the sources 
of the tragic emotion” rendered in monochromic paint (Newman, 1992, p.170). And indeed, 
Who’s afraid of Red, Yellow and Blue became famous because of its power to reveal strong 
emotional reactions in its recipients and gained even more attention when Who’s afraid of 
Red, Yellow and Blue III was vandalized in 1986 by a realist-painter who slashed Newman’s 
work with a knife to destroy its emotional impact. As Newman aimed to trace the true origin 
of emotion in his artwork, this thesis proposes an attempt to grasp the biological origin of 
anxiety, investigating three neural biomarkers of anxiety; increased locus coeruleus drive, 
amygdala hypersensitivity, and decreased prefrontal control.   
Anxiety is an essential human condition that prepares the individual for a well-suited 
reaction to potential threat (Bateson et al., 2011). It affects our cognition, behaviour, and 
physiology in order to anticipate risk and prevent future harm. Anxiety is differentiated from 
fear. While fear occurs in response to a concrete threatening event, anxiety is a less intense 
reaction that shapes cognitions and behaviours that are associated with potential threat or 
ambiguous threat that might occur (Blanchard et al., 2011, p.3). Importantly, high anxiety 
does not necessary imply the presence of a mental disorder and the impossibility of a 
successful life. Many successful and high-achieving individuals, among them, famous leaders, 
celebrities, professional athletes or musicians report anxiety. While often considered as a 
negative emotion, that we like to avoid or suppress, anxiety is an important cognitive and 
behavioural motivator that not only saves us from risky actions, but also is indispensable 
for social conformity. Anxiety impels us to anticipate the future and to make thoughtful 
decisions in order to avoid any risk. In social contexts, it drives us to be sensitive to other 
people’s thoughts and actions. Anxious individuals tend to behave highly responsible, avoid 
risk and adapt their behaviour to social expectations. 
Yet, as is so often the case, too much of a good thing tends to have detrimental effects. 
While an appropriate degree of anxiety benefits human survival, excessive anxiety in a 
context that actually does not pose a serious threat to the individual can be highly disabling. 
Elevated anxiety is widely spread in the general population; 19% of women and 12.5% of 
men between the age of 25 and 65 report moderate to severe levels of anxiety on the 
Hospital Anxiety and Depression Scale (HADS) (Breeman et al., 2015). Anxiety tends to 
decrease with increasing age. Hence, young adults are particularly prone to experience 
increased levels of anxiety. The high rate of elevated anxiety that we observed among 
university students, a healthy and highly functioning population speaks for itself. For this 
work, I asked 2206 individuals to fill in the HADS. Of those, 780 (35.3%) reported HADS 
scores higher than seven, which indicates moderate to severe levels of anxiety. Yet, the 
vast majority of this subclinical group is still able to cope with their anxiety and does not 
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experience their anxiety as disabling. In contrast, severe and persistent symptoms of anxiety 
that lead to significant impairment in daily life functioning are the hallmark of an anxiety 
disorder (Mendlowicz, 2000). With a lifetime prevalence of 25%, anxiety disorders belong 
to the most common mental health problems around the globe, particularly among young 
adults (2.5–9.1%)(Remes et al., 2016). Even higher rates are observed in Western cultures. In 
the United States, the lifetime prevalence to suffer from any anxiety disorder even reaches 
33.7% (Kessler et al., 2012). Why is severe anxiety such a common mental disorder, and to 
a less intense extent a frequent phenomenon in healthy populations? From an evolutionary 
perspective, anxiety appears highly adaptive and increased anxiety in the absence of a real 
threat, a “false alarm”, would be less harmful than no anxiety despite actual danger. This 
evolutionary adaptation does not hold anymore for a modern society with circumstances 
that do not ultimately lead to serious threat of life requiring the individual to prepare for 
fight or flight, and has been considered as evolutionary mismatch (Bergstrom & Meacham, 
2016; Williams & Nesse, 1991).
First choice treatment for anxiety disorders is exposure-based cognitive behavioural therapy 
(CBT) (Bandelow et al., 2014; Courtois et al., 2017; National Collaborating Centre for Mental 
Health Great Britain, 2013). However, the response rate of patients with various anxiety 
disorders for this initial treatment are in a range of 45 to 65% (Bandelow et al., 2014; 
Loerinc et al., 2015). High variation in treatment response constitutes a major challenge in 
psychiatry and has been related to the individual nature of a mental disorder considering 
the variety of environmental and genetic factors. However, variance in treatment response 
has also been attributed to the biological complexity of anxiety itself. In terms of biological 
correlates, anxiety has been related to multiple neural mechanisms and neurotransmitter 
systems. Heterogeneity of those underlying neurobiological mechanisms among patients 
with anxiety disorders might cause substantial variation in treatment effects. Individuals 
might express similar symptoms of anxiety. However, the neural mechanisms causing 
those symptoms might differ between individuals. Scientific understanding of individual 
differences regarding those anxiety evoking neurobiological mechanisms potentially leading 
to heterogeneous therapy outcome is still limited. In the first part of this work, I investigated 
individual differences in neural mechanisms underlying anxiety in healthy individuals with 
elevated anxiety traits. I focused on three neural mechanisms that have been established in 
previous research but have never been considered in conjunction. Those three streams of 
research propose amygdala hypersensitivity, decreased prefrontal control, and increased 




Red, Yellow, and Blue: Three neurobiological correlates of anxiety
From a neural perspective, the amygdala plays a central role in anxiety processing. The 
amygdala is a bilateral cluster of nuclei located deep in the medial temporal lobes and 
was first described in the early 19th century by the anatomist Burdach (1819-1822). The 
amygdala modulates the emotional reaction by enhancing the perception of stimuli of 
emotional relevance (LeDoux, 1998). Anxiety symptoms are evoked by amygdala activation 
in response to threat. This was first demonstrated in animals and has been replicated in 
numerous human studies (Davis & Whalen, 2001). Accordingly, lesions of the amygdala lead 
to impaired evaluation of emotional significance and reduced reaction to aversive stimuli 
(Anderson & Phelps, 2001). Neuroimaging studies reported increased amygdala activity 
in highly anxious individuals and patients with various anxiety disorders (Del Casale et al., 
2012; Etkin & Wager, 2007; Shin & Liberzon, 2009; Stein et al., 2007). Hence, amygdala 
hypersensitivity to threat has been considered as the neurobiological basis of anxiety.
Yet, the complexity of the human brain requires models going beyond the assignment of a 
single region to a certain phenomenon. Over the last decade, neuroscience has shifted from 
mapping single brain regions to functions or symptoms towards network-based approaches. 
The amygdala is embedded in multiple regulatory networks composed of cortical and 
subcortical brain regions. While the amygdala is the primary structure evoking the emotional 
response, those regulatory networks indirectly effect anxiety by up- or downregulating the 
activation level of the amygdala. 
The amygdala is interconnected with prefrontal regions that are involved in emotional 
processing, including the evaluation and regulation of emotions. Downregulation of amygdala 
activation in response to threat is based on inhibitory projections from regulatory prefrontal 
areas towards the amygdala (Kanske et al., 2011; McRae et al., 2010). Neuroimaging studies 
Figure 1: The bilateral amygdala
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have investigated prefrontal neural activation in patients with anxiety disorders while those 
had to downregulate their emotion in response to aversive stimuli. Numerous studies 
reported lower involvement of prefrontal regions in patients with various anxiety disorders 
relative to healthy controls (Wang et al. 2018). Thus, instead of the amygdala being inherently 
hypersensitive, increased amygdala response might stem from a lack of prefrontal control. 
Therefore, decreased prefrontal control has been considered as another, rather indirect neural 
mechanism, yet leading to the same anxious phenotype. 
Anxiety is associated with a range of physiological changes. During acute stress, elevated 
cortisol levels, increase in heart rate, changes in pupil dilation and sweating are indicators 
for increased activation of the sympathetic system, which gears the organism towards a 
state of hypervigilance. The locus coeruleus, a cylindrical nucleus in the rostral brainstem, 
is the central structure modulating the sympathetic system (Aston-Jones & Cohen, 2005). 
Modulations of the sympathetic systems shift the level of arousal and are based on the 
neurotransmitter noradrenaline. The locus coeruleus is the major source of noradrenaline 
in the human brain (Szabadi, 2013). Noradrenaline is projected from the locus coeruleus 
throughout the entire brain and increases the activation level of neurons in various brain 
regions, including the amygdala. Those noradrenaline-induced modulations not only induce 
physiological changes but also effect cognitive processes. Stress leads to noradrenaline 
release which causes improved memory performance and amplified attention to information 
that might be of relevance in the acute stress situation (Henckens et al., 2009). During 
such stress-induced increased arousal states, the locus coeruleus releases elevated levels 
of noradrenaline provoking a holistic shift of the entire organism in order to be optimally 
prepared for a fight or flight response. Pharmacological studies demonstrated a reduction 
of amygdala activation in response to aversive stimuli after blocking noradrenaline release 
from the locus coeruleus (Hurlemann et al., 2010; Onur et al., 2009). Moreover, patients 
with anxiety disorders revealed globally increased levels of noradrenaline implying that 
an increased drive of the locus coeruleus might initiate elevated amygdala activation in 
response to threat (Yamamoto et al., 2014). 
Importantly, while excessive noradrenaline release causes hypervigilance, a lack of 
noradrenaline leads to inefficiency (Arnsten, 2009). On a cognitive level, the Yerkes Dodson 
framework, stating that optimal performance is reached at a medium level of arousal, 
illustrates dynamic changes of the noradrenergic system (Yerkes & Dodson, 1908). Anxious 
individuals that express an increased drive of the locus coeruleus as primary neural 
mechanism of anxiety might experience constantly elevated arousal levels, preventing them 




Neural heterogeneity between individuals
In this thesis, I focused on amygdala sensitivity, reduced prefrontal control and increased 
locus coeruleus activation as potential neural mechanisms underlying anxiety (figure 3). In 
chapter two and three we hypothesized that highly anxious individuals can be stratified based 
on the neural mechanism underlying their anxious phenotype. Yet, many more mechanisms 
have been associated with anxiety. To name but a few, multiple neurotransmitter systems 
play a significant role in the manifestation of an anxiety disorder. High anxiety traits are 
associated with genetic variations leading to reduced uptake of serotonin (Lesch et al., 
1996). Thus, chronic treatment with selective serotonin reuptake inhibitors (SSRIs) is a 
state of the art pharmacological therapy for symptoms of anxiety. Moreover, imbalances 
in dopamine, glutamate and GABA have been associated with impaired extinction learning, 
thereby leading to increased levels of anxiety  (Singewald et al., 2015).  
Figure 2: Considering the inverted u-shape relation between performance and arousal, increased locus coeruleus 
drive elevates the arousal and would constantly shift the individual to the right leg of the curve.
Figure 3: The amygdala (yellow) is embedded in regulatory circuits; prefrontal areas (blue) downregulate amygdala 
activation, while the locus coeruleus (red) increases amygdala activation via noradrenergic projections. Reduced 
prefrontal control and increased locus coeruleus drive both lead to increased amygdala responsiveness.
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Considering the complexity of potential mechanisms leading to the manifestation of an 
anxiety disorder and the observed variance in treatment success suggests a high diversity 
between anxious individuals regarding their neurobiological profile despite presenting 
the same clinical symptomatology. So far, the vast majority of studies investigating neural 
mechanisms of anxiety focused on one mechanism and compared patients with anxiety 
disorders to healthy individuals. Such group comparisons where the group average of 
the healthy population defines a ‘blueprint’ and any deviation indicates a pathological 
state proposes a one-dimensional perspective on a complex phenomenon. Moreover, 
heterogeneity within the patient group would explain why studies of small sample sizes 
often yielded various results. 
Beyond group comparison: Stratification approaches to capture neural 
heterogeneity
While group comparisons are common research practise, there has been a trend towards large 
cohort studies allowing for stratification of individuals based on multiple biological features. 
Such approaches group patients into subpopulations based on several measurements. 
In general terms, unsupervised data clustering aims to detect natural groupings within a 
multidimensional dataset. Based on quantitative comparisons on multiple dimensions, 
subgroups of data points (individuals) are formed that show the highest resemblance along 
all included dimensions (Jain, 2010). 
A most common clustering method that has been also applied on neuroimaging data is 
k-means clustering, which is based on an unsupervised algorithm that defines a number k 
of cluster centres (centroids) within a dataset (figure 4.A). Every data point is assigned to 
the nearest centroid. In other words, individuals that are most similar on all dimensions are 
grouped into one cluster around that centroid. Mathematically, this resemblance is based on 
Figure 4: Simplified depictions of a (A) K-means model and a (B) Gaussian mixture model in a 2-dimensional space. 
Most commonly, clustering models are applied on multidimensional datasets; the clustering approach implemented 




the minimization of the in-cluster sum of squares (Jain, 2010). Through iterative calculation, 
the centroids stabilize when the smallest sum of squares is reached. In this work, I aimed 
to investigate the manifestation of the three mechanisms of interest in a study population 
of highly anxious individuals. In that perspective, k-means clustering has a significant 
shortcoming. The algorithm yields a strict cluster assignment. Assuming that a cluster defines 
one neural mechanism, a k-means approach would assign an individual to the cluster with the 
strongest resemblance, stating that this mechanism is the most prominent mechanism in the 
given individual. Hence, it does not provide any information about the manifestation of the 
other two mechanisms in that individual. 
Gaussian mixture based modelling overcomes this drawback as it allows a ‘soft cluster 
assignment’, providing the probability for an individual to belong to every given cluster. 
Gaussian mixture modelling draws on the assumption that a dataset is composed of a set 
of Gaussian distributions (figure 4.B). It provides the probability of the existence of several 
normally distributed subgroups within a population. For each individual the likelihood to 
belong to a distribution k within the dataset is calculated. With regard to the three neural 
mechanisms investigated in this work, a Gaussian mixture model indicates how strong each 
mechanism is pronounced in the individual. Clustering-based stratification approaches 
on multidimensional datasets do justice to the complexity of mental disorders and the 
individuality of the human brain. They provide the chance to capture heterogeneity within a 
population that cannot be detected by state-of-the-art group comparisons. 
Emotion regulation in highly anxious individuals
The second part of this work (chapter four and five) takes a closer look at one of the three 
proposed biomarkers - lack of prefrontal control - by investigating neural correlates of emotion 
regulation. From an evolutionary perspective, emotions are the adaptive physiological and 
behavioural response to the environment (Levenson, 1994). Emotions motivate us for fast 
reactions. Thinking of the fight or flight paradigm in a Darwinian perspective, emotions lead 
to a reproductive advantage; being anxious, we quickly react, either fighting a dangerous 
situation or fleeing from it. Psychologists have defined emotions from a physiological and 
a cognitive angle. James and Lange define emotions as an affective reaction evoked by a 
physiological experience; ‘I feel my hands trilling, thus I must be anxious’ (James, 1894). 
In contrast, cognitive theories state that emotions result from the cognitive interpretation 
of a physiological reaction. Hence, emotions arise from the interplay of physiological and 
cognitive aspects (Schachter & Singer, 1962). Over the last century, cognition gained a 
more prominent role in the definition of emotion; Lazarus postulated the appraisal theory, 
proposing that a cognitive state causes an emotional affect which goes along with a 
physiological reaction (Lazarus & Folkman, 1984). However, regardless of whether emotions 
are considered as being a result of a physiological reaction or cognitive processes, emotions 
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are not always beneficial. Inappropriate or extreme emotions can harm mental well-being 
and social interactions. In this work, I focused on anxiety, which is commonly perceived as 
an unpleasant emotion. Humans have the inherent tendency to downregulate unpleasant 
emotions. Successful emotion regulation is an essential asset for mental health. Chronic 
inefficiency of emotion regulation, hence being constantly not in control of one’s emotions 
can result in various mental disorders. Accordingly, impaired emotion regulation is a 
transdiagnostic phenomenon across numerous mental disorders (Berking & Wupperman, 
2012). In the neuroimaging literature, the concept of emotion regulation is based on 
the appraisal theory. Since according to the appraisal theory, a cognitive state evokes an 
emotion, changing the cognitive state would modify the emotional response. A conscious or 
unconscious attempt to modify the emotional response requires a deployment of attention 
towards certain aspects of the stimulus or situation and a re-evaluation of the stimulus or 
situation (Gross, 1998; Ochsner et al., 2012). Redirecting attention to aspects that indicate 
a more positive attribution, in other words trying to see the situation in a “more positive 
light”, reduces the negative emotional response. This cascade of processing an emotion 
evoked by a stimulus or situation, and its re-evaluation in order to reduce the emotional 
reaction is commonly referred to as reappraisal. Since patients with mental disorders 
oftentimes express impaired emotion regulation, training of emotion regulation, specifically 
the reappraisal model is a common element of cognitive behavioural therapy (Hollon & 
Beck, 1979; D’Zurilla, 1988).
In this work, I studied emotion regulation in healthy but highly anxious individuals. This 
particular group represents a subclinical fraction of the general population that despite 
expressing increased levels of anxiety does not fulfil the criteria of an anxiety disorder. 
Mental disorders are often considered as a continuum. According to the mental health 
continuum, where the left side represents a healthy level of anxiety and the right 
spectrum captures extreme manifestations of anxiety leading to anxiety disorders, we 
might assume that a subclinical population expresses a similar neural profile as observed 
in clinical population, yet of less severe degree. However, our study population allows for 
more complex considerations. Participants were not only healthy young adults. In fact, 
the population was mainly composed of university students; hence, a highly functioning 
population despite their high anxiety traits. This group is of particular interest as it allows 
asking, whether some individuals that express a predisposition of high anxiety traits can 
compensate their anxiety with efficient emotion regulation and therefore are spared from 
developing an anxiety disorder.
On a neural level, emotion regulation relies on the emotion regulation network which 
comprises the superior temporal gyrus, angular gyrus and the supplementary motor area, 
as well as dorso- and ventrolateral portions of the PFC and a cluster in the anterior middle 




of ventrolateral, dorsomedial and dorsolateral portions of the prefrontal cortex and the 
amygdala during emotion regulation suggesting that these areas are the key regions involved 
in emotion processing and regulation of the amygdala (Berboth & Morawetz, 2021). Chapter 
four investigates neural activation patterns and functional connectivity between prefrontal 
brain regions during emotion regulation in highly anxious individuals. We hypothesized that 
effective emotion regulation is characterized by increased functional connectivity between 
ventral and dorsal prefrontal areas and the amygdala, which might protect healthy but 
highly anxious individuals from developing clinically relevant anxiety.
Anxiety in times of Corona 
I am writing these parts of my thesis while the third pandemic wave is filling our hospitals 
and is shutting down most public life. The last year of my PhD work was marked by the 
global crisis of the Covid-19 pandemic, which arrived in the Netherlands in March 2020. The 
Covid-19 pandemic led to drastic changes in our everyday lives. Regulations enforcing social 
distancing to reduce infection rates led to high degrees of social isolation and a period of 
economic uncertainty. These major societal changes translated into a range of emotional 
reactions and numerous studies reported increased psychological distress among the 
general population (Torales et al., 2020). The pandemic gave rise to a vast body of research 
aiming to understand the detrimental impact of the pandemic on mental wellbeing in the 
general population (Holmes et al., 2020). Although a global stressor like the pandemic 
affects the entire population, vulnerable groups might be particularly affected. Individuals 
with mental problems, elderly being at higher risk for a severe course of the Covid-19 
disease, caregivers or groups of lower socioeconomic status might experience more severe 
psychosocial difficulties (Pfefferbaum & North, 2020). In a recent large-scale online study 
The Lancet reported severe impacts on mental health in individuals with mental disorders 
(Pan et al., 2021).
Yet, the extraordinary situation also presented a research opportunity, providing the unique 
chance to study the effects of a global and long-term stressor in a real life situation. We 
had investigated our study population only in a laboratory situation without any real-life 
context and had evaluated their emotion regulation and stress coping abilities merely 
based on self-assessment questionnaires. The current pandemic raised the question how 
our particular study population, a young and healthy but highly anxious subclinical group 
would react to such a significant real-life stressor. Universities had to close for months and 
especially young adults were experiencing social isolation and times of meaninglessness. 
Since the risk for a severe course of the Covid-19 disease is rather low in this age cohort, 
this population would presumably suffer strongly from pandemic-related social restrictions 
rather than the fear of becoming infected. The Covid-19 pandemic elicited the research 
presented in the fifth chapter. Chapter five is based on an online follow-up study which 
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was conducted during the first wave of the Covid-19 pandemic in the Netherlands in April 
2020. In contrast to the majority of research conducted on stress and anxiety during the 
pandemic, we had evaluated anxiety and emotion regulation strategies before the outbreak 
of the pandemic. All experimental work had been completed before the outbreak of the 
pandemic. This gave us the advantage of a baseline measure and provided the chance to 
retrospectively find predictors in a pseudo-prospective design. We investigated predictors 
of how well individuals coped with a long-term stressor like the pandemic. 
We hypothesized that individuals that had expressed high anxiety traits already before 
the outbreak of the pandemic might be particularly affected by the pandemic and related 
regulations. Eventually, individuals that were able to control high anxiety traits at normal 
times would now be at risk of developing clinical degrees of anxiety. On the other hand, 
our research on emotion regulation in this particular group had revealed highly efficient 
emotion regulation (chapter four). This raised the question whether emotion regulation 
would predict how well individuals would cope with the current situation of the pandemic.
While chapter four discusses the neural basis of emotion regulation, chapter five considers 
the predictive value of different emotion regulation strategies towards anxiety and stress. 
Emotion regulation strategies vary in their effectiveness and psychology distinguishes 
between adaptive and maladaptive emotion regulation strategies (Aldao et al., 2010; Gross, 
1998). Adaptive emotion regulation involves conscious and proactive strategies like i.e. 
problem solving in order to modify a situation or reappraisal (Aldao & Nolen-Hoeksema, 2012). 
In contrast, maladaptive emotion regulation strategies like i.e. suppression, withdrawal, or 
rumination, lead to less efficient emotion regulation and have been associated with social 
anxiety disorder and depression (D’Avanzato et al., 2013). 
However, extreme situations like the occurrence of a global pandemic might challenge 
emotion regulation and our definition of adaptive and maladaptive. The pandemic poses 
an uncontrollable threat that can merely be modified by the individual applying problem 
solving strategies. Moreover, social distancing literally enforces social withdrawal and limits 
our options for proactive strategies. Hence, different times might call for different strategies.
Thesis outline
Anxiety relies on various physiological and neurobiological mechanisms. This work aims 
at understanding the complex interplay of neural characteristics of anxiety in a population 
of healthy but highly anxious individuals. In particular, this work tackles the challenges of 
detecting diverse neural mechanisms within an anxious population. The first part of this 
thesis proposes a biomarker model to capture neural heterogeneity integrating three 





Since anxiety has been associated with characteristic alterations in neural networks 
underlying emotion regulation, the second part focuses on neural underpinnings of emotion 
regulation, investigating neural patterns associated with an anxious phenotype. Chapter 
five explores the preventive effect of emotion regulation strategies on stress and anxiety 
during the Covid-19 pandemic in this particular population of healthy but highly anxious 
individuals.
PART I: NEURAL BIOMARKERS OF ANXIETY
Chapter two presents the research on three potential mechanisms of anxiety; amygdala 
hypersensitivity, decreased prefrontal control, and increased drive of the locus coeruleus. 
This work reviews and combines several streams of research and proposes a comprehensive 
biomarker model aiming to provide a rational for future experimental studies. The review 
includes a study proposal to investigate the existence of the three proposed biomarkers in 
conjunction and lies out the basis for the experimental part of this work. 
Chapter three describes a neuroimaging study that implemented the biomarker model 
proposed in chapter two in a study population of healthy but highly anxious individuals. 
Participants were selected based on an online screening on anxiety traits, resulting in a 
population of healthy but highly anxious individuals.  An fMRI recording was performed while 
participants completed three cognitive tasks that tapped into the three neural mechanisms 
of the biomarker model. Neural activation was measured in two regions of interest; the 
amygdala and the emotion regulation network. Gaussian mixture modeling was applied in 
order to stratify participants based on the neural mechanism that was most prominent in 
the individual. The resulting cluster solution was validated on an independent physiological 
measure. This proof-of-concept study tested the feasibility of the proposed biomarker 
model. Moreover, we demonstrate the advantages of applying data-driven clustering based 
approaches on neuroimaging data in order to capture within-group neural heterogeneity.
PART II: EMOTION REGULATION IN HIGHLY ANXIOUS INDIVIDUALS
Chapter four investigates the neural underpinnings of emotion regulation in highly anxious 
individuals. We conducted a neuroimaging study on 136 individuals with elevated anxiety 
traits. Participants performed an emotion regulation task while being in the fMRI scanner 
and completed self-evaluation questionnaires on anxiety and emotion regulation strategies. 
A GLM-analysis including a regression with anxiety ratings was conducted in order to identify 
neural activation patterns during emotion regulation that are associated with anxiety traits. 
Moreover, a psychophysiological interaction analysis was conducted to detect functional 
connectivity patterns in this particular group. Results were associated with emotion 
regulation strategies by applying moderation analyses.
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Chapter five presents an online follow-up study on the same study population, investigating 
the effects of the Covid-19 pandemic on stress and anxiety and the role of efficient emotion 
regulation strategies. This study was conducted during the first wave of the Covid-19 
pandemic in the Netherlands in April 2020. Adaptive and maladaptive emotion regulation 
strategies had been evaluated before the outbreak of the pandemic. In a pseudo-prospective 
design, we investigated whether anxiety levels increased during the pandemic compared to 
the baseline measure collected before the outbreak of the pandemic. Moreover, we tested 
the predictive effect of emotion regulation strategies that had been established before the 
pandemic on anxiety and stress levels during the pandemic in a population characterized by 
high anxiety traits.
Chapter six summarizes and discusses the main findings of the preceding chapters. Limitations 
and open questions, as well as implications for future research are discussed. Furthermore, the 
general discussion highlights the clinical relevance of biomarker-based models in psychiatric 
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Increased amygdala responsiveness is the hallmark of fear and a characteristic across 
patients with anxiety disorders. The amygdala is embedded in a complex regulatory 
circuit. Multiple different mechanisms may elevate amygdala responsiveness and lead to 
occurrence of an anxiety disorder. While top-down control by the prefrontal cortex (PFC) 
downregulates amygdala responses, the locus coeruleus (LC) drives up amygdala activation 
via noradrenergic projections. This indicates that the same fearful phenotype may result 
from different neural mechanisms. We propose a mechanistic model that defines three 
different neural biomarkers causing amygdala hyper-responsiveness in patients with anxiety 
disorders: (a) inherent amygdala hypersensitivity (b) low prefrontal control, and (c) high 
LC drive. First-line treatment for anxiety disorders is exposure-based cognitive behavioural 
therapy (CBT), which strengthens PFC recruitment during emotion regulation and thus 
targets low prefrontal control. A treatment response rate around 50% (Loerinc et al., 2015) 
might indicate heterogeneity of underlying neurobiological mechanisms among patients, 
presumably leading to high variation in treatment benefit. Transforming insights from 
cognitive neuroscience into applicable clinical heuristics to categorize patients based on 
their underlying biomarker may support individualized treatment selection in psychiatry. 
We review literature on the three anxiety related mechanisms and present a mechanistic 
model, that may serve as a rational for pathology-based diagnostic and biomarker-guided 
treatment selection in psychiatry. 
Published as:
Brehl, A.K., Kohn, N., Schene, A., & Fernández, G. (2020). Review: A mechanistic model 
for individualised treatment of anxiety disorders based on predictive neural biomarkers. 
Psychological Medicine, 50(5), 727-736. 
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Introduction
Anxiety disorders are among the most common mental health problems. In the United States 
for instance, the lifetime prevalence to suffer from any anxiety disorder is 33.7% (Kessler et 
al., 2012). Unlike relatively mild and transient fear caused by threatening events or places, 
anxiety disorders are characterized by severe and persistent symptoms causing significant 
impairment in daily life functioning (Mendlowicz, 2000). If untreated, anxiety disorders tend 
to become chronic conditions (Fifer et al., 1994). 
In clinical practice, diagnosis of an anxiety disorder is based on clusters of symptoms rather 
than the underlying pathophysiology and potential individual neurobiological variation. First 
choice treatment for anxiety disorders is exposure-based cognitive behavioural therapy 
(CBT) (Bandelow et al., 2014; Courtois et al., 2017; National Collaborating Centre for Mental 
Health (Great Britain), 2013). However, the response rate of patients with various anxiety 
disorders for this initial treatment are in a range of 45 to 65% (Bandelow et al., 2014; Loerinc 
et al., 2015). There are certainly many reasons why treatment is non-effective in a substantial 
number of patients. Yet, heterogeneity of underlying neurobiological mechanisms among 
patients might cause substantial variation in treatment effects. Scientific understanding of 
underlying individual differences leading to heterogeneous therapy outcome is still limited. 
To increase treatment response, we may be in need of such a more personalized approach. 
So far, psychiatry still follows a symptom-based approach to classify patients. Moreover, 
research on neurobiological mechanisms of mental disorders has mainly focused on neural 
processes common to groups of affected individuals. A shift towards probing individual 
differences in pathology related neural processes is emerging. 
We need models to refine our understanding of the underlying working mechanisms of 
biomarkers in order to individualize treatment in psychiatry by adapting treatment to 
individual biological predispositions. Here we propose a neurobiology-based mechanistic 
model that might help to clarify some of the clinical heterogeneity among patients with 
anxiety disorders. The model may foster treatment selection tailored to the anxiety evoking 
neurobiological mechanism of the individual patient. 
Research demonstrated that anxiety is characterized by functional and structural alterations 
in cortical and subcortical areas that have been primarily related to amygdala hyperactivity 
(Etkin & Wager, 2007). We propose three potential mechanisms that all result in increased 
amygdala responsiveness; (a) inherent amygdala hypersensitivity, (b) low prefrontal control, 
and (c) high LC drive. There is ample evidence that local, for instance GABAergic mechanisms 
in the amygdala are critical for amygdala responsiveness (Braga et al., 2004). However, a 
considerable body of animal and patient related research points towards noradrenergic 
projections that drive amygdala hyper-responsiveness. Located in the brain stem, the 
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LC is the major noradrenaline source of the brain (Szabadi, 2013). During acute stress, 
noradrenaline is released by LC neurons and from there projected to almost the entire 
brain. Such projections to the amygdala enhance amygdala responsiveness (Hermans et al., 
2011), while high noradrenaline release to the prefrontal cortex (PFC) distracts attentional 
processes and working memory (Arnsten & Li, 2005; Sara, 2009). In contrast, inhibitory 
prefrontal regulation reduces amygdala responsiveness (Etkin et al., 2015; Etkin & Wager, 
2007; Kohn et al., 2014). Correspondingly, anxiety disorders have been associated with 
impaired prefrontal control (Etkin & Wager, 2007; Sylvester et al., 2012). 
Taken together, amygdala hyper-responsiveness is a neurobiological correlate of symptoms in 
anxiety disorders that results from imbalances in amygdala-centred regulatory mechanisms, 
where the PFC and LC are the core regulatory hubs. Alterations in one of those hubs lead 
to increased amygdala responsiveness and thus symptoms of anxiety.  Adapting treatment 
specifically to the altered regulatory mechanism might increase therapeutic effects. Since 
CBT has been shown to increase prefrontal control, patients with reduced prefrontal 
control may benefit most from CBT (Arnsten et al., 2015). Amygdala hyper-responsiveness 
without indication for reduced prefrontal control might be treated more efficiently with 
pharmacological options, like GABA-ergic drugs to downregulate intrinsic amygdala 
hypersensitivity, and α2 agonistic drugs targeting the noradrenergic system may reduce 
LC drive most effectively. Pharmacological studies in post-traumatic stress disorder (PTSD) 
revealed successful symptom reduction after regulating noradrenaline imbalances with α1-
receptor antagonists or α2A-receptor agonists (Arnsten et al., 2015; Detweiler et al., 2016). 
As a guideline for potential treatment selection, we outline a model that supports treatment 
selection based on the patient’s underlying anxiety evoking neurobiological mechanism. 
Such a relatively simple and highly pragmatic mechanistic model would allow to allocate 
patients based on their neurobiological disposition to the most beneficial, personalized 
treatment. In the first part, we lay out the three potential biomarkers of anxiety. In the 
second part we translate findings from cognitive and clinical neuroscience into biomarker-
based treatment selection hypotheses for clinical practice.
Biomarkers of anxiety
Amygdala hypersensitivity – Mechanism or symptom of anxiety?
Fear is a basic survival mechanism occurring in response to threat. It goes along with a 
well-orchestrated brain state allowing for appropriate adaptive behaviour. The amygdala 
is the central structure organizing this brain state (Bouret & Sara, 2005; LeDoux, 2003). 
Such adaptive fear response is associated with variation in amygdala activation(Phan et al., 
2004) and based on the cognitive appraisal of potential threat. The basolateral amygdala 
receives information about the outside world from the thalamus, the hippocampus and 
frontal cortex (Davis & Whalen, 2001). In order to adapt behavioural responses adequately, 
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information regarding positive or negative valence of sensory stimuli is (re)transmitted 
from the basolateral amygdala to diverse cortical regions, especially the midline and orbital 
prefrontal cortices, for further processing (Janak & Tye, 2015). 
Excessive and context inadequate fear response is the main characteristic of anxiety 
disorders. In humans, the basolateral amygdala has been shown to initiate active escape 
due to threat (Terburg et al., 2018). Imaging studies demonstrated increased amygdala and 
insula activity as a shared neuronal response to aversive stimuli across different anxiety 
disorders (Del Casale et al., 2012; Etkin & Wager, 2007; Fonzo et al., 2010, 2015; Kraus et al., 
2018; Linares et al., 2012; Shin & Liberzon, 2009).
At a neurobiological level, glutamate is the major excitatory neurotransmitter in the 
amygdala (Pape & Pare, 2010). Noradrenaline and GABA are neuro-modulators that affect 
this excitatory information transfer. Inhibitory GABA-interneurons gate the information 
flow between the basolateral amygdala and the central amygdala (Royer et al., 1999) 
and counterbalance excitatory action of glutamate (Lydiard, 2003), while noradrenaline 
suppresses GABAergic inhibition (Tully et al., 2007). Alterations in those modulators, like 
decreased GABA transmission and increased noradrenaline release enhance amygdala 
excitability (Davis et al., 1994). GABAergic inhibition by application of a GABA-A-receptor 
antagonist to the basolateral amygdala induced symptoms of anxiety in rats (Sanders & 
Shekhar, 1995). Accordingly, dysfunctional GABAergic inhibition was observed in patients 
with panic disorder (Ströhle et al., 2003). Binding at the GABA-A-receptor, benzodiazepines 
enhance GABAergic inhibition. Reduced binding sites for benzodiazepines have been 
demonstrated in patients with panic disorder and PTSD, indicating lower GABA transmission 
(Lydiard, 2003). This corresponds to a genotyping study revealing a linkage between 
panic disorder and specific candidate genes that define GABA A receptor characteristics 
(Hodges et al., 2014). Alternatively, reduced GABA transmission might result from increased 
noradrenaline levels in the amygdala, since noradrenaline suppresses GABAergic inhibition 
in the amygdala (Tully et al., 2007). Arousal evokes noradrenaline release from the LC (Tanaka 
et al., 2000). Excessive noradrenaline release from the LC to the basolateral amygdala as it 
may occur during stressful experiences, might disrupt GABA transmission and thereby cause 
increased excitability of the amygdala due to increased glutamate transfer. 
Beside this LC regulated circuit, the amygdala is also embedded in prefrontal regulatory 
circuits. Impairment of inhibitory frontal functions that support emotion regulation lead 
to elevated amygdala activation, also resulting in increased anxiety (Clausen et al., 2017; 
Linares et al., 2012; Shin & Liberzon, 2009)(Shin & Liberzon, 2009; Linares et al., 2012; 
Clausen et al., 2017). In the following, we review potential disruptions in those two major 
regulatory circuits in patients with anxiety disorders.
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The PFC-biomarker: Disrupted prefrontal regulation in anxiety
Different regions of the PFC are involved in distinct aspects of emotional processing related 
to anxiety. An early model by Philips (Phillips et al., 2003) suggested two distinct systems, a 
ventral and a dorsal one. Ventral regions of the anterior cingulate cortex (ACC) and PFC are 
involved in identification, evaluation of significance and production of affective states, while 
dorsal regions support effortful conscious emotion regulation (Phillips et al., 2003). Patients 
with anxiety disorder show altered activation levels in both systems, however the direction 
of activation changes differs between studies.
Processing threat-related information has been associated with increased prefrontal 
activation in patients with anxiety disorders compared to healthy controls. When exposed 
to emotional stimuli, patients with PTSD revealed increased activation in the dorsolateral 
and ventromedial PFC (Bruce et al., 2013). Similarly, in panic disorder, the anticipation of 
aversive sounds resulted in elevated activation in the amygdala, the ventromedial and 
ventrolateral PFC, as well as the dorsal ACC, dorsomedial and dorsolateral PFC (Brinkmann 
et al., 2017). In patients with generalized anxiety disorder, exposure to a narrative of threat-
related content versus neutral content evoked increased activation in the ventrolateral and 
dorsomedial PFC, amygdala, and thalamus relative to healthy controls, while activation in 
the ventromedial PFC and subgenual ACC was reduced relative to healthy controls (Buff et 
al., 2018). Social anxiety disorder was associated with increased activation in the amygdala, 
insula and the subgenual ACC in response to emotional faces (Ball et al., 2012; Labuschagne 
et al., 2012). Hence, the majority of studies reports elevated activation in ventral and dorsal 
portions of the PFC and ACC during perception and evaluation of emotional stimuli for 
patients with various types of anxiety disorders.   
In healthy subjects, consciously up- and down-regulating emotions induces activation in the 
dorsal PFC and ACC while amygdala activation increases or decreases in accordance with 
the regulatory goal (Morawetz, Bode, Baudewig, et al., 2017a). Reappraisal of a stimulus in 
order to downregulate a negative emotional response evokes increased activation levels in 
the dorsolateral PFC (Kohn et al., 2014; Ochsner & Gross, 2008; Stein et al., 2007). A recent 
meta-analysis on fMRI studies that applied an emotional reappraisal task in patients with 
PTSD and various anxiety disorders concluded that these patients reveal decreased activation 
in the dorsomedial PFC and dorsal ACC in comparison to healthy controls when trying to 
regulate their emotions (Wang et al., 2018). As opposed to merely processing emotional 
cues, which is associated with increased ventral and dorsal PFC activation in patients with 
anxiety disorders, recruitment of dorsal route areas (dorsolateral PFC, supplementary 
motor area, dorsal ACC) in contexts that require emotion regulation is decreased in patients 
compared to healthy controls, resulting in increased anxiety. 
Impaired PFC-amygdala communication is also reflected in altered functional PFC-amygdala 
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connectivity. Patients with anxiety disorders have been characterized by reduced resting 
state connectivity between amygdala and dorsolateral PFC, and right amygdala and 
ventrolateral PFC, respectively (Jung et al., 2018; Makovac et al., 2016). In contrast, in 
healthy individuals, exposure to stress enhanced functional coupling between amygdala 
and dorsal ACC in a resting state period following moderate psychological stress (van Marle 
et al., 2010). Negative coupling between the amygdala and dorsal ACC, pregenual ACC, and 
posterior cingulate cortex related to the amount of perceived threat (van Wingen et al., 
2011). Hence, the appraisal of a potential threat affects amygdala connectivity and might 
alter amygdala regulation thereafter. 
Taken together, increased amygdala sensitivity in anxiety disorders might either result from 
deficient PFC-based conscious regulatory processes, or stem from increased PFC excitability 
in response to the initial perception and evaluation of potentially threatening stimuli. Latter 
case might as well originate from elevation in noradrenaline transmission triggered by the 
LC during chronic phases of stress (Arnsten, 2009). High noradrenaline release to the PFC 
might potentiate overall excitability, intensifying the emotional affect and downregulate the 
executive control network which entails dorsal PFC regions involved in emotion regulation, 
while simultaneously increasing amygdala responsiveness (Hermans et al., 2014).
The LC-biomarker: Noradrenergic dysregulation in anxiety
Located in the pons, LC neurons are the major source of noradrenaline in the brain with 
monosynaptic connections throughout the entire central nervous system (Szabadi, 2013). 
Noradrenaline is a neuromodulator that shapes neural plasticity and firing properties 
of diverse neurons. Focusing on the amygdala as the most prominent anxiety-related 
structure, whole-cell recordings from amygdala slices demonstrated that noradrenaline 
release suppresses the inhibitory effect of GABAergic neurons and thereby increases the 
excitability of the amygdala (Tully et al., 2007). Accordingly, in the living rat, provoking 
increased noradrenaline transmission in the amygdala, hypothalamus and LC through 
administration of yohimbine, an α2-receptor antagonist, has been associated with anxiety 
symptoms in response to environmental stressors (Tanaka et al., 2000). This fear response 
might be specifically driven by noradrenergic projections from the LC to the amygdala. 
Earlier studies have shown that direct electrical or pharmacological stimulation of the LC in 
rats and mice induced fear (Bremner et al., 1996) while bilateral lesion of the LC reduced fear 
(Neophytou et al., 2001). In humans, administration of the noradrenaline-reuptake-inhibitor 
reboxetine elevates activation in the basolateral amygdala in response to fearful faces (Onur 
et al., 2009), while the noradrenergic antagonist propranolol reduces basolateral amygdala 
activation in response to fearful faces (Hurlemann et al., 2010). 
Interestingly, noradrenaline also affects a range of prefrontal processes. Selective activation 
of LC projections to the PFC in rats evokes anxiety-like behaviour and working memory 
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impairment (Hirschberg et al., 2017). While medium rates of noradrenaline support 
attentional processes, a lack of noradrenaline leads to inefficiency and an excess of 
noradrenaline causes hypervigilance (Arnsten, 2009).
 This non-linear effect following an inverted U-shape function might be based on the changing 
receptor preference of raising noradrenaline concentration. Blockade of α2-adrenergic 
receptors to the dorsolateral PFC leads to working memory deficits (Avery et al., 2013). While 
medium noradrenaline levels activate postsynaptic α2-adrenergic receptors and improve 
cognitive performance, high noradrenaline release stimulates postsynaptic α1-receptors in 
the PFC causing working memory impairment (Arnsten, 2000). 
Taken together, increased noradrenaline release from LC neurons elevates amygdala 
excitability and weakens dorsolateral PFC functions (Arnsten et al., 2015). Hence, top-
down control onto the amygdala might be disrupted while amygdala sensitivity is further 
strengthened via noradrenergic modulation of GABAergic processes. 
Anxiety symptoms in psychiatric patients are associated with overall increased noradrenaline 
transmission (Yamamoto et al., 2014). Patients with PTSD reveal elevated baseline levels of 
noradrenaline in the cerebrospinal fluid and exposure to trauma-related cues increase these 
levels even further (Geracioti et al., 2001; Strawn & Geracioti, 2008). It remains unclear if 
pre-traumatic elevated noradrenaline levels are causal in the vulnerability to develop PTSD 
or if elevated noradrenaline transmission results from the psychopathological state itself. 
Yet, imbalances in noradrenaline might stem from genetic predispositions. Panic disorder 
and increased anxiety traits were associated with reduced expression of SLC6A2, which 
regulates noradrenaline homeostasis (Hommers et al., 2018).
The α2-adrenergic receptor agonist clonidine diminishes noradrenaline release by activating 
inhibitory autoreceptors at presynaptic sites in the LC (Olson et al., 2011). Major therapeutic 
effects of clonidine are attained in treatment of hypertension, and during acute opioid 
withdrawal where it blocks elevated startle response (Gregoretti et al., 2009). Fewer binding 
sites for clonidine in patients with anxiety disorders indicate that a decreased amount of 
inhibitory autoreceptors might result in elevated noradrenaline levels and provoke anxiety 
(Cameron et al., 1990). Therapeutic effects of clonidine have been reported for symptoms 
like hyperarousal, hypervigilance, sleep disruption, and re-enactment (Arnsten et al., 2015; 
Detweiler et al., 2016). Hence, sensitization of the noradrenergic system might contribute to 
arousal symptoms associated with anxiety (Arnsten et al., 2015). However, in other studies 
clonidine infusion did not lead to symptom reduction (Hood et al., 2011; Kalk et al., 2012). 
Furthermore, the administration of the α2-receptor agonist guanfacine, which also activates 
presynaptic α2-receptors did not cause effective symptom reduction (Neylan et al., 2006). 
A MECHANISTIC MODEL FOR INDIVIDUALIZED TREATMENT 35
2
Variable results and differences in drug effects might stem from variation in the drug or 
might be based on heterogeneity in terms of underlying pathophysiology.
While α2-receptors are presynaptically involved in a negative feedback loop, downregulating 
noradrenaline release, α1-receptors are located postsynaptically. Anxiety-related symptoms 
have been treated successfully with prazosin, an α1-adrenergic receptor antagonist that 
blocks postsynaptic α1-receptors and reduces trauma-related nightmares and overall 
symptom severity (Keeshin et al., 2017; Peskind et al., 2003; Raskind et al., 2013; Taylor et 
al., 2006). However, drugs acting on neurotransmitter systems are not entirely selective for 
one receptor type. More trials are needed to clarify the therapeutic effect of manipulating 
noradrenaline transmission by targeting adrenergic receptors, also in combination with CBT 
based state of the art treatments 
Increased noradrenaline levels might reduce benefits from CBT. Increased pupil dilation in 
response to emotional faces was related to reduced treatment benefit from CBT in patients 
with social anxiety disorder (Kleberg et al., 2019). As noradrenaline is associated with pupil 
dilation, these findings might indirectly point to underlying imbalances in the noradrenaline 
system dampening the effect of CBT.
Considering the prominent role of noradrenaline in vigilance processes, it might be 
concluded that agents acting on the noradrenaline system lead to relief of a wide array of 
anxiety symptoms. Due to limited evidence, treatment of anxiety with agents interacting 
with noradrenergic receptors is no common clinical practice. Limited efficacy of agents 
acting on noradrenaline might be based on a missing general effect, since patients might 
differ regarding their pathophysiological mechanism. In the broader framework of this 
model, divergent findings might point out the overall heterogeneity of underlying pathology 
among patients. 
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Taken together, we suggest that the biological origin of amygdala hyper-responsiveness 
might be based on imbalances in amygdala-centred regulatory mechanisms, consisting of 
three core regulatory hubs (biomarkers) that might upregulate amygdala responsiveness. 
The amygdala-biomarker is defined by disruption of GABA-based inhibitory processes within 
the amygdala. The PFC-biomarker is characterized by reduced recruitment of inhibitory top-
down projections. The LC-biomarker is based on increased noradrenaline release from the 
LC, which drives up amygdala activation by disrupting GABA-ergic inhibition and intensifies 
emotion processing by amplifying attentional processes. Yet, those three biomarkers form 
an amygdala-centred network and manifestations in one biomarker might affect the other 
mechanisms driving the network. 
Finding the right match: Biomarker guided treatment of anxiety
We propose inherent amygdala hypersensitivity or alterations in amygdala-centred regulatory 
circuits (reduced dorsal PFC recruitment during emotion regulation and increased LC-drive 
during stress) all lead to the same fearful phenotype. Although the three mechanisms might 
be interconnected, and targeting one mechanism would affect amygdala responsiveness 
either way, we propose that individualized treatment selection that specifically targets the 
causative neural biomarker in a given patient would increase treatment efficiency. Targeting 
the causative biomarker would treat an anxiety disorder at its core mechanism and would 
Figure 1: The 3-Biomarker model
(A) Despite high PFC control, increased amygdala (AMG) response occurs due to inherent amygdala hypersensitivity. 
(B) A lack of emotion regulation is based on low PFC control, which results in increased amygdala responsiveness. 
(C) Elevated noradrenaline release due to high LC drive leads to increased amygdala responsiveness and distraction 
in cortical processes involved in emotion processing.
A B C
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allow patients to be allocated to a treatment according of the biological origin of their 
anxiety. This might reduce expensive and time-consuming detours in treatment procedures. 
Importantly, this section aims to give an outlook on the potential impact of biomarker 
characterization on clinical practise. Deriving treatment guidelines from biomarkers is still a 
matter of research and this work intends to stimulate future studies on biomarkers with a 
focus on treatment implications.  
Targeting amygdala hypersensitivity
In this model, we assume that patients with amygdala hypersensitivity experience symptoms 
of anxiety despite being capable of appropriate cognitive emotion regulation strategies. 
This might indicate that cognitive therapy does not target amygdala hypersensitivity. As 
discussed above, disruption of GABA-ergic inhibition might be the underlying neurobiological 
mechanism of amygdala hypersensitivity. To specifically target disruption of GABA-ergic 
inhibition, treatment with benzodiazepines might be indicated. Benzodiazepines enhance 
GABA-ergic inhibition and have been demonstrated as effective treatment, preferably as 
short-term treatment for patients with anxiety symptoms that have not responded to other 
treatments (Baldwin et al., 2005). 
Considering the burden of side effects and issues of sustained success, psychotherapeutic 
treatment might be an alternative. Yet, it remains unclear if any psychotherapeutic 
treatment is less effective in patients with amygdala hypersensitivity as compared to patients 
having impaired prefrontal control. Potentially, patients with predominant amygdala 
hypersensitivity might show more physiological symptoms of anxiety and those tend to 
become the object of fear. Interoceptive exposure to reappraise physiological symptoms has 
been demonstrated to diminish efficiently symptoms of anxiety (Holtz et al., 2019). Similarly, 
mindfulness-based interventions train a detached observational state that might attenuate 
negative emotions and have been demonstrated to reach clinical improvement in patients 
with anxiety disorders (Goldin & Gross, 2010). On the neural level, mindfulness training has 
been shown to decrease amygdala responses during emotional processing (Taylor et al., 
2011). 
Prefrontal engagement in emotion processing vs. emotion regulation predicts 
exposure-based CBT outcome
Within the framework of the proposed model, a lack of prefrontal recruitment during 
emotion regulation is classified as a PFC-biomarker. We assume that patients with a PFC-
biomarker have a higher benefit from exposure-based CBT than patients with a different 
biomarker, since exposure-based CBT specifically increases PFC recruitment during emotion 
regulation (Goldin et al., 2013).
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So far, therapy outcome has not been evaluated after stratification of patients based on 
different biomarkers prior to treatment. Yet, studies report post-hoc predictions of treatment 
benefit based on PFC recruitment during emotion regulation and emotion perception before 
exposure-based CBT. 
In patients with social anxiety disorder, reduced dorsolateral PFC activation during emotional 
reappraisal prior to treatment predicted better treatment outcome of CBT (Klumpp et al., 
2017b). Also in a sample of patients with various anxiety disorders and major depression, 
reduced ACC response to an emotion regulation task and increased ACC activation during 
a threat interference paradigm defined treatment responders (Klumpp et al., 2017a). The 
underlying cognitive process triggered by the experimental paradigm might define the 
direction of activation predicting treatment response. Hence, decreased activation during 
emotion regulation and increased activation during emotional processing were associated 
with better treatment response. Sorting studies based on the experimental paradigm, it 
appears that studies that applied paradigms that tap into emotional processing without the 
attempt of emotion regulation report increased PFC recruitment as predictor for treatment 
response. Patients with PTSD that initially showed greater engagement of dorsolateral 
PFC, dorsal ACC, and left amygdala during an emotional reactivity task, experienced 
more symptom reduction after exposure therapy, while greater baseline activation of the 
ventromedial PFC as well as ventral striatal activation during an emotional conflict task 
was associated with better treatment outcome from exposure therapy (Fonzo et al., 2017). 
Similarly, in patients with social anxiety disorder, greater activation of the pregenual ACC, 
ventromedial PFC/middle frontal gyrus, and left amygdala in response to social rejection 
cues was associated with higher symptom reduction after exposure (Burklund et al., 2017). 
Prior enhanced dorsal ACC and dorsomedial PFC activation in response to emotional faces 
was also associated with better outcome from exposure therapy in social anxiety disorder 
(Klumpp et al., 2014).
Hence, initially increased prefrontal activation during emotional processing might be 
associated with a more salient discrimination between threatening and non-threatening 
stimuli, which facilitates symptom reduction during exposure therapy. Activation of the 
dorsal ACC and the amygdala predicted treatment outcome of internet-based CBT with 
an accuracy of 92% (Månsson et al., 2015). Moreover, patients with PTSD that revealed 
enhanced amygdala and right ventral ACC activation during non-conscious threat processing 
showed poor treatment response, indicating that excessive amygdala response might as well 
hinder treatment success (Bryant et al., 2008). Despite heterogeneous results, a systematic 
review on biomarkers predicting treatment outcome in anxiety disorders reports increased 
dorsal ACC and ACC-amygdala interaction related to threat processing as a predictor for 
exposure-treatment response (Lueken et al., 2016).
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Overall, two lines of argumentation can be inferred. Initially decreased prefrontal recruitment 
during regulatory processes might predict higher treatment benefit, since decreased 
prefrontal engagement can be balanced by exposure-based CBT where regulatory strategies 
are trained. Exposure-based CBT directly affects prefrontal activation in patients with social 
anxiety disorder, also increased dorsolateral as well as dorsomedial PFC activation, and 
strengthened inverse dorsomedial PFC-amygdala connectivity during an emotion regulation 
task (Goldin et al., 2013). Furthermore, exposure treatment led to enhanced amygdala-
ventromedial PFC connectivity during an affect-labelling task, while symptom reduction was 
associated with more negative amygdala-ventromedial PFC connectivity (Young et al., 2017). 
Hence, exposure therapy might balance prior deficiencies in regulatory areas. In contrast, 
elevated activation during emotion processing before treatment might as well relate 
to treatment response. Patients who initially recruit prefrontal resources for emotional 
processing seem to benefit from a therapy form that reinforces distinction between threat-
related and safe stimuli. 
The precise characterization of a PFC-biomarker remains challenging. More refined 
localization of cortical regions is restricted by heterogeneous functional labels of anatomical 
locations across studies. A precise distinction between the triggered cognitive processes 
might be a first step towards clarification. Studies applied various paradigms that either trigger 
emotion perception, conscious emotion regulation, or presumably tap into both processes. 
Furthermore, model-based approaches restricting the analysis to predefined regions of 
interest eventually lead to different results than if predictive regions are derived from whole 
brain analyses. The diverse outcome might as well reflect neurobiological heterogeneity 
among patients. Study populations have been too restricted in size to identify predictive 
effects due to potential heterogeneity of underlying biomarkers. Hence, studies that report 
increased PFC activation in patients with anxiety disorders might either tap into emotion 
processing instead of regulatory processes, or indicate a different underlying biomarker. 
Within the framework of the proposed biomarker model we suggest that increased PFC 
activation during emotion processing might stem from increased noradrenaline release 
from the LC to prefrontal regions in response to threat. Increased noradrenaline influx to 
the PFC would elevate PFC activation. While intermediate levels of noradrenaline allow 
optimal PFC control, increased noradrenaline levels harm PFC efficiency by exceeding the 
optimal activation level (Arnsten, 2009). In case of increased noradrenaline levels being 
the primary cause of elevated PFC activation, treatment might be supported by targeting 
the noradrenergic system. Hence, a patient with increased PFC recruitment during threat 
should be tested for increased LC-drive in order to eventually increase treatment efficiency 
by administration of noradrenaline antagonists.
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Treatment of noradrenergic hyperfunction
We suggest increased LC-drive as another biomarker of anxiety disorders. Controlling for 
altered noradrenergic release from the LC might reveal if increased PFC activation originates 
from increased LC drive, and thus would be treated more effectively by targeting noradrenergic 
hyperfunction.
In monkeys, increased tonic LC activation disrupts prefrontal processes related to attention 
as it led to weaker performance in a discrimination task (Aston-Jones et al., 1999). This 
might implicate that in humans, the evaluation of an emotional cue might be disturbed by 
increased tonic LC activation. Also, increased LC activation induces physiological symptoms 
of stress, which might bias the evaluation of the outside world as being more threatening. 
Patch-clamp recordings  in rats have shown that LC cells that are projecting to the medial 
PFC have a lower excitation threshold than LC neurons projecting to other cortical areas, like 
the motor cortex (Chandler et al., 2014). Thus, increased LC activation might have a stronger 
impact on cognitive processes that involve the medial PFC. Transferring these findings to 
emotion processing in humans, high LC drive might maintain increased PFC activation 
during emotion processing making effective emotion regulation more difficult. Emotion 
regulation is trained in exposure-based CBT and hence, high LC drive might interfere and 
reduce treatment effects. Although increased noradrenaline transmission (indirectly 
measured via noradrenaline concentration in CSF samples) has been reported for patients 
with PTSD  (Geracioti et al., 2001; Strawn & Geracioti, 2008), and effective treatment with 
noradrenaline antagonists has been demonstrated (Raskind et al., 2013; Taylor et al., 2006), 
there are to our knowledge no studies investigating the predictive value of measuring 
initial noradrenaline levels on treatment outcome of exposure therapy, or pharmacological 
approaches that target the noradrenergic system. 
Figure 2: 
Biomarker characterization in patients with anxiety disorders based on the three potential mechanisms of anxiety; 
amygdala hypersensitivity, low PFC control, and high LC drive may provide a heuristic for pathology-guided 
treatment selection. Inherent amygdala hypersensitivity indicates treatment with GABA-based medications like 
benzodiazepines, low PFC control can be treated by exposure interventions, and high LC drive might be targeted 
by noradrenergic agents.
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Considering the prominent effect of noradrenaline on physiological symptoms of anxiety, 
psychotherapeutic approaches that rather focus on physiological symptoms and cognitive 
distraction like attention deficits and working memory impairment might be a more 
sustainable alternative for patients with increased LC drive. Tonic firing of the LC is present 
during high arousal, and associated with mind wandering. Mindfulness-based programs 
train attention, reduce mind-wandering and might decrease tonic LC-firing (Russell & 
Arcuri, 2015). However, a potential direct effect of mindfulness techniques on noradrenaline 
release has not been investigated yet. Prospective studies are necessary to investigate the 
potential link between noradrenaline and mind-wandering.
Outlook 
Biomarker characterization based on neuroimaging data
Specifying predictive biomarkers requires large cohort studies that allow stratification of 
patients based on the activity of their anxiety evoking neural mechanism. We propose an 
fMRI-based study design combining and integrating three behavioural tasks that trigger 
activation in the three regions of interest. A supervised classification and clustering 
approach based on activity within and the dynamic interaction between the core hubs of 
the amygdala-centred regulatory mechanisms might be used to stratify a highly anxious 
population into three mechanistically defined clusters of individuals (a) amygdala sensitivity, 
(b) low PFC-control, and (c) high LC-drive. An emotion regulation task could be applied to 
Figure 3: 
Based on the model, all three biomarkers reveal increased amygdala (AMG) activation. For patients with amygdala 
hypersensitivity (AMG biomarker) increased AMG activation is the key feature, while PFC and LC activation are not 
deviating in this biomarker. The PFC biomarker is characterized by low PFC activation. Patients with an LC biomarker 
would express increased LC activation as a key feature, while PFC activation might increase due to regulatory 
attempts of the PFC. Yet, high noradrenaline release form the LC to the PFC might upregulate PFC activation, 
causing to exceed the optimal activation level of the PFC.
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monitor activation in the PFC during regulatory attempts (Ochsner et al., 2002). Amygdala 
reactivity could be monitored by applying a face recognition task (Hariri et al., 2000). 
Salience processing (i.e. an oddball task) in combination with a threat-of-shock paradigm 
could monitor LC activation (Hermans et al., 2011). Manipulation of alertness by applying a 
threat of shock paradigm would indirectly manipulate the level of phasic LC activation, while 
an oddball task would trigger tonic activation. This approach would allow defining a neural 
profile for each biomarker. Based on correspondence of the neural profile of a patient, the 
primary biomarker could then be determined (figure 3).
Alternatively, stratification on functional connectivity data during resting state scans might 
be another avenue to take. A PFC biomarker would be characterized by reduced resting state 
connectivity between amygdala and dorsolateral PFC, and right amygdala and ventrolateral 
PFC, respectively (Jung et al., 2018; Makovac et al., 2016). LC activation could be measured 
by a neuromelanin scan (Sasaki et al., 2006), and the amygdala biomarker might be present 
in cases that neither reveal reduced amygdala-PFC connectivity nor increased LC activation.
A selected array of physiological measure that are known to be related to the three regions 
of interest might help to distinct the three biomarkers. Pupil dilation is a reliable proxy 
for LC hyperactivity (Gilzenrat et al., 2010). Heart rate has been associated with increased 
prefrontal activation and efficacy of emotion regulation processes (Makovac et al., 2017; 
Thayer & Lane, 2000). Characterizing patients along additional physiological measures 
might be of advantage, as secondary effects of a biomarker mechanism on the other two 
mechanisms would be less pronounced potentially on the secondary physiological readouts. 
Predictive biomarkers in clinical practice 
Defining a biomarker in individual patients might allow personalized therapy selection 
tailored to the individual neural disposition of a given patient. Studies are needed that 
evaluate therapy induced activation changes during emotion processing and emotion 
regulation separately and evaluate, if exposure-based CBT balances initial alterations of 
activation during those processes. The predictive value of prefrontal control regarding 
treatment success of exposure therapy might be clarified by considering noradrenaline 
transmission as a second factor. Increased noradrenaline release to the PFC, specifically to 
regions underlying emotion processing, might prevent therapy-induced reduction of initially 
increased activation levels and therefore predict reduced benefit from CBT. Thus, in a case 
of increased noradrenaline (LC-biomarker) the model rather supports an intervention that 
downregulates LC drive. However, it is unknown if decreased PFC activation causes increased 
noradrenaline levels. The existence of a potential association between decreased PFC 
control and increased noradrenaline levels would need to be clarified in order to establish a 
reliable noradrenaline-based predictor for CBT outcome. Furthermore, the LC might not be 
a homogenous modulator of PFC activation but might have a stronger effect on medial as 
compared to other frontal areas (Chandler et al., 2014).
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Limitations
The proposed model is highly simplified and only considers three biomarkers as origin 
of increased amygdala response. Animal studies attribute a crucial role to dopamine and 
serotonin regarding extinction learning, which potentially might have predictive value as 
well (Singewald et al., 2015). Furthermore, this model is focussed on neural mechanistic 
interactions of three neural mechanisms. It is to be expected that a combination of genetic 
and environmental factors are causing these deficits, but the exact contributions of genetic 
variance and factors like experience and learning history are currently unknown. Proposed 
treatment indications are based on the assumption that targeting the causative biomarker 
might be more efficient. There is no direct evidence yet that biomarker-targeted treatment 
would increase treatment benefit in the context at issue.  To provide a heuristic model for 
treatment selection, measurements need to be clinically feasible and thus, individualized. 
A neuroimaging-based biomarker characterization might not be clinically feasible; however, 
reliable indirect physiological measurements as proxies for neural mechanisms as well as 
reference frames to categorize patients based on those are still a matter of research.
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Abstract
Background: Imaging studies demonstrated increased amygdala reactivity is a neural 
correlate of anxiety disorders. Alternatively, anxiety might stem from reduced regulatory 
control of the emotion regulation network (ERN) onto the amygdala. We applied multivariate 
clustering to stratify highly anxious individuals based on their neural activation profile in the 
amygdala and the ERN.  
Methods: BOLD activation in the bilateral amygdala and the ERN was recorded in a 
subclinical population of 217 individuals oversampled for high anxiety traits (n = 172; HADS 
> 7). To stimulate the two regions of interest, participants performed a face-matching task, 
an emotion regulation task, and an oddball task combined with a threat-of-shock paradigm 
in the MRI scanner. To detect biological subgroups, we implemented a 12-dimensional 
Gaussian mixture model of median BOLD activation of experimental and control conditions 
of all three tasks in the two regions of interest. For further physiological characterization, we 
simultaneously recorded pupil dilation.
Results: Gaussian mixture modeling indicated three different neural activation profiles 
within the population. External validation revealed significant differences in pupil dilation; 
different neural activation profiles were associated with different characteristics in arousal 
as indicated by differential pupil dilation in responses to threat.
Conclusions: We demonstrated that an fMRI-based clustering approach identifies neural 
heterogeneity that cannot be detected by state-of-the-art group analyses. This base work 
might serve as a reference for new data, enabling single subject stratification. Multivariate 
clustering approaches to detect individual neural differences underlying of clinical conditions 
might pave the way towards biomarker-based stratification in psychiatry. 
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Introduction
A symptom can have many different causes. Yet, to this day, patients in psychiatry 
are diagnosed based mainly on symptomatology with little consideration of related 
neurobiological mechanisms. Scientific understanding of individual differences in 
neurobiological mechanisms underlying the same psychopathology is still limited. So far, 
neuroimaging studies have focused on neural characteristics of affected groups diagnosed 
based on symptom levels relative to healthy controls. Such case-control studies might 
obscure potential diversity within the affected group and fail to differentiate neurobiological 
mechanisms leading to the same pathology. In the present study, we applied a novel 
analytical approach that aims to create groups of affected individuals based on different 
neurobiological characteristics rather than symptoms, in our case anxiety symptoms. 
Research revealed at least three potential neurobiological mechanisms related to anxiety. 
Most notably, amygdala hypersensitivity has persistently been reported as a neurobiological 
correlate of anxiety (Del Casale et al., 2012; Etkin & Wager, 2007; Fonzo et al., 2010, 2015; 
Kraus et al., 2018; Linares et al., 2012; Shin & Liberzon, 2009). Alternatively, increased 
amygdala responsiveness might stem from imbalances within the emotion regulation network 
(ERN): Conscious down-regulation of emotions is associated with increased activation in the 
dorsolateral prefrontal cortex (PFC) leading to a decrease in amygdala activation (Kohn et 
al., 2014; Morawetz, Bode, Baudewig, et al., 2017a). Reduced dorsomedial PFC engagement 
during emotion regulation leads to inefficient top-down control onto the amygdala in 
patients with various anxiety disorders  (Wang et al., 2018). In contrast, patients with PTSD 
and panic disorder revealed increased activation in dorsal and ventral portions of the PFC 
and anterior cingulate cortex (ACC) in response to aversive stimuli, presumably reflecting 
increased emotion processing which precedes regulatory attempts (Brinkmann et al., 2017; 
Bruce et al., 2013). 
A third  stream of research points towards increased noradrenaline transmission as a key 
mechanism of anxiety (Kalk et al., 2011; Yamamoto et al., 2014). Located in the pons, the 
locus coeruleus (LC) projects noradrenaline across the entire brain modulating the state 
of alertness (Szabadi, 2013).  Increased noradrenaline release from LC neurons elevates 
amygdala and prefrontal excitability leading to hypervigilance and spatial working memory 
deficits (for review: Arnsten, 2009; Arnsten et al., 2015; Avery et al., 2013). 
We recently presented an integrated biomarker model, proposing amygdala hypersensitivity, 
decreased prefrontal control, and high LC drive as three potential neural biomarkers related 
to the same anxious phenotype (Brehl et al., 2020). In the present study, we applied three 
behavioural tasks during an fMRI scan to probe those three proposed mechanisms in a large 
group of highly anxious individuals. Amygdala reactivity was monitored by applying a face-
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matching task (Hariri et al., 2000), ERN involvement was tested with an emotion regulation 
task (Ochsner et al., 2002), and LC activation was modulated applying a salience task (oddball 
task) while manipulating the state of alertness with a threat of shock paradigm (Hermans et 
al., 2011). Finally, we recorded pupil dilation as a physiological indicator of alertness and a 
proxy for LC activation (Boucsein, 2000, p.279; Gilzenrat et al., 2010; Yoss et al., 1970).
Averaged BOLD signal of the two regions of interest (ROIs), the amygdala and the ERN were 
integrated into a Gaussian mixture clustering approach to stratify highly anxious individuals based 
on the activation and interplay of their anxiety-evoking neural mechanisms. For subsequent 
validation, we tested the resulting subgroups on physiological differences in their stress response 
reflected in pupil dilation (as previously implemented by Henckens et al., 2009).
Methods
Study population
We recruited our subjects between November 2017 and January 2020 based on an online 
screening, consisting of the Hospital-Anxiety-and-Depression-Scale (HADS, Zigmond & 
Snaith, 1983), demographical data, and screening for MRI-compatibility (conducted on 
www.soscisurvey.de). The screening was advertised on Radboud University websites and 
announced in university lectures. The HADS evaluates anxiety and depression and is a valid 
tool to investigate variance of trait anxiety in a healthy population (Breeman et al., 2015). 
To oversample for high trait anxiety, we invited all individuals with elevated scores (>7) on 
the HADS anxiety-subscale (HADS-A), while individuals with normal scores (HADS-A ≤7) 
were selected for study participation based on a 25%-probability. Of 2206 subjects that 
completed the screening, 486 potential participants received a study invitation for our 
study on neural biomarkers of anxiety. In the case of HADS-A scores > 15, presumably 
indicating clinical levels of anxiety, a structured interview (DSM-IV-based M.I.N.I) (van Vliet 
& de Beurs, 2007) was conducted with the study psychologist (AKB). Of the 245 subjects 
that agreed to participate in our fMRI study, one subject was excluded due to a suspected 
psychiatric diagnosis to ensure an at-risk, but healthy study population. Further, 27 subjects 
were excluded because of reduced data quality, incidental findings, falling asleep during 
the fMRI session, or incomplete data collection due to premature termination. In total 217 
participants (67 males, 150 females, mean age 22.7 (SD: 4.66)) successfully completed the 
test session including fMRI, continuous pupil dilation measurements, and questionnaires. 
The majority of our subjects were university students with elevated HADS-A scores; 172 
participants had a HADS-A score of > 7(42 males, 130 females), and 45 participants had a 
HADS-A score ≤ 7 (15 males, 30 females). This study was approved by the regional ethics 
committee (commissie mensgebonden onderzoek (CMO)) of the Radboudumc in Nijmegen/ 
The Netherlands (CMO 2017/3588).
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Questionnaires
Right after the fMRI scan, participants completed a questionnaire battery assessing anxiety, 
depression, personality traits, and emotion regulation strategies. For the present study, 
trait and state anxiety were evaluated on the HADS and the state-trait-anxiety-index (STAI) 
(Spielberger et al., 1983) (for details see supplementary material). 
fMRI procedure
Three tasks were applied during the fMRI scan; a face-matching task (Hariri et al., 2000), an 
emotion regulation task adapted from previous studies on emotion regulation (Kanske et al., 
2015), and an oddball task (Collin et al., 2014) which was combined with a threat-of-shock-
paradigm (for a detailed description of all tasks see supplementary material). In short, the 
face-matching task was conducted to evoke amygdala activation (Hariri et al., 2002). Angry or 
anxious faces were  presented on the screen (three at a time) and participants were  asked 
to match faces that show the same emotional expression. In the control condition, three 
geometrical shapes have to be matched for spatial orientation. To activate the prefrontal 
emotion regulation network, we applied a cognitive emotion regulation task. Participants were 
shown 40 neutral and negative emotional pictures and were instructed to either just view 
the pictures or view and downregulate their emotional response to a picture by reappraising 
the presented scene. After each picture, participants rated their current emotional state and 
arousal. Finally, an oddball task combined with a threat of shock paradigm was conducted 
aiming to modulate the state of arousal. Participants were asked to respond by button press 
to a target stimulus (oddball stimulus) presented in the centre of the screen. Target and 
non-target stimuli were either presented within a green or red frame indicating an unsafe 
or safe phase. During an unsafe phase (threat condition), participants were at risk to receive 
an electric stimulation to their left palm. By alternating between safe and unsafe blocks, we 
manipulated the level of arousal. All participants completed the face-matching task at first. 
The order of the two subsequent tasks was randomized to minimize order effects. In-between 
the second and third tasks, a high-resolution T1-weighted anatomical brain scan was recorded. 
After completion of all three tasks, a resting state scan of seven minutes was conducted.
fMRI data acquisition and analysis
Structural and functional multiband 4 sequences (slice number = 68, TR = 1500ms, TE = 
39.6ms, flip angle = 75°, voxel size = 2x2x2mm3, slice gap = 0mm, FOV = 210mm) were 
acquired on a 3T Magnetom PrismaFit MRI Scanner (Siemens AG, Healthcare Sector, 
Erlangen, Germany) using a 32-channel head coil. For anatomical reference, we obtained 
a high-resolution T1-weighted image (slice number = 192, TR = 2300ms, TE = 3.03ms, flip 
angle = 8°, voxel size = 1x1x1 mm3, FOV = 256x256x192mm3, base resolution = 256, sagittal 
acquisition). Data preprocessing was based on the preprocessing pipeline of fMRIPrep 
version 1.4.1 (Esteban et al., 2019). BOLD reference was unwarped using field map based 
estimation of susceptibility distortions in the B0-field.
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Unwarped BOLD reference was co-registered to the T1-weighted reference using boundary-
based registration (9 degrees of freedom). To correct for head motion and B0-distortions, 
we resampled the BOLD time series onto native space and then normalized it to MNI-space 
(MNI152NLin6Asym). Spatial smoothing was performed using a 6mm full-width at half 
maximum (FWHM) Gaussian kernel and application of a high-pass filter (>100s) to reduce 
inter-subject variability. Brain extraction was performed based on the binarized whole-
brain mask provided by fMRIPrep. The following preprocessing steps were performed in 
FSL version 6.0.1 (FMRIB Software Library, University of Oxford, UK; www.fmrib.ox.ac.uk/
fsl; Jenkinson et al., 2012). Motion artefacts were removed applying ICA-AROMA forcing a 
maximum of 150 components (Pruim et al., 2015). In the last step, nuisance regression was 
applied with the time series extracted from cerebrospinal fluid and white matter probability 
masks (98% probability thresholded and binarized). 
For all task conditions, the median BOLD signal was extracted for our two regions of interest 
(ROI). We retrieved the median BOLD signal of the amygdala based on the anatomical 
bilateral amygdala mask from the Juelich Histological Atlas at a probability of .7 (Amunts et 
al., 2020).  For extracting the prefrontal ROI, we created a prefrontal mask of regions of the 
ERN by PFC parcellation using time courses of instantaneous connectivity during the resting 
state scan to subdivide the entire PFC into functionally connected sub-regions (van Oort et 
al., 2018). A detailed description of the task designs and instructions, data acquisition, data 
processing, ROI extraction, and group analysis is provided in the supplementary material. 
Pupil dilation recording
Pupil dilation of the left eye was recorded continuously throughout the whole fMRI scan. For 
the present study, we only analysed pupil dilation recorded during the oddball task as pupil 
dilation has been demonstrated to be a reliable physiological proxy for the noradrenergic 
activity of the LC (Aston-Jones & Cohen, 2005; Gilzenrat et al., 2010) and the modified 
oddball task was designed to modulate LC activity. For each task condition of the oddball 
task, mean dilation values were calculated, resulting in four mean values per individual; 
mean pupil dilation during the threat blocks for targets (1) and non-targets (2), and mean 
pupil dilation during the safe blocks for targets (3) and non-targets (4). A detailed description 
of eye-tracking recording and processing is provided in the supplementary material.
Cluster analysis: Gaussian mixture modeling
To identify differences in neural activation between potential subgroups in the study 
population, we performed a cluster analysis by feeding the median BOLD activation of 
(1) the bilateral amygdala and (2) the ERN into a Gaussian mixture model (Scrucca et al., 
2016). For both ROIs, median activation values of six task conditions were included; (1) the 
emotion condition and (2) control condition of the face-matching task, (3) the negative view 
condition, and (4) the reappraisal condition of the emotion regulation task, as well as (5) the 
threat and (6) safe condition of the oddball task. 
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In contrast to other clustering approaches like principal component analysis or k-means 
models, Gaussian mixture models are probabilistic models based on the assumption that a 
population can be divided into a finite number of normally distributed subgroups. Gaussian 
mixture modeling allows dividing a dataset into clusters of different orientations, shapes, 
and sizes. Furthermore, instead of strict cluster assignments, Gaussian mixture modeling 
calculates an estimate for each data point (in this case; each individual in a study population) 
to belong to a given cluster k. 
Multivariate Gaussian mixture modeling was performed in RStudio (version 1.2.1335)
(RStudio Team, 2019, http://www.rstudio.com) applying the mclust package (version 
5.4.7) (Scrucca et al., 2016). The mclust package provides 14 Gaussian mixture models 
characterized by cluster shape, size, and orientation. Each cluster parameter can be set to 
equal or variable across all clusters. Implementing an iterative expectation-maximization 
(EM) algorithm for Gaussian mixture models yields the optimal setting of those model 
parameters and the optimal number of clusters. The EM algorithm calculates the probability 
for each data point to originate from each possible Gaussian mixture and determines the 
model parameter setting with the highest likelihood. The Bayesian Information Criterion 
(BIC) represents the maximized log-likelihood as an indication for the optimal number of 
clusters and model parameter setting. Optimizing the number of clusters decreases the BIC 
towards zero.
Physiology-based model validation
To validate the cluster solution resulting from Gaussian mixture modeling, we chose the 
independent physiological parameter (pupil dilation) that had not been included in the 
modeling process. Gaussian mixture modeling provided three estimates for each subject to 
belong to a certain cluster. We divided the population into three subgroups based on the 
highest estimate of a given subject. Conducting a MANOVA, we tested for group differences 
in pupil dilation in the four task conditions of the oddball task to determine if the subgroups 
that had been formed based on their neural activation profile also differed on another 
physiological parameter. 
Results
Oversampling for elevated anxiety traits 
Figure 1 displays the distribution of trait anxiety (HADS-A subscale) in the screened 
population and the study population. The study population consisted of 73 participants 
with low anxiety (HADS-A ≤ 7) and 144 participants with mild to severe anxiety (HADS-A > 
7). There was no significant difference between females (mean = 9.25, sd = 3.31) and males 
(mean = 8.66, sd = 3.52) regarding their level of anxiety on the HADS-A, t(215) = -1.13, p = 
0.258, Welch’s t(1) = 1.108, p = 0.273.
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Threat-induced changes in pupil dilation
After preprocessing and outlier removal, 211 pupil dilation datasets were included in the 
analysis. Comparing the mean pupil dilation for the factors threat – safety context and 
oddball (target) - standard (non-target) stimulus indicated that the task manipulation 
regarding threat – safety context had been effective: A repeated measure two-way ANOVA 
revealed a significant effect of threat induction, F(210) = 413.396, p < .001, and an effect of 
stimulus type (target vs non-target), F(210) = 4.443, p = .036, but no interaction between the 
factors of threat induction and stimulus type, F(210) = 2.018, p = .157. 
Response accuracy was positively correlated with the difference in pupil dilation between 
targets and non-targets in the threat condition, r = .191, p = .007, as well as in the safe 
condition, r = .283, p < .001, proposing difference in pupil dilation as a physiological proxy 
for successful stimulus differentiation. 
Task-related neural activation 
Median activation extracted from the ERN (including a bilateral ventrolateral, a bilateral 
dorsomedial, and right dorsolateral cluster) and the bilateral amygdala are reported in table 1 
(for more information on the extracted ROIs, see supplementary material). 
Cluster analysis: Gaussian mixture modeling
Gaussian mixture modeling with mclust provides the three best-fitting Gaussian mixture models 
verified by the Bayesian Information Criterion (BIC). The expectation-maximization algorithm 
implemented in the mclust function provides an overview of the three best models with the 
optimal number of clusters. Optimal model selection leads to minimization of the BIC. Including 
the 12 median activation values (three tasks x two conditions x two regions of interest) as 
Figure 1: 
Distribution of trait anxiety (HADS-A) in the screening population and the selected study population. HADS-A 
scores ≤ 7 correspond to normal levels of anxiety, scores of 8 to 10 indicate mild anxiety, scores of 11 to 15 
indicate moderate anxiety and scores of ≥ 16 indicate severe anxiety. A: Distribution of anxiety scores in the 
online screening; mean = 6.61 sd = 3.89. B: Distribution of anxiety in the selected study population; mean = 8.88, 
sd = 3.78. Skewness to the right indicates the oversampling for elevated anxiety traits.
A B
NEURAL DIVERSITY IN THE ANXIOUS PHENOTYPE 53
3
parameters to construct a Gaussian mixture model, the BIC indicated a two or three-component 
Gaussian mixture with clusters (components) of various volume, equal or various shape and 
equal orientation. A model with two clusters of various size (cluster 1: n = 167, cluster 2: n = 50) 
but equal in shape and orientation resulted in the lowest BIC; log-likelihood = -2658.38, df = 104, 
BIC = -5856.259. A three-component solution yielded the second-best data fit, log-likelihood 
= -2629.579, df = 118 , BIC = -5893.985 (for more details on the model selection process, see 
supplementary material). The BIC penalizes model complexity, which contributed to a three-
component solution only being presented as the numerically second-best model fit. Finally, we 
had originally hypothesized a three-component solution. Thus, we followed a theory-driven 
Table 1: Averaged median activation of the two a-priori defined regions of interest; the prefrontal emotion 
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Figure 2: Gaussian Mixture Model
For each subject, three estimates are calculated indicating their correspondence to cluster one, cluster two, and 
cluster three. The three axes represent the correspondence of a subject with the neural activation of cluster one 
(red), cluster two (yellow), and cluster three (blue). The highest cluster estimate of a subject determines to which 
cluster a subject was assigned to. Each point represents one subject color-coded based on their cluster assignment. 
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Table 2: Averaged median activation in the two classes of ROIs (ERN and amygdala) per task separated for the 
three clusters resulting from Gaussian mixture modeling.






















































































































approach and proceeded with the three-component solution. The three-component solution 
clustered the data in three clusters of various sizes, equal shapes and equal orientations, log-
likelihood = -2629.579, df = 118, BIC = -5893.985. Overall, 47.8% of the population were classified 
as cluster 1 (n = 108), 27.2% were classified as cluster 2 (n = 58), and 24.9% were identified as 
cluster 3 (n = 51). 
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Neural cluster profiles
To further characterize differences between clusters that resulted from Gaussian mixture 
modeling, we conducted a MANOVA comparing averaged median activation between the 
three clusters across all tasks and conditions. There was a significant difference in neural 
activation between subjects assigned to the different clusters, F (24, 406) = 22.025, p < 
.001; Wilk’s Λ = 0.189, partial η2 = .566, indicating that subjects assigned to different cluster 
revealed significantly different neural activation profiles across the prefrontal ROIs and the 
amygdala (figure 3). Post hoc tests revealed significant differences in amygdala activation in 
the emotion regulation task and the face-matching task, as well as a significant difference 
in PFC involvement across all tasks (for post hoc comparisons see supplementary material). 
Figure 3: 
Averaged median activation in the amygdala and prefrontal ROI across all tasks and conditions. Values are scaled 
around 0 A: Amygdala activation profile of the three clusters of participants across all tasks and conditions. 
Cluster 3 (red) was characterized by higher amygdala activation during the emotion regulation task and face 
matching relative to the other two clusters. Cluster 1 (blue) had the lowest overall amygdala involvement. While 
significant differences in amygdala activation between the clusters occurred in the emotion regulation task and 
the face-matching task, there was no significant difference in amygdala activation in the oddball task. B: Prefrontal 
engagement of the three clusters of participants across all tasks and conditions. Overall, cluster 3 was characterized 
by the highest involvement of the emotion regulation network, while cluster 1 had the lowest overall PFC 
involvement. Yet, prefrontal engagement of cluster 3 was only increased during the emotion regulation task and 
the oddball task, while the Hariri task evoked significantly less prefrontal activation in cluster 3 compared to the 
other two clusters. Cluster 1 revealed the lowest overall engagement of the emotion regulation network.
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Anxiety profiles
While subjects assigned to different clusters were characterized by significant differences in 
their neural activation profile, there was no difference in anxiety (HADS-A) between the three 
clusters, F(2) = 1.374, p = .255, indicating that three different neural profiles are associated 
with similar levels of anxiety (figure 4). For further validation, we tested the three groups on 
the state and trait anxiety scale of the STAI (for detail see supplementary material). While 
the overall model was approaching significance, F(4,424) = 2.308, p = .057, Wilk’s Λ = 0.958, 
partial η2 = .021, post hoc testing indicated a slightly higher trait anxiety score in cluster 3 
compared to cluster 1 (p = .02) (see supplementary material for all post hoc tests). 
Physiology-based pupil validation
To validate the model using an external criterion, we tested the three clusters for differences 
in pupil dilation, an independent physiological parameter that was not included in the 
cluster construction. Subjects of different cluster assignments showed differences in pupil 
dilation, F (8, 410) = 2.286, p = .021; Wilk’s Λ = .916, partial η2 = .044. Post hoc test revealed 
a significant difference between cluster 2 and 3 during the threat condition; cluster 2 had 
a significantly greater pupil dilation during the threat condition when a target stimulus was 
presented compared to cluster 3 (p < .001). The difference in pupil dilation after a target 
vs a non-target stimulus during the threat condition was significantly larger in subjects 
assigned to cluster 2 (p = .003), as well as the difference in pupil dilation in response to a 
target stimulus comparing the threat and safe condition (p = .001) (for all post hoc tests, 
see supplementary material). Moreover, investigating the effect of threat induction on 
Figure 4: Anxiety score per cluster
Distribution of anxiety scores (HADS-A) separated per cluster. There were no significant differences in anxiety 
between subjects assigned to different clusters.
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pupil dilation response within the clusters revealed three different profiles in pupil dilation 
response to targets vs non-targets. While threat induction did not affect the difference in 
pupil dilation response to targets vs non-targets in subjects assigned to cluster 1, cluster 
2 reacted with significantly increased differentiation between targets and non-targets. In 
contrast, subjects assigned to cluster 3 had a lower differentiation between targets and non-
targets during threat (figure 5).
Discussion
Aiming to identify distinct neurobiological biotypes of anxiety, we applied Gaussian mixture 
modeling to cluster highly anxious individuals based on their neural activation profile. A 
multivariate fMRI-based Gaussian mixture model differentiated three neural profiles 
among these anxious individuals. Sharing the same anxious phenotype, the three detected 
clusters significantly differed in amygdala activation and engagement of prefrontal regions 
of the emotion regulation network (ERN) in response to emotional stimuli, during emotion 
regulation, and in a salience task combined with a threat of shock paradigm. 
Figure 5: Pupil dilation per cluster
Mean difference (target – non-target) in pupil dilation in the safe and threat condition separately presented for the 
three clusters.  The dotted lines illustrate the direction of change in the mean difference of pupil dilation (target 
– non-target) comparing the safe to the threat condition. There was no effect of threat on the differentiation 
between a target and non-target in subjects assigned to cluster 1, t(105) =-1.156, p = .250. While subjects assigned 
to cluster 2 had a significant higher difference in pupil dilation between targets and non-targets during threat, t(56) 
= 2.650, p = .01, subjects assigned to cluster 3 showed a lower differentiation between targets and non-targets 
during threat, t(47) = -1.974, p = .054.
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We previously proposed a biomarker model outlining three neural mechanisms that all lead 
to the same anxious phenotype; amygdala hypersensitivity, decreased prefrontal control, 
and high LC drive (Brehl et al., 2020). The observed clustering of neural activity in dedicated 
tasks aligns with the proposed anxious phenotypes.
Cluster 1 comprised 47.8% of subjects and was characterized by overall lower prefrontal 
engagement, particularly in an oddball task combined with a threat of shock paradigm, and 
an emotion regulation task. The prefrontal ROI extracted in the present study contained 
ventrolateral, dorsolateral, and dorsomedial portions of the PFC and aligns well with a 
network recently identified as ERN (Morawetz et al., 2020). Reduced recruitment of the 
prefrontal ERN, specifically within the bilateral ventrolateral and dorsolateral PFC, while 
downregulating negative emotions has been observed in patients with anxiety and mood 
disorders (Picó-Pérez et al., 2017; Zilverstand, 2017). A meta-analysis on studies conducting 
an emotion regulation task in patients with PTSD and various anxiety disorders reported 
decreased dorsomedial and dorsal ACC recruitment during reappraisal relative to healthy 
controls (Wang et al., 2018). Moreover, patients with generalized and social anxiety disorder 
revealed impaired cognitive control during a working memory task combined with a threat 
of shock paradigm which was associated with reduced dorsolateral PFC activation in the 
threat context (Balderston et al., 2020). Based on these associations, we would identify 
subjects assigned to cluster 1 as decreased prefrontal control biotype.  Also on a behavioural 
level, cluster 1 was associated with less regulatory success. The cluster estimate for cluster 1 
indicates the resemblance of a given subject with the activation profile of cluster 1 and was 
negatively correlated with the subjective rating of regulation success after reappraising a 
negative image, r = -.144, p = .034. The stronger a subject aligned with the activation profile 
of cluster 1 the less success in emotion regulation a subject reported. 
In contrast to lack of prefrontal control, 24.9% of our subjects (cluster 3) were characterized 
by elevated prefrontal recruitment during emotion regulation and the oddball task. Cluster 
3 revealed the highest amygdala activation in response to both conditions of the emotion 
regulation task. Elevated amygdala activation paired with increased prefrontal processing 
has been reported across several anxiety disorders in response to threat-related stimuli (Ball 
et al., 2012; Brinkmann et al., 2017; Bruce et al., 2013; Buff et al., 2018; Labuschagne et al., 
2012). A recent stratification study clustered patients with euthymic bipolar 1 disorder based 
on their neural activation in the ERN during the same emotion regulation paradigm and 
identified a subgroup that expressed increased amygdala and ventrolateral PFC activation 
during emotion regulation (Njau et al., 2020). Moreover, that subgroup had higher numbers 
of hospitalization, eventually indicating more severe cases. In our study, participants in 
cluster 3 fail to downregulate their amygdala response during emotion regulation despite 
increased prefrontal engagement during emotion regulation. Hence, increased prefrontal 
engagement might reflect intensified emotional processing rather than regulatory attempts.
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Increased activation levels across the amygdala and prefrontal regions might be a 
consequence of elevated noradrenergic transmission. Pharmacological studies have 
demonstrated the regulatory effect of noradrenaline agonists and antagonists on amygdala 
activation (Hurlemann et al., 2010; Onur et al., 2009). Moreover, noradrenaline also elevates 
prefrontal activation levels and has been associated with hypervigilance and working 
memory impairment (Arnsten, 2000, 2009). We would define the activation profile in cluster 
3 as indirect evidence for the biotype ‘high LC drive’. Increased noradrenergic projection 
from the LC towards the amygdala and PFC might form the neurobiological basis of anxiety 
in cluster 3.
While cluster 1 and cluster 3 expressed neural features that could be related to the proposed 
biomarker model, cluster2 could not be directly associated to the model. Significantly higher 
prefrontal involvement paired with significantly lower amygdala response during emotion 
regulation relative to the view condition points towards successful explicit emotion regulation 
(Morawetz, Bode, Baudewig, et al., 2017a). However, successful emotion regulation in 
cluster 2 was not reflected in lower anxiety, as all three clusters showed the same level of 
anxiety. Furthermore, cluster 2 expressed the highest mean difference comparing prefrontal 
engagement during the threat to the safe condition in the oddball task, implying that the 
task manipulation led to the strongest prefrontal effects in cluster 2.  Similar to cluster 3, this 
might imply an increased LC drive, but could also stem from amygdala hyperresponsivness 
that gets well regulated.
For external model validation, we compared the three clusters in their pupil dilation 
response when differentiating target stimuli from non-target stimuli in a safe and threatening 
context. Pupil response to targets versus non-targets might be considered as a physiological 
proxy of performance, with increasing differences in pupil dilation indicating more precise 
differentiation between stimuli and therefore better performance (Rondeel et al., 2015). 
Three distinct pupil response patterns emerged during the threat condition when arousal 
increased. While differentiation between targets and non-targets only marginally altered 
by threat in cluster 1, cluster 2 showed a significant increase in pupil dilation difference of 
target vs non-target. In contrast, subjects assigned to cluster 3 showed less pronounced 
differentiation between targets and non-targets during a threat. These patterns of results 
indicate an arousal-related performance decrease from safe to threat in cluster 3, a mild 
performance increase in cluster 1, and a more pronounced increase in cluster 2. 
The Yerkes Dodson law states an inverted u-shape relationship between arousal and 
performance, with optimal performance levels being reached at an individually defined 
optimal level of arousal while lower or higher levels of arousal lead to reduced performance 
(Cohen, 2011; Yerkes & Dodson, 1908). The observed pupil response patterns might reflect 
three physiological biotypes that differ regarding their optimal level of arousal when best 
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performance is reached. Embedding our findings into the theoretical framework of Yerkes & 
Dodson illustrates that the three groups are characterized by different locations along with 
the inverted u-shape relationship between arousal and performance (figure 6).
Based on the activation profile, cluster 1 fits to the decreased prefrontal control biotype. 
In arousal-performance association as indicated by pupil dilation, threat-induced elevation 
in arousal does not lead to significant changes in performance. We propose the marginal 
change in performance is brought about by a strong, largely unregulated increase in tonic 
arousal caused by the threatening context that shifts performance from the increasing to 
the decreasing leg of the inverted U-shape. The decreased frontal control of the biotypes 
causes this large shift on the curve. On a psychological level, a constant feeling of lacking 
control regardless of the current state is safe or unsafe might be predominant in this biotype, 
leading to intermediate performance across both conditions. 
Custer 2 expressed the emotion regulation efficacy in the emotion regulation task as well as 
the strongest increase in prefrontal recruitment comparing the safe to the threat condition 
in the oddball task. As pupil dilation responses in cluster 2 showed significantly increased 
differentiation of targets versus non-targets during threat, participants assigned to cluster 
2 might experience a performance benefit from elevated arousal. Based on the neuronal 
Figure 6: Cluster dependent performance differences in reaction to threat
Theoretical embedding into the Yerkes & Dodson framework: The inverted u-shape indicates that optimal 
performance is reached at a medium level of arousal. Arousal increases depending on the experimental condition 
(safe vs threat). Performance is reflected by the difference in pupil dilation responses to targets vs non-targets. 
Based on their pupil response patterns the three biotypes have different locations along with the inverted u-shape 
relation between arousal and performance. The individual position of the biotypes along the inverted u-shape 
during a safe and a threat condition reflects how an increase in arousal affected the level of performance.
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activity profile, cluster 2 could not be related to a specific biotype. Yet, within the framework 
of our model, the biotype characterized by amygdala hypersensitivity is the only one not 
assigned. Amygdala hypersensitivity would probably lead to difficulty in regulating phasic 
responses, but potentially, due to concomitant well-practiced frontal control an elevated 
ability to regulate tonic arousal. Thus, cluster 2 supposedly shows the lowest change in tonic 
arousal, which puts them on the highest performance level in the threat context. This would 
be supported by cluster 2 having the smallest numeric difference in pupil dilation between 
targets and non-targets during the safe condition.
Cluster 3, characterized by overall increased prefrontal engagement without a regulatory 
effect onto the amygdala, might capture a biotype that even more than the other types, 
constantly operates in an alert state regardless of a safe or unsafe context. The overshot 
in prefrontal recruitment during threat might interfere with physiological differentiation, 
reducing their performance. While in general, subjects of this biotype might have a feeling 
of control in safe circumstances, they appear to experience high-stress sensitivity, causing a 
loss of control during threat due to prefrontal hyperactivity.  
Conclusion
Applying a multivariate fMRI-based clustering approach, we provided evidence that highly 
anxious individuals can be stratified based on their neural activation profile. We detected 
three neural subtypes that all express the same anxious phenotype. Validation on an 
external measure supported the differentiation of three different biotypes that vary in their 
physiological response to threat. Two of those subtypes could be related to a previously 
presented biomarker model comprising three neural biotypes of anxiety. One subgroup 
expressed decreased prefrontal control, while another subgroup was characterized by 
increased prefrontal and amygdala activation presumably caused by high LC drive. We 
demonstrated that clustering based on neural variability reveals distinct neural biomarkers 
that cannot be detected by state-of-the-art group analyses. Multivariate fMRI-based 
clustering approaches might be a chance to integrate neural heterogeneity to pave the 
way towards biomarker-based treatment in psychiatry. Future research might implement 
biomarkers as potential predictors for treatment outcome.
Limitations
The study population mainly consisted of healthy university students that expressed 
elevated anxiety but did not fulfil the criteria of an anxiety disorder. The detected biotypes 
might either be more strongly pronounced or deviate in clinical populations. The proposed 
biomarker model provided the theoretical framework for this study. As we only applied 
tasks that presumably evoked neural activation in the hypothesized anxiety-related neural 
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mechanisms, other mechanisms that were not included in the model might have remained 
undetected. Moreover, we only investigated neural activation in the amygdala and the 
prefrontal regions of interest but did not access neural activation in the locus coeruleus. 
To confirm increased noradrenergic transmission as an underlying mechanism of anxiety, 
neural activation in the LC would need to be included as a model parameter in the clustering 
procedure. The BIC indicated a 2-cluster solution as most reliable. Yet, we proceeded with 
the second-best 3-cluster solution. A purely data-driven approach including more potential 
neural parameters might add more reliable insight towards neural heterogeneity within the 
anxious phenotype.
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1. Description of all applied questionnaires 
HADS-A: The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) consist of 
two scales (7 items each) evaluating anxiety and depression and is a valid tool to investigate 
variance of anxiety in a healthy population (Breeman et al., 2015; Bocéréan & Dupret, 
2014). For the present study, only the HADS-A scale was of interest. All items are rated 
on a 4-point scale (0 to 3). A HADS-A score above seven is considered as an indicator for 
moderate anxiety. A score of more than or equal to 11 is defined as a definitive case of 
elevated anxiety (Breeman et al., 2015).
STAI: The State Trait Anxiety Inventory (Spielberger et al., 1983) consists of 40 items, 
measuring symptoms of anxiety. The questionnaire distinguishes between permanent 
trait and fluctuating state components of anxiety. The STAI-S subscale tests state anxiety, 
consisting of 20 items that refer to the current situation. The STAI-T subscale assess trait 
anxiety on 20 items referring to the last week.  All items are rated on a 4-point scale (almost 
never to almost always) with higher scores indicating greater anxiety.
2. Trait anxiety distribution in the study population
The study population consists of a group of healthy participants with elevated anxiety traits. 
Persistently high but non-pathological levels of anxiety can be defined as sub-clinical anxiety, 
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where episodes of high but non-pathological anxiety could develop clinical relevance 
overtime, or constitute a trait in a healthy individual. A trait is commonly defined as 
personality characteristic that is stable over time. Individuals were selected for participation 
based on their score on the anxiety subscale of the HADS. For additional validation, we 
also applied the trait anxiety scale of the STAI during the test session. The HADS-A score 
were highly correlated with the trait scale of the STAI (r = .551, p < .001), indicating that 
the population expressed elevated symptoms of anxiety that are stable over time and can 
potentially be considered as trait anxiety. Correlations of the HADS with the trait and state 
scale of the STAI revealed a numerically higher correlation between the HADS and the trait 
scale compared to the state scale (r = .489, p < .001). 
3. fMRI tasks
All tasks were presented using Presentation software (Version 20.2, Neurobehavioral Systems, 
Inc., Berkeley, CA, www.neurobs.com).
3.1 Hariri face mating task
Three emotional faces were presented at a time and participants were instructed to select 
the face presented at the bottom that expressed the same emotion as the target face 
presented on top of the screen. Overall, 36 images (18 angry and 18 fearful face expressions) 
were taken from the Radboud Faces Database (RaFD; http://www.socsci.ru.nl:8180/RaFD2/
RaFD; Langner et al., 2010). All faces were only used once as a target image, but could 
be repeated as non-target images. In a control condition, participants were instructed to 
match identical geometric shapes. The task consisted of six blocks per condition resulting in 
a total of eighteen task blocks per subject. Each block consisted of three trials with a length 
of 5 seconds per trial (block length = 15 seconds). The order of block order was pseudo-
randomized and the inter-trial interval was jittered pseudo-randomly, varying between 
5000 and 7000 msec. During these intervals, a white fixation cross appeared on a black 
background. Subjects received a standardized instruction before the fMRI-session.
Suppl. Figure 1. Hariri face matching task
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Task instruction (translated from Dutch) During this task, try as quickly and accurately 
as possible to match the emotion from the top facial expression (target) with the correct 
emotion from one of the two facial expressions at the bottom. You can press the left button if 
the bottom-left face expresses the correct (target) emotion or the right button if the bottom-
right face expresses the correct emotion. The same applies to the shape condition.
Task instruction (Dutch version). Probeer bij deze taak zo snel en correct mogelijk de emotie 
van het bovenste gezicht (of de bovenste vorm) te matchen met de juiste emotie (vorm) 
beneden. Druk hiervoor de linker knop als het linke gezicht de juiste emotie laat zien oftewel 
de rechter knop als het rechter gezicht de emotie van het gezicht boven laat zien. Hetzelfde 
geldt voor de vormen.
3.2 Emotion regulation task
Participants were exposed to 40 photographs (20 emotionally negative and 20 neutral 
scenes), which were taken from the International Affective Picture System (Lang et al., 
1997), and EmoPics (Wessa et al., 2010). Participants were instructed to either just view 
the pictures (instruction: view) or view and downregulate their emotional response evoked 
by a picture by reappraising the presented scene (instruction: decrease). Participants 
received a standardized instruction for emotional reappraisal before the fMRI scan (see 
task instruction below). Negative pictures were presented in both conditions (view and 
regulation) while neutral pictures were only presented in the view-condition, resulting in 60 
pseudo-randomized trials (trial length: 16sec, inter-stimulus-interval: 1500ms). Each picture 
was presented for 8 seconds in total, the instruction to downregulate or view followed after 
the first two seconds superimposed on the picture. After each picture, participants rated 
their current emotional state on an eight-point scale ranging from sad to happy, and their 
arousal on a ten-point scale ranging from active to quiet.
Task instruction (Translated from Dutch) Please watch each photo carefully. In the view 
condition (VIEW superimposed on photo), try to just let the picture take its effect on you. 
In the decrease condition (DECREASE superimposed on photo), watch the photo, but this 
time, as you watch, try to think about the situation you see in a more positive light. You can 
Suppl. Figure 2. Emotion regulation task
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achieve this in several different ways. For example, try to imagine advice that you could give 
to the characters in the photo to make them feel better. This could be advice that would 
help them think about the positive bearing this event could have on their lives. Think about 
the good things they might learn from this experience. Keep in mind that even though a 
situation may be painful in the moment, in the long run, it could make one’s life better, or 
have unexpected good outcomes. You can alternatively try to put yourself in the position of a 
professional watching this photo (psychologist, veterinarian, social worker) or put your focus 
on technical aspects of the photo. 
Task instruction (Dutch version). Gelieve elke foto aandachtig te bestuderen. Probeer tijdens 
de weergavefase (wanneer VIEW staat vermeld op de foto) de afbeelding zijn effect op u uit 
te laten werken. In de beoordelingsfase (wanneer VERMINDER staat vermeld op de foto) 
bekijkt u de foto, maar deze keer, terwijl u kijkt, probeert u de situatie die u bekijkt in een 
positiever licht te zien. U kunt dit op verschillende manieren bereiken. Bijvoorbeeld door u in 
te beelden welk advies u de personen uit de foto zou geven, om zich beter te laten voelen. Dit 
kan advies zijn dat hen helpt om na te denken over de positieve invloed van de gebeurtenis 
op hun leven. Denk na over de goede dingen die de personen zouden kunnen leren van 
deze ervaring. Houd in u gedachten dat, hoewel een situatie pijnlijk kan zijn op het moment 
zelf, het kan zijn dat op de lange termijn iemands leven er juist beter van wordt, of andere 
onverwachtse goede uitkomsten. Als alternatief zou u ook kunnen proberen om met de blik 
van een professional (psycholoog, dierenarts, sociaal hulpverlener) naar de foto te kijken of 
de focus leggen op de technische aspecten van de foto.
3.3 Oddball task + Threat of shock paradigm
An oddball paradigm with a threat-of-shock manipulation. Participants were instructed to 
attend the fixation cross in the middle of the screen. In this location, the train of stimuli 
which consisted of ‘O’s and ‘X’s, was presented on a grey background. Participants were 
instructed to ignore the non-target (‘O’), and respond by button press to the oddball ‘X’. 
The task consisted of 32 blocks (16 threat-of-shock and 16 safe blocks, block duration: 
Suppl. Figure 3. Oddball task combined with a threat of shock paradigm
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30sec). Each block contained 15 semi-randomized stimuli which were presented for 100ms. 
In between the stimulus presentations, a fixation cross was shown. The inter-trial-interval 
(ITI) was jittered pseudo-randomly, and varied between 1400ms and 2400ms. Each block 
contained one to three oddballs, with an average of two oddballs per block. Following 
each oddball, the ITI was 2400ms. Stimuli were surrounded by a green or red frame. The 
participants were informed that when a red frame was present, a shock might be applied 
during this block (threat-of-shock block). The green frame indicated a safe block. Participants 
were not informed about the total number of shocks they would receive. In reality, each 
participant received two shocks throughout the task. The first shock was administered 
in the fourth threat block (block number 7 or 8 in total), the specific trial number varied 
between participants. The second shock was administered at the same time point for each 
participant; in the eighth threat block (block number 15 or 16 in total) following the tenth 
stimulus. Half of the participants started with a threat block, the other half started with a 
safe block. The order of the threat-of-shock and safe blocks alternated.
Peripheral stimulation. Electric shocks were delivered with two Ag/AgCl electrodes attached 
to the middle phalanges of the fourth and fifth fingers of the left hand. Shocks were delivered 
with an Innostim tens 2K pulse generator for 250µs. Shock was adjusted for each participant 
with a stepwise protocol and varied between 20–80mA. 
Shocker calibration. Shocker intensity was adjusted to the individual before the start of the 
fMRI session. Participants received electrical one shock at a time and were asked to rate 
the intensity on a scale from one to five. A rating of 1 referred to not being painful at all, a 
rating of 5 indicated painful. Depending on the rating of the participant the shock intensity 
was adjusted following a stepwise procedure resulting in an individual rating of 4 for every 
individual. The final level was always reached after five exposures (table 1).
Suppl. Table 1: Instruction for stepwise procedure for shocker adjustment.
shocker level (bars) subjects rating 
(bars that were adjusted for the next level)



















































4. fMRI data acquisition and image processing
T2*-weighted EPI BOLD-fMRI images were acquired, applying a multiband 4 sequence (slice 
number = 68, TR = 1500ms, TE = 39.6ms, flip angle = 75°, voxel size = 2x2x2mm3, slice gap = 
0mm, FOV = 210mm). For anatomical reference, a high-resolution T1-weighted image (slice 
number = 192, TR = 2300ms, TE = 3.03ms, flip angle = 8°, voxel size = 1x1x1 mm3, FOV = 
256x256x192mm3, base resolution = 256, sagittal acquisition) was obtained.
Data quality checks were performed by visual inspection of structural and functional scans, 
spike checks and signal-to-noise ratio plots. For pre-processing, the first five volumes of each 
functional time series were discarded, allowing magnetization effects and initial transient 
signal changes. Further pre-processing steps included three-dimensional movement 
correction, spatial smoothing using a 6mm full-width at half maximum (FWHM) Gaussian 
kernel to reduce inter-subject variability, and application of a high-pass filter (>100s). Before 
all group analyses, data was normalized to MNI-space and re-sampled to 2mm³ resolution 
using the FMRIB’s Nonlinear Image Registration Tool (FNIRT). Data-denoising was conducted 
by applying ICA-AROMA, which automatically identifies and removes motion-related 
artefacts (Pruim et al., 2015).
For every subject and task, data was modelled in FEAT (FMRI Expert Analysis Tool, version 
6.0) and BOLD time-courses were analysed within the framework of mass-univariate General 
Linear Modelling (GLM), resulting in primary parameter estimates and estimates of residual 
noise variance converted into z-statistic maps. Onsets and durations of the experimental 
and control conditions, and a noise regressor were implemented as separate regressors in 
every subject-level model.  
Face matching task. We created blocks of emotion conditions and shape matching conditions 
and included emotion and shape matching as two contrasts of interest for the clustering 
analysis. Instructions before a task were modelled as a separate noise regressor.   
Emotion regulation task. Onsets and durations of neutral, negative view and reappraisal 
conditions were modelled as three separate regressors. We used the conditions negative 
view and reappraisal as conditions of interest for the clustering analysis. Rating periods were 
modelled as a separate noise regressor.
Oddball task + Threat of shock paradigm. Onsets and durations of the threat (red frame) 
and safety (green frame) blocks were modelled as two separate regressors and taken as 
contrasts of interest for the clustering analysis. Additionally, as regressors of no interest, we 
modelled responses to stimuli, and shock onsets in two separate regressors. 
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4.1 PFC parcellation 
To segment the PFC into functionally correlated parcels, instantaneous connectivity 
parcellation (ICP) was applied on the resting state data. Following a top-down parcellation 
strategy, we used the time courses of instantaneous connectivity within the PFC to subdivide 
the PFC into sub-regions (van Oort et al., 2018). ICP amplifies the differences in (groups of) 
voxel time series in order to detect functionally connected subregions. The ICP yielded 50 
independent PFC regions. For selecting the region of interest, cluster size threshold was 
set to a minimum of 5 voxels, resulting in five clusters that were identified as ventrolateral, 
dorsolateral and dorsomedial PFC (table 2). We selected the VLPFC-DLPFC cluster that 
overlaps most strongly with previous emotion regulation meta-analyses (Morawetz et al., 
2020; Kohn et al., 2014) and reports in the context of anxiety disorders (Brehl et al., 2020)
4.2 Gaussian Mixture model selection
Suppl. Table 2: Cluster centres of gravity (cog) for clusters resulting from the connectivity based PPFC parcellation 
that were defined as regions of interest.
number of voxels cog(X) cog(Y) cog(Z)
Left ventrolateral PFC 569 -48 38 -6
Right ventrolateral PFC 1210 50 30 -2
Right dorsolateral PFC 41 42 12 46
Right dorsomedial PFC 25 10 52 44
Right dorsomedial PFC 16 16 24 56
Suppl. Figure 4. Model selection. The color code indicates the 14 different Gaussian mixture models. The x-axis 
presents the number of clusters (model components). With increasing number of clusters, the BIC decreases across 
all model solutions. The BIC (y-axis) indicates a two-component mixture (dotted red line) as best model fit and a 
three-component mixture (dotted orange line) as second best model fit.
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We used the mclust package in R for identification of our biotypes. The mclust package 
provides 14 different Gaussian mixture models obtained by eigenvector decomposition 
that are fitted to the data (Scrucca et al., 2016). Those models differ on three geometric 
characteristic (volume, shape, and orientation) which can be either equal or variable. 
The expectation maximization algorithm implemented in the mclust function provides an 
overview of the three best models with the optimal number of clusters. Optimal model 
selection leads to minimization of Bayesian information criterion (BIC), (figure 5). 
In our case, the BIC indicated a two- or three-cluster solution with clusters of variable 
volume, equal or variable shape and equal orientation as optimal fits (table 3).
4.3 Neural activation profiles of the three subgroups: Multiple comparisons
Suppl. Table 3: BICs for the three best model fits.
Model 1 Model 2 Model 3
Model VEE
(various volume, equal 
shape, equal orientation)
VEE
(various volume, equal 
shape, equal orientation)
VEE
(various volume, various 
shape, equal orientation)
Number of clusters 2 3 2
BIC -5856.269 -5893.985 -5908.159
BIC difference - -37.716 -51.89
Suppl. Table 4: Post hoc tests (Turkey’s HSD) comparing activation in the prefrontal ROI and the bilateral amygdala 



















emotion regulation  
(negative view)
1 2 2.69 1.27 0.087 -0.30 5.68
3 7.65* 1.32 0 -10.78 -4.54
2 1 -2.69 1.27 0.087 -5.68 0.30
3 -10.34* 1.49 0 -13.87 -6.82
3 1 7.65* 1.32 0 4.54 10.78
2 10.34* 1.49 0 6.82 13.87
emotion regulation 
(reappraisal)
1 2 2.92 1.46 0.114 -0.52 6.37
3 -12.41* 1.52 0 -16.01 -8.82
2 1 -2.92 1.46 0.114 -6.37 0.52
3 -15.33* 1.72 0 -19.40 -11.27
3 1 12.41* 1.52 0 8.82 16.01
2 15.33* 1.72 0 11.27 19.40




1 2 -5.74* 2.16 0.023 -10.85 -0.65
3 4.20 2.26 0.152 -1.12 9.53
2 1 5.74* 2.16 0.023 0.65 10.85
3 9.95* 2.55 0 3.93 15.97
3 1 -4.20 2.26 0.152 -9.53 1.12
2 -9.95* 2.55 0 -15.97 -3.93
face matching 
(shape)
1 2 -8.85* 1.99 0 -13.55 -4.17
3 7.65* 2.07 0.001 2.76 12.55
2 1 8.85* 1.99 0 4.17 13.55
3 16.50* 2.34 0 10.98 22.04
3 1 -7.65* 2.07 0.001 -12.55 -2.76
2 -16.50* 2.34 0 -22.04 -10.98
oddball task 
(safety)
1 2 -3.80 1.75 0.079 -7.94 0.33
3 -11.44* 1.83 0 -15.76 -7.13
2 1 3.80 1.75 0.079 -0.33 7.94
3 -7.64* 2.07 0.001 -12.52 -2.77
3 1 11.44* 1.83 0 7.13 15.76
2 7.64* 2.07 0.001 2.77 12.52
oddball task 
(threat)
1 2 -9.92* 1.82 0 -14.21 -5.63
3 -11.97* 1.90 0 -16.45 -7.50
2 1 9.92* 1.82 0 5.63 14.21
3 -2.05 2.14 0.604 -7.11 3.00
3 1 11.97* 1.90 0 7.50 16.45




1 2 0.04 1.41 1 -3.29 3.36
3 -5.73* 1.47 0 -9.20 -2.26
2 1 -0.04 1.41 1 -3.36 3.29
3 -5.76* 1.66 0.002 -9.69 -1.84
3 1 5.73* 1.47 0 2.26 9.20
2 5.76* 1.66 0.002 1.84 9.69
emotion regulation 
(reappraisal)
1 2 2.48 1.45 0.206 -0.96 5.91
3 -5.68* 1.52 0.001 -9.27 -2.11
2 1 -2.48 1.45 0.206 -5.91 0.96
3 -8.16* 1.72 0 -12.22 -4.12
3 1 5.68* 1.52 0.001 2.11 9.27
2 8.16* 1.72 0 4.12 12.22


















5. Behavioural task results
Hariri face-matching task. There was a significant main effect of type of stimulus on 
response time, F(2,217) = 379.631, p < .001, partial η2 = .778 (note that behavioural data 
for the Hariri face-matching task was only available for 211 subjects.) Pairwise comparisons 
(LSD) revealed a significant difference in response time between the shape condition and 
the emotion conditions. Subjects responded faster during shape matching as compared to 
emotion matching. There was no differences in behavioural performance between the two 
emotion matching conditions (anger vs fear, figure 5).
face matching 
(face)
1 2 -7.27* 1.91 0.001 -11.79 -2.77
3 -6.89* 1.99 0.002 -11.60 -2.19
2 1 7.27* 1.91 0.001 2.77 11.79
3 0.38 2.25 0.984 -4.93 5.70
3 1 6.89* 1.99 0.002 2.19 11.60
2 -0.38 2.25 0.984 -5.70 4.93
face matching 
(shape)
1 2 -5.60* 1.91 0.01 -10.10 -1.10
3 -3.77 1.99 0.142 -8.46 0.92
2 1 5.60* 1.91 0.01 1.10 10.10
3 1.83 2.25 0.694 -3.47 7.13
3 1 3.77 1.99 0.142 -0.92 8.46
2 -1.83 2.25 0.694 -7.13 3.47
oddball task 
(safety)
1 2 -1.62 1.54 0.542 -5.25 2.00
3 1.73 1.60 0.529 -2.06 5.51
2 1 1.62 1.54 0.542 -2.00 5.25
3 3.35 1.81 0.156 -0.93 7.62
3 1 -1.73 1.60 0.529 -5.51 2.06
2 -3.35 1.81 0.156 -7.62 0.93
oddball task 
(safety)
1 2 -0.19 1.66 0.993 -4.10 3.72
3 1.87 1.73 0.527 -2.21 5.95
2 1 0.19 1.66 0.993 -3.72 4.10
3 2.06 1.95 0.544 -2.55 6.67
3 1 -1.87 1.73 0.527 -5.95 2.21
2 -2.06 1.95 0.544 -6.67 2.55
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Emotion regulation task. Behavioural ratings of emotional state and arousal showed that 
the task manipulation worked as expected (figure 6). Ratings of emotional state differed 
significantly between the three conditions, F(2,215) = 720.706, p < .001, partial η2 = .870. 
Rating of emotional state was the highest when subjects had been exposed to neutral 
pictures and the lowest when being exposed to negative pictures. Reappraisal significantly 
increased the rating of emotional state compared to the negative view condition, but was 
still significantly lower compared to the neutral view condition. Ratings of arousal showed 
the same pattern, F(2,215) = 281.058, p < .001, partial η2 = .723 (figure 6).
Suppl. Figure 5: Hariri face matching task: reaction times. Reaction times in the Hariri face-matching task during 
two emotion conditions: matching anxious and fearful faces, and the control condition when participants had to 
match geometric shapes.
Suppl. Figure 6: Emotion regulation task: ratings. Subjective ratings of emotional state and arousal following the 
exposure to a neutral or a negative picture or exposure to a negative picture with the instruction to reappraise the 
presented scene. Emotional state was rated an eight-point scale ranging from sad (0) to happy (8), and their arousal 
on a ten-point scale ranging from active (0) to quiet (10).
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Oddball task. Mean response time during threat blocks was significantly shorter than during 
safe blocks, t(199) = -7.232, p < 0.001 (note that pupil dilation and behavioural data was only 
available for 200 subjects). Task performance was also affected by threat (figure 7). While 
more target stimuli were correctly detected during threat blocks, t(199) = 3.446, p = .001, 
there was also a higher rate of false alarms during threat blocks (button press in response to 
a non-target stimulus), t(199) = 4.165, p < 0.001. 
Suppl. Figure 7: Oddball task + threat of shock paradigm: responses. Reaction times, accuracy rates and false rates 
when detecting an oddball stimulus during a threat and a safe condition.
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6. Anxiety profiles of the three subgroups
Suppl. Table 5: Post hoc tests (Turkey’s HSD) comparing anxiety scores between the clusters. Significant differences 

















HADS-A 1 2 .14 .548 .966 -1.16 1.43
3 .90 .572 .262 -.45 2.25
2 1 -.14 .548 .966 -1.43 1.16
3 .76 .645 .469 -.76 2.28
3 1 -.90 .572 .262 -2.25 .45
2 -.76 .645 .469 -2.28 .76
STAI-S 1 2 -.10 1.523 .998 -3.69 3.50
3 1.91 1.589 .453 -1.84 5.66
2 1 .10 1.523 .998 -3.50 3.69
3 2.01 1.793 .503 -2.22 6.24
3 1 -1.91 1.589 .453 -5.66 1.84
2 -2.01 1.793 .503 -6.24 2.22
STAI-T 1 2 1.45 1.758 .687 -2.70 5.60
3 4.98* 1.835 .020 .65 9.31
2 1 -1.45 1.758 .687 -5.60 2.70
3 3.52 2.070 .207 -1.36 8.41
3 1 -4.98* 1.835 .020 -9.31 -.65
2 -3.52 2.070 .207 -8.41 1.36
Suppl. Table 6: Person’s Correlations (r) for cluster estimates and anxiety scores to test for associations between 
cluster correspondence and level of anxiety. * Significant correlations at the 0.05 level, no correlation survived 
Bonferroni correction.
HADS-A STAI_S STAI_T
Cluster estimate 1 r .081 .051 .135*
p .236 .453 .047
N 217 216 216
Cluster estimate 2 r .018 .044 .022
p .796 .521 .751
N 217 216 216
Cluster estimate 3 r -.108 -.102 -.173*
p .111 .134 .011
N 217 216 216
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7. Pupil dilation 
7.1 Recording and processing
Pupil dilation of the left eye was recorded with an SMI Eyetracker camera, using the iView X 
software with a sampling rate of 50Hz (SensoMotoric Instruments). Data preprocessing was 
conducting following previously described procedures (Kret & Sjak-Shie, 2019). Following 
each stimulus (targets and non-targets), we extracted the pupil dilation size in pixels within 
a time window of 1400ms, including 70 samples. Samples below or above three standard 
deviations were defined as outliers and removed. Trials in which participants received an 
electrical stimulation plus four trials following those were excluded. To correct for eye blinks, 
samples of less than 10 pixels were removed including two preceding and two subsequent 
samples. In case 30 or more samples within a trial had been removed, the entire trial was 
not included in further analyses. 
After z-standardization (based on the individual mean and standard deviation), we calculated 
the mean dilation for each trial. Finally, the dataset was compressed to four mean dilations 
per subject:  the mean pupil dilation during threat blocks for (1) targets and (2) non-targets, 
and the mean pupil dilation during safe blocks for (3) targets and (4) non-targets.
7.2 Pupil dilation results per task condition: Post hoc tests
Although subjects assigned to different clusters varied in pupil dilation differences between 
targets and non-targets during threat, there were no significant differences in response 
accuracy between the three groups (statistics all p > 0.5).
Suppl. Table 7: Post hoc tests comparing pupil dilation in the different task conditions between subjects assigned 

















Threat non-target 1 2 -0.03 0.03 0.47 -0.10 0.04
3 0.03 0.03 0.54 -0.04 0.11
2 1 0.03 0.03 0.47 -0.04 0.10
3 0.07 0.04 0.13 -0.02 0.15
3 1 -0.03 0.03 0.54 -0.11 0.04
2 -0.07 0.04 0.13 -0.15 0.02
Threat target 1 2 -0.09 0.04 0.06 -0.19 0.00
3 0.10 0.04 0.07 -0.01 0.20
2 1 0.09 0.04 0.06 0.00 0.19
3 .18* 0.05 0.00 0.07 0.30
3 1 -0.10 0.04 0.07 -0.20 0.01
2 -.18* 0.05 0.00 -0.30 -0.07
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Safe non-target 1 2 0.04 0.03 0.33 -0.02 0.10
3 -0.03 0.03 0.60 -0.09 0.04
2 1 -0.04 0.03 0.33 -0.10 0.02
3 -0.06 0.03 0.10 -0.13 0.01
3 1 0.03 0.03 0.60 -0.04 0.09
2 0.06 0.03 0.10 -0.01 0.13
Safe target 1 2 0.04 0.03 0.48 -0.04 0.11
3 -0.05 0.03 0.35 -0.13 0.03
2 1 -0.04 0.03 0.48 -0.11 0.04
3 -0.08 0.04 0.07 -0.18 0.01
3 1 0.05 0.03 0.35 -0.03 0.13
2 0.08 0.04 0.07 -0.01 0.18
Non-target
(threat – safe)
1 2 -0.07 0.05 0.37 -0.20 0.05
3 0.06 0.06 0.54 -0.07 0.19
2 1 0.07 0.05 0.37 -0.05 0.20
3 0.13 0.06 0.10 -0.02 0.28
3 1 -0.06 0.06 0.54 -0.19 0.07
2 -0.13 0.06 0.10 -0.28 0.02
Target
(threat – safe)
1 2 -0.13 0.06 0.08 -0.27 0.01
3 0.14 0.06 0.07 -0.01 0.29
2 1 0.13 0.06 0.08 -0.01 0.27
3 .27* 0.07 0.00 0.10 0.44
3 1 -0.14 0.06 0.07 -0.29 0.01
2 -.27* 0.07 0.00 -0.44 -0.10
Safe 
(target – non-target)
1 2 0.00 0.03 1.00 -0.06 0.06
3 -0.02 0.03 0.72 -0.09 0.04
2 1 0.00 0.03 1.00 -0.06 0.06
3 -0.02 0.03 0.76 -0.10 0.05
3 1 0.02 0.03 0.72 -0.04 0.09
2 0.02 0.03 0.76 -0.05 0.10
Threat
(target – non-target)
1 2 -0.06 0.03 0.13 -0.13 0.01
3 0.06 0.03 0.13 -0.01 0.14
2 1 0.06 0.03 0.13 -0.01 0.13
3 .12* 0.04 0.00 0.04 0.21
3 1 -0.06 0.03 0.13 -0.14 0.01
2 -.12* 0.04 0.00 -0.21 -0.04

















CHAPTER 4   
Highly anxious but everything under control  - 
Effective emotion regulation in heathly individuals  
with elevated anxiety
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Background: Emotion regulation is a key element of effective treatment of patients with 
anxiety disorders. Efficient emotion regulation skills might protect healthy but highly 
anxious individuals from developing clinically relevant anxiety. We investigated the neural 
underpinnings of emotion regulation in healthy individuals with high anxiety traits aiming 
to detect neural mechanisms that might support protective factors towards pathological 
anxiety. 
Methods: 751 individuals were screened on anxiety. Oversampling for elevated anxiety 
traits resulted in a study population of 128 healthy participants. Of those, 93 were highly 
anxious (Hospital-Anxiety-and-Depression-Scale ≥ 8), but did not fulfil diagnostic criteria 
for an anxiety disorder. Participants underwent fMRI while performing a cognitive emotion 
regulation task. A GLM-analysis, regression with anxiety ratings and psychophysiological 
interaction analysis were conducted to assess the protective function of emotion regulation 
in elevated anxiety. Grounding in behaviour was tested with moderation analyses. 
Results: Anxiety traits did not affect emotion regulation efficiency. A whole-brain regression 
analysis revealed increasing activation in the ventrolateral prefrontal cortex (VLPFC) during 
emotion regulation with increasing anxiety. The VLPFC was negatively coupled to the 
dorsomedial PFC (DMPFC) and middle temporal gyrus (MTG) during emotion regulation, 
which might suggest a regulatory effect onto the VLPFC. Furthermore, functional VLPFC-
DMPFC connectivity during emotion regulation was associated with lower anxiety traits. 
Conclusions: Increased VLPFC activation and coupling to areas involved in regulatory 
processes might be the neural basis of compensatory emotion regulation in highly anxious 
individuals. Regulatory networks might adapt to high anxiety traits by enhancing functional 
VLPFC-DMPFC connectivity to counterbalance high anxiety.
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Introduction
High anxiety is a common trait in the healthy population. Normative data for the Hospital 
Anxiety and Depression Scale (HADS) demonstrates that 19% of females and 12.5% of males 
are characterized by moderate to severe anxiety (Breeman et al., 2015). The high proportion of 
highly anxious individuals indicates that high anxiety traits do not per se lead to clinically relevant 
anxiety. Healthy but highly anxious individuals might show behavioural and neural characteristics 
that allow them to regulate their anxiety preventing them from clinically relevant symptoms 
of anxiety. While limited emotion regulation capacity is a transdiagnostic symptom across 
psychiatric disorders (Sloan et al., 2017), effective emotion regulation might be a protective 
factor. Emotion regulation capacities have been investigated in patients with anxiety disorders, 
but sub-clinical groups of individuals with persistently high but non-pathological anxiety levels 
have received substantially less attention. However, sub-clinical groups are ideally suited to 
identify neural activation patterns underlying effective emotion regulation that eventually 
protect a highly anxious individual from developing pathological anxiety.
Humans have the inherent tendency to downregulate unpleasant emotional responses by 
applying emotion regulation strategies. Those strategies can be adaptive or maladaptive 
depending on the efficiency and costs they carry. A growing body of research has improved 
our understanding of emotion regulation by exploring the neural basis of this process. Early 
integration of animal studies, lesion data and human brain imaging associated emotion 
processing with ventral pathways and emotion regulation with dorsal neural pathways. Ventral 
regions of the prefrontal cortex (PFC) are involved in the identification, evaluation of significance 
and generation of affective states, while dorsal regions of the PFC and the anterior cingulate 
cortex (ACC) are associated with effortful conscious emotion regulation (Phillips et al., 2003). 
Neuroimaging studies in humans identified a set of brain regions involved in the regulation of an 
emotional response. The ventrolateral PFC (VLPFC), subsuming the anterior insula and inferior 
frontal gyrus, as well as the supplementary motor area (SMA) were associated with emotion 
regulation independent of the regulatory strategy  (Morawetz, Bode, Derntl, et al., 2017b). 
Reappraisal is one of the most studied regulation strategies (Ochsner & Gross, 2008). In 
classical reappraisal studies, subjects are required to regulate their emotional response to 
negative emotional stimuli by reframing the content of the picture or situation to decrease 
their emotional impact. Reappraisal, therefore, involves an interplay of cognitive control 
and emotional appraisal of a stimulus and is specifically associated with increased activation 
of ventral and dorsal lateral PFC, dorsomedial PFC (DMPFC) extending from pre-SMA into 
dorsal ACC, middle and superior temporal, as well as parietal brain regions. Amygdala 
activation is found to be decreased, putatively as a consequence of down-regulating an 
emotion (Kohn et al., 2014; Morawetz, Bode, Derntl, et al., 2017b; Ochsner et al., 2004). A 
recent meta-analysis on 15 neuroimaging studies reported convergent coupling between 
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the amygdala and the left VLPFC, the right dorsolateral PFC (DLPFC), and the DMPFC during 
reappraisal (Berboth & Morawetz, 2021).
Successful regulation of negative emotions has similarly been associated with activation in 
the ventromedial PFC, DMPFC and dorsolateral PFC in healthy individuals (Orem et al., 2019). 
Furthermore, functional connectivity between regions that support emotion regulation 
and regions that are associated with emotion evaluation was related to successful emotion 
regulation (Morawetz, Bode, Baudewig, et al., 2017a). Hence, effective emotion regulation might 
be supported by increased functional connectivity between ventral areas underlying emotion 
processing and dorsal areas involved in emotion regulation, as well as elevated recruitment 
of prefrontal areas related to regulatory efficiency. In support, increased ventromedial PFC 
recruitment was a common characteristic among individuals with resilience to develop 
posttraumatic stress disorder (PTSD) despite high anxiety traits (Andrewes & Jenkins, 2019; 
Lin et al., 2015). The beneficial effect of upregulating prefrontal activation raises the question 
if inherently increased recruitment of areas involved in emotion regulation, or pronounced 
functional connectivity between areas associated with emotion processing and areas involved in 
emotion regulation might constitute a protective factor diminishing the risk for anxiety disorders. 
We hypothesize that effective emotion regulation is characterized by specific neural activation 
patterns (increased functional connectivity between ventral and dorsal prefrontal areas) 
which might protect healthy but highly anxious individuals from developing clinically relevant 
anxiety. For this purpose, 128 young adults of which 93 expressed elevated anxiety traits were 
tested on an emotion regulation task in the fMRI scanner. Additionally, to validate that neural 
activation patterns underlying effective emotion regulation relate to efficient regulation 
strategies, we tested the influence of emotion regulation strategies on momentary emotion 
regulation success, and evaluated if these activation patterns on a habitual level relate to a 
general tendency for use of certain emotion regulation strategies.
Methods and Materials
Online screening for elevated anxiety
Subjects were recruited based on an online screening, consisting of the HADS (Zigmond & 
Snaith, 1983), demographical data, and screening for MRI-compatibility (conducted on www.
soscisurvey.de). The screening was advertised on university websites and announced in 
university lectures. To oversample for high anxiety traits, all individuals with elevated scores 
(≥8) on the HADS anxiety-subscale (HADS-A) received a study invitation, while individuals with 
normal scores (HADS-A <8) were selected for study participation based on a 25%-probability.
Study population
Of 751 individuals that completed the screening, 225 potential participants received a 
study invitation. Of those, 144 were interested to participate and contacted the research 
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team. Seven of those 144 candidates were excluded from participation due to a confirmed 
DSM-IV-diagnosis, psychotherapy or psychiatric medication in the preceding 6 months. 
Six participants did not finish the fMRI-session, because of discomfort during fMRI. Three 
datasets had to be excluded due to high sleepiness, later revealed substance use (cocaine) 
or indication for anatomical variation from the norm (assessed by a trained neurologist). 
Finally, 128 participants were included in the analysis (95 females, 33 males, age range 18–
47 years, mean = 22.9 years, sd = 5.55). 
Participants provided written informed consent after receiving a written detailed description 
of all study procedures and received financial compensation of 10 euro per hour. All 
participants that completed the online screening regardless if they participated in the 
study, took part in a lottery to win an iPad Mini. The study protocol has been approved 
by the Commissie Mensgebonden Onderzoek (CMO) of the Radboudumc in Nijmegen/ The 
Netherlands (NL61806.091.17).
Procedures
This study was part of a bigger research project investigating biomarkers of anxiety. All 128 
participants completed the full study that included an fMRI-session consisting of three 
paradigms, continuously recorded physiological measurements and questionnaires (for 
details see supplementary material). For the present study, only the emotion regulation 
task and questionnaires on anxiety and emotion regulation were analysed. Four participants 
revealed a HADS-A score ≥ 15 and therefore completed a structured interview (DSM-IV-
based M.I.N.I) (van Vliet & de Beurs, 2007) with the study psychologist (AKB). In none of 
these individuals, a psychiatric diagnosis was confirmed.
Trait and state anxiety were evaluated on the HADS and the State Trait Anxiety Index (STAI) 
(Spielberger et al., 1983). The HADS was assessed at two time-points, during the online 
screening and  after the fMRI scan to test if the level of anxiety remains stable over time 
and therefore indicates trait rather than state anxiety (in the following referred to as pre-
HADS and post-HADS, for details see supplementary material). Furthermore, the FEEL-E was 
recorded to evaluate emotion regulation strategies (Grob & Horowitz, 2015). We tested for 
associations between anxiety and (mal)adaptive emotion regulation strategies.
fMRI paradigm
An emotion regulation task adapted from previous studies on emotion regulation was 
applied (Kanske et al., 2015). In short, participants were exposed to 40 neutral and negative 
emotional photographs and were instructed to either just view the pictures (instruction: 
view) or view and downregulate their emotional response evoked by a picture by reappraising 
the presented scene (instruction: decrease) (for detail see supplementary material). After 
each picture, participants rated their current emotional state on an eight-point scale ranging 
from sad to happy, and their arousal on a ten-point scale ranging from active to quiet.
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fMRI data acquisition and analysis
Functional and structural multiband sequences were acquired on a 3T Magnetom PrismaFit 
MRI Scanner (Siemens AG, Healthcare Sector, Erlangen, Germany) using a 32-channel head 
coil. Imaging data-processing, data-denoising, and group analyses were conducted by 
using the FMRIB Software Library (FSL, University of Oxford, UK; www.fmrib.ox.ac.uk/fsl; 
Jenkinson et al., 2012). We followed standard preprocessing recommendations (for details 
on data acquisition and processing see supplementary material).
Contrasts of parameter estimates (COPE) of interest were included in a mixed effect model in FSL 
FLAME1. Individual COPE z-maps were calculated to isolate (1) activation in response to emotion 
regulation (regulation – negative view), and (2) activation in response to negative emotionality 
of a stimulus in the absence of explicit emotion regulation (negative view > neutral view). All 
results were thresholded using a cluster forming threshold of z > 3.1 (equal to p < .01) and a 
cluster significance threshold of p < .05 controlling for family-wise error at the cluster level.
In a whole-brain correlation analysis, the pre-HADS-A score was included as a covariate to 
evaluate potential associations between emotion regulation related to brain activity and the 
level of anxiety.  The mean activity of significant clusters was extracted per condition and 
plotted against the anxiety score for descriptive purposes. To test convergent validity, the 
mean activity of the resulting clusters was correlated with an alternative measure of anxiety 
(STAI). Pearson’s correlation coefficient for correlations of anxiety scores and the resulting 
cluster of activation, as well as analysis of behavioural data, were conducted in SPSS 23(SPSS 
Statistics for Windows, 2015). 
Functional connectivity analysis to detect the anxiety-related emotion regulation network
To test the functional connectivity of the identified anxiety-related regions, we performed 
a PPI (psychophysiological interaction) model. We implemented the PPI analysis according 
to the procedure laid out on the FSL homepage (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
PPIHowToRun). In each individual’s first level design, we used the contrast of regulation 
> negative view as psychological regressor and the cluster resulting from the whole brain 
level covariance analysis with the anxiety scores (pre-HADS) as a seed for the physiological 
regressor. Consequently in the interaction term, we investigated which other voxels change 
their level of activation in correspondence with this seed and in interaction with the task. 
On the group level, we investigated the interaction of the seed time-course with the task 
contrast and to assess whether functional interactions (e.g. psycho-physiological interactions) 
between the seed and other regions are associated with the level of anxiety, we also in the 
PPI analysis included anxiety scores (pre-HADS-A) as a regressor.  Additionally, to inform the 
inference on the association of connected regions, we conducted a serial mediation model 
with the PROCESS macros (Hayes, 2015) and tested if functionally connected regions mediate 
the relation between anxiety and neural activation patterns in the whole-brain analysis.
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The effect of neural activation in the emotion regulation network on regulatory success 
and emotion regulation strategies 
To relate habitual tendencies for specific emotion regulation strategies to the applied 
emotion regulation task, we tested pairwise associations between regulation strategies 
(FEEL-E scores) and regulatory success (behavioural ratings of arousal and emotional state 
after each trial). Next, we conducted a moderation model to test if those associations 
were affected by activation in the emotion regulation network. Therefore, detected 
neural activation patterns were tested for their potential interaction effect on significant 
associations between emotion regulation strategies (FEEL-E scores) and emotional state as 
a measure of regulatory success in the emotion regulation task (figure 3.E and F). 
For the serial mediation model and the moderation model, significance was defined by 
determining the significance of the two-way-interaction (Hayes, 2015). Both models were 
tested using 5000 bootstrapping samples and a confidence interval of 95%.
Results 
Online screening for elevated anxiety
Figure 1 displays the distribution of anxiety based on the HADS-A subscale in the screened 
population and the selected study population. The study population consisted of 35 
participants with low anxiety (HADS-A ≤ 7) and 93 participants with mild to severe anxiety 
(HADS-A > 7), (see supplementary material, table 1). There was no significant difference 
between females (mean = 9.12, sd = 3.57) and males (mean = 8.21, sd = 4.29) regarding their 
level of anxiety on the HADS-A, t(125) = -1.084, p = 0.238, Welch’s t(1) = 1.176, p = 0.28 (for 
details,  see supplementary material).
Figure 1: 
Color intensity indicates severity of anxiety; HADS-A scores < 8 correspond to normal levels of anxiety, scores of 8 
to 10 indicate mild anxiety, scores of 11 to 15 indicate moderate anxiety, and scores of ≥ 16 indicate severe anxiety. 
A: Distribution of anxiety scores in the online screening; mean = 6.77, sd = 3.95. B: Distribution of anxiety in the 
selected study population; mean = 8.88, sd = 3.78. Skewness to the right indicates the oversampling for elevated 
anxiety traits.
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Behavioural ratings in the emotion regulation task
Behavioural ratings showed that the task worked as expected. Including the pre-HADS-A 
score as a covariate in the repeated measures ANOVA, there was no effect of anxiety on 
the ratings of emotional state nor arousal (figure 2, for details see supplementary material). 
Emotion regulation strategies in anxious individuals and their relation to regulation success
To identify regulation strategies that might be associated with brain activity patterns in elevated 
anxiety, anxiety scores on the HADS were correlated with emotion regulation strategies on the 
FEEL-E (table 1). For additional validation, emotion regulation strategies were also correlated 
with the STAI scales for trait and state anxiety. All anxiety measures correlated positively with 
the summative scale of maladaptive emotion regulation strategies. All anxiety measures 
correlated positively with the sub-scales ‘rumination’, ‘giving up’, and ‘self-devaluation’. 
Adaptive emotion regulation strategies correlated negatively with some but not all anxiety 
scores. This pattern of results indicates that highly anxious individuals have a higher tendency 
for maladaptive than adaptive regulation strategies. Subsequent analyses to relate emotion 
regulation strategies to neural activation associated with emotion regulation were proceeded 
only on the FEEL-E subscales that correlated with all anxiety measures. 
Figure 2: 
A: Subjective ratings of emotional state on a scale from 0 (sad) to 8 (happy) across the three test conditions neutral 
view, negative view and regulation. B: Subjective ratings of arousal on a scale from 0 (active) to 10 (calm) across the 
three test conditions. ** Significant difference on the p < .01 level
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Table 1: Correlations Anxiety and Emotion regulation strategies; Pearson correlations (r) of FEEL-E scales for 
adaptive and maladaptive emotion regulation strategies and anxiety scores assessed on the HADS-A at two time 
points (pre and post fMRI measurement) and the STAI (trait and state anxiety). Significant correlations are marked 
in grey, *correlations significant at the p < 0.05 level (2-tailed), **correlations surviving multiple comparison 










Adaptive regulation strategies 
for anxiety
r .032 -.130 -.211* -.274**
p .718 .143 .017 .002
Cognitive problem solving r .056 -.099 -.125 -.147
p .529 .267 .160 .099
Re-evaluation r .069 -.034 -.038 -.071
p .438 .701 .669 .429
Problem orientation r -.087 -.270* -.366** -.275*
p .332 .002 .000 .002
Acceptance r -.034 -.290* -.349** -.261*
p .703 .001 .000 .003
Forgetting r -.054 -.148 -.150 -.095
p .544 .094 .092 .284
Positive mood r -.117 -.321** -.398** -.434**
p .190 .000 .000 .000
Maladaptive regulation strategies 
for anxiety
r .298* .482** .584** .485**
p .001 .000 .000 .000
Rumination r .270* .317* .367** .324*
p .002 .000 .000 .000
Giving up r .278* .513** .615** .531**
p .002 .000 .000 .000
Self-devaluation r .422** .389** .420** .292*
p .000 .000 .000 .001
Withdrawal r .167 .371** .476** .405**
p .060 .000 .000 .000
Negative thinking r .114 .297* .298* .269*
p .204 .001 .001 .002
Allocating blame r -.177* .062 .085 .097
p .047 .484 .341 .275
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Emotion regulation strategies measured on the FEEL-E that were associated with all anxiety 
scores (rumination, giving up, and self-devaluation) were correlated with subjective ratings 
of emotional state and arousal (table 2). For subjective ratings of emotional state, rumination 
correlated negatively with ratings in the regulation condition and positively with the 
difference in arousal between the neutral view and the regulation condition. Rumination is 
categorized as a maladaptive emotion regulation strategy, and a higher difference in arousal 
indicated lower success in emotion regulation. Hence, the higher the general tendency for 
rumination, the lower the success in emotion regulation. The regulation strategy ‘giving up’ 
correlated positively with the difference in arousal between the regulation and the neutral 
view condition. There was no correlation between ‘giving up’ and emotional state, nor 
between ‘self-devaluation’ and ratings of emotional state or arousal. Since rumination was 
the only regulation strategy that correlated with behavioural ratings of emotional state and 
arousal across several conditions, only rumination was associated with imaging data in the 
next step of the analysis.
Table 2: Correlation between habitual emotion regulation strategies and behavioural ratings in the emotion 
regulation task. Pearson correlations (r) of FEEL-E subscales that were positively associated with anxiety (table 
1) with ratings on emotional state and arousal in the emotion regulation task for the contrasts of interest. 
*correlations significant at the p < 0.05 level (2-tailed), **correlations surviving multiple comparison correction 
(Bonferroni, correcting for 3 tests (3 strategies).
Rumination Giving up Self-devaluation
Emotional State
Regulation r -.206* .025 -.167
p .020 .776 .060
Regulation > Negative View r -.001 -.054 .096
p .988 .547 .282
Regulation > Neutral View r .162 -.085 .112
p .067 .342 .208
Arousal
Regulation r -.231** -.024 -.042
p .009 .790 .637
Regulation > Negative View r -.069 -.123 -.103
p .439 .166 .248
Regulation > Neutral View r .214* .193* .154
p .015 .029 .082




Whole-brain level analyses revealed increased BOLD signal in the left middle and superior 
temporal gyrus, bilateral caudate, precuneus cortex, frontal pole, left thalamus and cerebellum 
for the contrast regulation > negative view, and increased activation in the lateral occipital 
cortex, frontal pole and right amygdala for the contrast negative view > neutral view (table 3). 
Table 3: Correlation between habitual emotion regulation strategies and behavioural ratings in the emotion 
activation clusters whole brain analysis for all contrasts of the emotion regulation task.
MNI-space coordinates (mm)
brain region voxels z-max x y z
Neutral View































































































































































Regulation > Neutral View
Lateral occipital cortex, inferior 81301 12.2 -2.54 -24.1 10




















Including the pre-HADS-A score as a covariate revealed a positive correlation between 
activation in a cluster of the VLPFC during the regulation contrast and anxiety. There was 
no significant correlation in any of the other contrasts. The correlation between mean 
activation in the extracted cluster for the contrast negative view > regulation and the pre-
HADS-A scores is displayed in figure 3B for descriptive purposes. To explore which of the 
processes occurring in the contrast regulation > view contributes to the correlation and 
in which way, we extracted the mean activation from the identified VLPFC cluster during 
emotion regulation for all contrasts. As additional validation, mean activation from the 
identified cluster was also correlated with the STAI for all contrasts (table 4). The correlation 
in the contrast regulation > neutral view was significant in all four anxiety measures.
Functional connectivity of the VLPFC during emotion regulation 
A PPI with the regulation contrast and the VLPFC time-course (MNI coordinates: x: -46 y: 54 
z: -4, 180 voxels, z-max = 4.83) as the seed was conducted to determine further areas related 
to these putatively regulatory processes. This analysis revealed functional connectivity to a 
cluster in the MTG (MNI coordinates: x: 18, y: 46, z: 26, 116 voxels, z-max = 4.28, results on 
VLPFC-MTG connectivity are discussed in the supplementary material). In a second step, we 
tested anxiety as a covariate in the PPI to determine anxiety-related functional connectivity. 
Including the pre-HADS-A score as a covariate, we found effective functional connectivity 
of the VLPFC seed with a dorsomedial PFC cluster (x: 60, y: -2, z: -12, 114 voxels, z-max = 
4.05). For additional validation, we correlated the detected dorsomedial PFC cluster with 
trait anxiety measured on the STAI. Activation in the dorsomedial PFC cluster was negatively 
correlated with trait anxiety (STAI-T, r = -.207, p < .05, figure 3A). 
Table 4: Correlations between anxiety and activation in the ventrolateral PFC cluster. Pearson correlations between 
mean activation in ventrolateral PFC cluster during all task conditions / condition contrasts and anxiety scores on 
the HADS-A (pre and post fMRI measurement), and STAI (STAI-T = trait anxiety, STAI-S = state anxiety). Significant 
correlations are marked in grey, * Correlations are significant at the 0.05 level (2-tailed), **correlations surviving 









Neutral View r -.124 -.063 .006 -.044
p .083 .240 .475 .309
Negative View r -.008 .006 .049 .034
p .465 .474 .292 .351
Regulation r .183* .098 .119 .069
p .020 .135 .090 .219
Regulation > Negative View r .327** .161* .134 .069
p <.001 .035 .065 .219
Regulation > Neutral View r .414** .216* .161* .152*
p .000 .007 .034 .044
Negative View > Neutral View  r .204* .120 .074 .136
p .011 .089 .204 .064
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Mediation model: Emotion regulation network mediates anxiety-related VLPFC activation
To determine whether the regulatory network identified by the PPI (MTG and DMPFC) 
drives the association between VLPFC activation and anxiety, we conducted a mediation 
analysis. MTG activation and VLPFC-DMPFC connectivity were included as potential 
mediators. Estimating a serial mediation model (figure 3.E) indicated a direct effect of VLPFC 
activation predicting anxiety (HADS-A), b = .078, t(125) = 2.316, p < .05, and an indirect 
effect of functional VLPFC-DMPFC connectivity predicting anxiety (HADS-A), b = -14.66, 
t(123) = -3.506, p < .001. MTG activation was no mediator of the relationship between VLPFC 
activation and anxiety but predicted functional VLPFC-DMPFC connectivity, b = .264, t(124) 
= 4.415, p < .001. The results show that next to a direct effect of VLPFC activation on anxiety, 
there is a partial mediation driven by functional VLPFC-DMPFC functional connectivity 
(figure 3.E). 
VLPFC-DMPFC coupling compensates for maladaptive emotion regulation strategies 
Since rumination was the only regulation strategy that correlated with all applied anxiety 
scales (table 1), rumination was included in a further explorative analysis aiming to associate 
anxiety-related neural activation in the emotion regulation task with the habitual use of 
rumination as emotion regulation strategy. As we interpret the VLPFC-DMPFC coupling during 
the task as reflecting strategy-use to regulate emotion, we conducted a moderation analysis 
probing the moderator influence of VLPFC-DMPFC coupling on the relation of rumination 
and regulatory success. We investigated if VLPFC-DMPFC coupling affects the detected 
relation between rumination (measured on the FEEL-E) and ratings of arousal during the 
emotion regulation task as a measure of regulatory success (table 2). A moderation analysis 
showed that different levels of functional VLPFC-DMPFC connectivity affect the significance 
of the relation between rumination and arousal as a measure of emotion regulation 
success, ∆R2 = .069, F(3,124) = 3.063, p < .05. Negative functional connectivity increased the 
significance level, while positive functional connectivity decreased the significance level of 
the association between rumination and arousal (figure 3.F, supplementary material). That 
is, strong VLPFC-DMPFC coupling removed the elevating influence that rumination had on 
arousal. In other words, an elevated VLPFC-DMPFC coupling protected anxious individuals 
who tend to use rumination from elevated arousal during emotion regulation trials. 
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Figure 3: 
A: A PPI model revealed functional connectivity between the ventrolateral PFC cluster and two prefrontal areas: a 
cluster in the MTG (MNI coordinates: x: 18, y: 46, z: 26, 116 voxel, z max = 4.28), and a cluster in the dorsomedial PFC 
(x: 60, y: -2, z: -12, 114 voxel, z max = 4.05). B: A whole-brain/whole group regression analysis revealed increasing 
BOLD activation during the regulation condition in a cluster located in the ventrolateral PFC (MNI coordinates: 
x: -46 y: 54 z: -4, 180 voxels, z max = 4.83) with increasing anxiety scores on the HADS-A (correlation for illustration 
purposes only). C: The more ventrolateral PFC activation was recruited, the less functional connectivity to the MTG 
was detected (correlation for illustration purposes only). D: Functional connectivity between the ventrolateral PFC 
and dorsomedial PFC was negatively correlated with anxiety (HADS-A) eventually indicating that ventrolateral-
dorsolateral PFC coupling increases the regulatory efficiency (correlation for illustration purposes only). 
E: Mediation Model: Direct effect between ventrolateral PFC activation and anxiety and a partial, serial mediation 
operating via the MTG and ventrolateral-dorsomedial PFC connectivity. F: Moderation Model: Ventrolateral-
dorsomedial PFC connectivity moderated the correlation between rumination (FEEL-E) and ratings of arousal as a 
measure of regulatory success in the emotion regulation task.
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Discussion
This study revealed the characteristic neural underpinnings of emotion regulation associated 
with elevated levels of anxiety. We conducted an emotion regulation task in a healthy 
population with elevated anxiety traits and demonstrated that increased levels of anxiety 
are related to increased left VLPFC recruitment during reappraisal of negative emotional 
stimuli, while on a behavioural level, anxiety did not affect perceived success of emotion 
regulation. Hence, while high anxiety does not affect emotion regulation on a behavioural 
level, recruitment of prefrontal neural resources increases with high anxiety. A subsequent 
PPI analysis revealed functional connectivity between the VLPFC and the MTG as well as the 
DMPFC. Individuals with increased VLPFC-DMPFC connectivity revealed lower anxiety traits 
and a less strong association between a habitual maladaptive emotion regulation strategy 
(rumination) and reduced regulatory success. Hence, VLPFC-DMPFC connectivity might 
attenuate the negative effect of rumination regarding effective emotion regulation. These 
results indicate that increased VLPFC recruitment, as well as potentially protective VLPFC-
DMPFC coupling, contribute to successful emotion regulation in highly anxious individuals. 
Increased VLPFC recruitment in highly anxious individuals
Considering emotion regulation as a two-step process, where a stimulus is first perceived 
and evaluated and subsequently re-evaluated to downregulate the emotional response, 
increased VLPFC activation might account for intensified perception and initial appraisal 
of a negative emotional stimulus. Accordingly, VLPFC activation was interpreted to signal 
salience and the need to regulate rather than the regulatory process itself (Kohn et al., 
2014; Ochsner et al., 2012). Increased VLPFC activation has been demonstrated in patients 
with a generalized anxiety disorder when exposed to an anxiety-inducing narrative script 
or anxiety-related words indicating increased fear processing (Buff et al., 2018; Moon et 
al., 2015). Patients with phobia reveal increased VLPFC recruitment when being exposed to 
pictures of spiders compared to healthy controls (Zilverstand et al., 2017). Similarly, anxious 
adolescents showed greater functional connectivity between the amygdala and the VLPFC 
when anticipating social evaluation (Guyer et al., 2008). 
However, the VLPFC has also been considered a regulatory node. Specifically, reappraisal 
has been associated with VLPFC involvement (Berboth & Morawetz, 2021; Morawetz, Bode, 
Baudewig, et al., 2017a; Wager et al., 2008). In this line, elevated VLPFC involvement might 
also be interpreted as increased efforts to establish emotion regulation. Healthy but anxiety-
prone individuals revealed increased recruitment of the left VLPFC and DMPFC during a 
reappraisal task, while on a behavioural level, anxious individuals were as successful in 
downregulating their emotions as non-anxious individuals (Campbell-Sills et al., 2011). 
Likewise, effective emotion regulation via neuro-feedback in patients with PTSD was 
associated with increased VLPFC activation (Nicholson et al., 2017). Hence, increased VLPFC 
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recruitment might implicate higher efforts to reach effective emotion regulation. Taken 
together, the VLPFC might be considered as an interface where the perception of emotion 
initiates the need for regulation of emotion. Thus, in highly anxious individuals increased 
VLPFC might reflect the intensified perception of emotional salience leading to increased 
recruitment of neural resources underlying regulatory processes.
VLPFC - DMPFC coupling: Increasing efficiency of emotion regulation
VLPFC-DMPFC connectivity was negatively associated with anxiety and mediated the 
association between ventrolateral activation and anxiety. The DMPFC has been associated 
with the efficiency of downregulating negative emotions; functional connectivity between 
the DMPFC and prefrontal structures involved in regulatory processes (VLPFC and DLPFC) was 
correlated with reappraisal success (Morawetz, Bode, Baudewig, et al., 2017a). Also, DMPFC 
activation during regulation was correlated with reappraisal success in healthy individuals 
(LeWinn et al., 2018). The DMPFC was not per se recruited during emotion regulation, but 
only active when regulating high-intensity as opposed to low-intensity emotional stimuli 
(Silvers et al., 2015). Accordingly, the DMPFC might rather be recruited as an additional 
neural resource when emotion regulation is more demanding. To reach effective emotion 
regulation, highly anxious individuals might recruit more ventrolateral and dorsomedial 
resources than low anxious individuals. In the present population of highly anxious 
individuals, VLPFC-DMPFC coupling was negatively correlated with trait anxiety, indicating 
that the more prefrontal resources were recruited, the lower the anxiety level assessed on 
the questionnaires. Similarly, DMPFC activation was negatively correlated with anxiety in 
patients with a generalized anxiety disorder (Ball et al., 2013). Hence, the DMPFC might 
increase the efficiency of emotion regulation and state a neural resource that is recruited in 
individuals who achieve effective emotion regulation. The correlation between low anxiety 
and increased VLPFC-DMPFC coupling might indicate that latter one constitutes a protective 
factor towards limited emotion regulation capacity. The present population of highly 
anxious individuals revealed an increased tendency for maladaptive emotion regulation 
strategies, specifically rumination, giving up and self-devaluation. Functional VLPFC-DMPFC 
connectivity moderated the association between rumination and low regulatory success. 
Since increased VLPFC-DMPFC coupling weakened the association between rumination and 
low regulatory success, VLPFC activation might account for automatic regulatory efforts 
while VLPFC-DMPFC connectivity might rather reflect the regulatory strategy. 
Conclusion
Individuals with subclinical anxiety show neural characteristics that compensate for the 
increased anxiety traits by recruiting more neural resources during regulatory processes. 
Specifically, increased VLPFC activation and functional VLPFC-MTG connectivity as well as 
VLPFC-DMPFC connectivity might be a neural characteristic of healthy but highly anxious 
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individuals. Ultimately, in highly anxious individuals, regulation via increased VLPFC was 
sufficient to reach the regulatory goal despite high anxiety.  Functional coupling with the 
DMPFC reduced the anxiety level and weakened the association between rumination 
and reduced regulatory success. Based on these findings, increased VLPFC activation and 
functional VLPFC-DMPFC connectivity might be considered as a protective factor against 
pathological anxiety. 
Limitations
The anxiety screening on the HADS-A was performed online. Therefore, there was 
no controlled environment and time point when a subject filled in the questionnaire. 
Nevertheless, we demonstrated that the majority of results holds with an alternative 
measure of anxiety that was taken under controlled laboratory conditions. The majority of 
our study population was recruited from university undergraduates eventually leading the 
results to be less representative to the general population. 
We selected a mediation model based on the assumption that a specific mediator might 
be associated with a certain outcome. We found statistical evidence for the presented 
mediation model. However, other statistical models that have not been tested in the 
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1. Trait anxiety distribution in the study population
The study population consists of a group of healthy participants with elevated anxiety traits. 
Persistently high but non-pathological levels of anxiety can be defined as sub-clinical anxiety, 
where episodes of high but non-pathological anxiety could develop clinical relevance 
overtime, or constitute a trait in a healthy individual. A trait is commonly defined as 
personality characteristic that is stable over time. Individuals were selected for participation 
based on their score on the anxiety subscale of the HADS. The HADS is not per definition 
a trait measure but evaluates anxiety symptoms referring to the last seven days. Increased 
scores on the HADS might not per se indicate elevated trait anxiety. Therefore, we repeated 
the HADS during the test session to assess stability of anxiety scores over time, and as 
additional validation also applied the trait anxiety scale of the STAI during the test session. 
Pre- and post-HADS were highly correlated with the trait scale of the STAI (see suppl. table 
2), indicating that the population expressed elevated symptoms of anxiety that are stable 
over time and can potentially be considered as trait anxiety. Correlations of the HADS with 
the trait and state scale of the STAI revealed a numerically higher correlation between the 
HADS and the trait scale compared to the state scale.  
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2. Study procedures
All 128 participants completed the full study that included an fMRI-session consisting of 
three paradigms (face-matching task (Hariri et al., 2000), emotion regulation task, and 
a visual oddball paradigm (Yoshiura et al., 1999) with a threat-of-shock manipulation), 
continuously recorded physiological measurements (heart rate, skin conductance, pupil 
Suppl. Table 1: Averaged median activation of the two a-priori defined regions of interest; the prefrontal emotion 
regulation network (ERN) and bilateral amygdala listed separately for all task conditions.
HADS-Anxiety subscale Females Males Overall

























































































































































Suppl. Table 2: Pearson correlations (r) between anxiety measures, all correlations are significant on the p < .001 









pre-HADS-A r .678 .519 .485
p < .001 < .001 < .001
post-HADS-A r .678 .729 .671
p < .001 < .001 < .001
STAI-T r .519 .729 .798
p < .001 < .001 < .001
STAI-S r .485 .671 .798
p < .001 < .001 < .001
98 CHAPTER 4
dilation, EMG-recording of the trapeze muscle) and questionnaires on anxiety, depression, 
personality and emotion regulation. A questionnaire on emotion regulation strategies 
(FEEL-E) was recorded to evaluate habitual tendencies for emotion regulation strategies (3). 
For the present study, only the emotion regulation task and questionnaires on anxiety and 
emotion regulation were analysed. Results from the other measurements will be reported 
separately. All questionnaires were applied in Dutch. 
The FEEL-E questionnaire consists of 72 questions evaluating six adaptive and six 
maladaptive emotion regulation strategies when dealing with anger, anxiety, or sadness. 
Each strategy is evaluated based on six items. Evaluated adaptive strategies include problem 
oriented acting, acceptance, problem solving, re-evaluation (reappraisal), lighten the mood, 
and forgetting (oblivion). Evaluated maladaptive strategies are withdrawal, self-devaluation 
(degrading and blaming oneself) giving up, negative thinking (catastrophic thinking), and 
allocating blame (blaming others) (Grob & Horowitz, 2015). 
2.1 Emotion regulation task
Participants were exposed to 40 photographs (20 emotionally negative and 20 neutral 
scenes), which were taken from the International Affective Picture System (Lang et al., 
1997), and EmoPics (Wessa et al., 2010). Participants were instructed to either just view the 
pictures (instruction: view) or view and downregulate their emotional response evoked by a 
picture by reappraising the presented scene (instruction: decrease). Participants received a 
standardized instruction for emotional reappraisal before the fMRI scan (see task instruction 
below). Negative pictures were presented in both conditions (view and regulation) while 
neutral pictures were only presented in the view-condition, resulting in 60 pseudo-
randomized trials (trial length: 16 sec, inter-stimulus interval: 1500msec). Each picture was 
presented for eight seconds in total, the instruction to downregulate or view followed after 
the first two seconds superimposed on the picture. After each picture, participants rated 
their current emotional state on an eight-point scale ranging from sad to happy, and their 
arousal on a ten-point scale ranging from active to quiet.
Suppl. Figure 1: Emotion Regulation Task.
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2.2 Task instruction 
Task instruction: 
Please watch each photo carefully. In the view condition (VIEW superimposed on photo), try 
to just let the picture take its effect on you. 
In the decrease condition (DECREASE superimposed on photo), watch the photo, but this 
time, as you watch, try to think about the situation you see in a more positive light. You can 
achieve this in several different ways. For example, try to imagine advice that you could give 
to the characters in the photo to make them feel better. This could be advice that would 
help them think about the positive bearing this event could have on their lives. Think about 
the good things they might learn from this experience. Keep in mind that even though a 
situation may be painful in the moment, in the long run, it could make one’s life better, or 
have unexpected good outcomes. You can alternatively try to put yourself in the position 
of a professional watching this photo (psychologist, veterinarian, social worker) or put your 
focus on technical aspects of the photo. 
Participants received the Dutch version:
Gelieve elke foto aandachtig te bestuderen. Probeer tijdens de weergavefase (wanneer 
VIEW staat vermeld op de foto) de afbeelding zijn effect op u uit te laten werken. In de 
beoordelingsfase (wanneer VERMINDER staat vermeld op de foto) bekijkt u de foto, maar 
deze keer, terwijl u kijkt, probeert u de situatie die u bekijkt in een positiever licht te zien. U 
kunt dit op verschillende manieren bereiken. Bijvoorbeeld door u in te beelden welk advies 
u de personen uit de foto zou geven, om zich beter te laten voelen. Dit kan advies zijn dat 
hen helpt om na te denken over de positieve invloed van de gebeurtenis op hun leven. Denk 
na over de goede dingen die de personen zouden kunnen leren van deze ervaring. Houd in 
u gedachten dat, hoewel een situatie pijnlijk kan zijn op het moment zelf, het kan zijn dat 
op de lange termijn iemands leven er juist beter van wordt, of andere onverwachtse goede 
uitkomsten. Als alternatief zou u ook kunnen proberen om met de blik van een professional 
(psycholoog, dierenarts, sociaal hulpverlener) naar de foto te kijken of de focus leggen op 
de technische aspecten van de foto.
2.3 fMRI data acquisition and image processing
T2*-weighted EPI BOLD-fMRI images were acquired, applying a multiband 4 sequence 
(slice number = 68, TR = 1500ms, TE = 39.6ms, flip angle = 75°, voxel size = 2x2x2mm3, slice 
gap = 0mm, FOV = 210mm). For anatomical reference, a high-resolution T1-weighted image 
(slice number = 192, TR = 2300ms, TE = 3.03ms, flip angle = 8°, voxel size = 1x1x1 mm3, 
FOV = 256x256x192mm3, base resolution = 256, sagittal acquisition) was obtained.
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Data quality checks were performed by visual inspection of structural and functional scans, 
spike checks and signal-to-noise ratio plots. For pre-processing, the first five volumes of each 
functional time series were discarded, allowing magnetization effects and initial transient 
signal changes. Further preprocessing steps included three-dimensional movement 
correction, spatial smoothing using a 6mm full-width at half maximum (FWHM) Gaussian 
kernel to reduce inter-subject variability, and application of a high-pass filter (>100s). Before 
all group analyses, data was normalized to MNI-space and re-sampled to 2mm³ resolution 
using the FMRIB's Nonlinear Image Registration Tool (FNIRT). Data-denoising was conducted 
by applying ICA-AROMA, which automatically identifies and removes motion-related 
artefacts (Pruim et al., 2015).
For every subject, data was modelled in FEAT (FMRI Expert Analysis Tool, version 6.0) and 
BOLD time-courses were analysed within the framework of mass-univariate General Linear 
Modelling (GLM), resulting in primary parameter estimates and estimates of residual noise 
variance converted into z-statistic maps. Onsets and durations of the experimental and 
control conditions, and a noise regressor were implemented as separate regressors in every 
subject-level model.  
3. Behavioural Results: Ratings emotion regulation task
A repeated-measures ANOVA with a Greenhouse-Geisser correction revealed significant 
differences in emotional state ratings after neutral view, negative view and regulation 
trials (Wilk’s Lambda = .120, F(2,126) = 462.220, p < .001). Post-hoc tests using Bonferroni 
correction revealed that ratings of emotional state were the highest in the view neutral 
condition. Viewing a negative picture reduced ratings of emotional state by -2.305 points 
(p < .01). When instructed to regulate their emotional reaction, emotional state was rated 
less differently to the view neutral condition (-1.137 points, p < .01). Ratings of arousal 
were also significantly different across all three conditions (Wilk’s Lambda = .297, F(2,126) 
= 149.407, p < .001). Viewing a negative picture without the instruction to regulate one’s 
emotion reduced the arousal rating by -.970 points compared to viewing a neutral picture (p 
< .01). Since lower values correspond to a more active state, participants report to feel more 
aroused when viewing a negative picture compared to viewing a neutral picture without 
any attempt to regulate their emotions. After viewing a negative picture with the instruction 
to regulate (condition: regulation), arousal was rated less differently to the view neutral 
condition (- .726 points, p < .01).
3.1 Anxiety effects on behavioural data
Anxiety scores had no effect on the subjective rating of arousal and emotional state across 
the three test conditions. Anxiety also did not affect the number of button presses on the 
self-rating scale for arousal and emotional state until a subject decided for a final answer.



































































































































































































































































































































































































































































































Suppl. Table 4: Local maxima in the whole-brain analysis for the condition negative view.
CLUSTER INDEX Z x y z





















































































































































Contrast 2: Negative View (local maxima)




























































































































































































































































































































Suppl. Table 6: Local maxima in the whole-brain analysis for the regulation condition.
CLUSTER INDEX Z x y z








































2 Lateral occipital cortex, superior 6.43 24 -62 64




















Contrast 3: Regulation (local maxima)

































































































































































































































































































































































































































Suppl. Table 8: Local maxima in the whole-brain analysis for the contrast regulation > negative view.
CLUSTER INDEX Z x y z




































































































Contrast 4: Regulation > Negative View (local maxima)
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5. Moderation of association between maladaptive emotion regulation and arousal
IV: Rumination (scale for maladaptive emotion regulation strategy on the FEEL-E)
DV: Arousal as a physiological measure for emotion regulation success, (difference score: 
regulation – neutral view)
Moderator: VLPFC-DMPFC (functional connectivity between the ventrolateral PFC and the 
dorsomedial PFC)
Total overall model (n = 128), ∆R2 = .069, F(3,124) = 3.063, p < .05
Suppl. Table 13: Moderation table. Values of VLPFC-DMPFC connectivity for the conditional effects are taken for 
the 16th, 50th, and 84th percentiles.
B se T p CI
Constant .961 .086 11.079 .000 .789 1.133
Rumination .057 .024 2.309 .022 .0082 .1067
VLPFC-DMPFC -.380 1.004 -.378 .705 -2.368 1.607
Interaction: 
rumination x VLFC-DMPFC
-.494 .284 -1.738 .084 -1.058 .068
Conditional Effects
VLPFC-DMPFC* B se T p CI
-.0621 .0882 .0294 3.0021 .0032 .0301 .1464
-.0064 .0606 .0248 2.4451 .0159 .0116 .1097
.0602 .0277 .0313 .8851 .3778 -.0342 .0896
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6. Emotion Regulation Strategies (FEEL-E): correlations with imaging data
Suppl. Table 14: Correlation of FEEL-E scales for adaptive and maladaptive emotion regulation strategies and 
functional connectivity between ventrolateral PFC and dorsomedial PFC, activation in the MTG,  activation in the 
ventrolateral PFC for the contrast regulation > negative view,* Correlations are significant at the 0.05 level (2-tailed), 







Adaptive regulation strategies 
for anxiety
r -.118 -.106 .157
p .184 .233 .077
Cognitive problem solving r -.269** -.058 .160
p .002 .516 .072
Re-evaluation r -.175* -.034 .070
p .048 .700 .434
Problem orientation r -.034 -.067 .096
p .706 .456 .281
Acceptance r -.087 -.032 .103
p .327 .721 .248
Forgetting r -.076 -.042 .018
p .392 .640 .843
Positive mood r -.003 -.102 .052
p .976 .254 .557
Maladaptive regulation strategies 
for anxiety
r -.116 .064 -.035
p .191 .470 .698
Rumination r -.057 -.015 .068
p .520 .865 .445
Giving up r -.157 -.026 .046
p .077 .774 .609
Self-devaluation r -.132 .021 .121
p .136 .817 .174
Withdrawal r -.067 .023 .006
p .453 .801 .943
Negative thinking r .074 .053 -.089
p .405 .553 .320
Allocating blame r .135 .115 -.073
p .128 .196 .412
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7. Gender effects on imaging data and behavioural data
Male and female did not differ in mean activation across all calculated contrasts. Gender 
also did not affect mean activation and connectivity of the dorsomedial PFC and middle 
temporal gyrus. Rating of emotional state after seeing a negative picture without instruction 
for emotion regulation was slightly lower in females (mean = 3.67, sd = .652) compared to 
male (mean = 4.04, sd = .722); t(126) = 2.712, p < .01).
8. Discussion: Functional connectivity between VLPFC and MTG
In the present study, a functional connectivity analysis revealed functional coupling between 
the VLPFC and the MTG. The MTG has been shown to be involved in emotion regulation 
previously and was associated with efficient downregulation of an emotion (Kohn et al., 
2014). Increased right MTG recruitment during emotion generation in patients with a major 
depressive disorder was interpreted as a compensatory mechanism, as increased MTG 
activation was associated with lower negative affection (Davis et al., 2018). Furthermore, the 
MTG plays a key role in integrating multi-modal emotional information and gates amygdala 
activation depending on whether emotional stimuli from different sensory modalities are 
coherent or incoherent. Integration of incoherent stimuli in the MTG leads to attenuated 
amygdala activation while the integration of coherent emotional information increases the 
amygdala response (Müller et al., 2012).
Increased MTG activation was also associated with threat anticipation in highly anxious 
individuals, where MTG engagement was detected as a function of trait anxiety levels (Geng 
et al., 2018). Similarly, increased MTG activation was observed in patients with generalized 
social anxiety disorder relative to healthy controls (Yuan et al., 2018). Considering the 
regulatory and integratory role of the MTG, functional VLPFC-MTG coupling during emotion 
regulation in highly anxious individuals might either account for increased regulatory efforts, 
or intensified salience processing concerning fear-related cues. However, in the present 
study, MTG activation was not associated with anxiety traits. VLPFC activation correlated 
negatively with VLPFC-MTG coupling during emotion regulation in highly anxious individuals. 
These results might indicate that sufficient VLPFC resources had been recruited to reach 
successful emotion regulation and therefore the MTG was less involved. Less MTG coupling 
with higher VLPFC activation might either point towards less need for further regulatory 
resources or indicate successful downregulation of anxiety, which prevents further fear 
processing associated with MTG activation.
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Background: The Covid-19 pandemic has led to drastic public health measures with a 
substantial impact on the individual. Previous studies reported elevated levels of stress, 
anxiety, and depression in the general population as a consequence of pandemic-related 
public health measures. In vulnerable individuals, exposure to an uncontrolled global 
stressor like the Covid-19 pandemic might be felt as particularly threatening. 
Methods: A population of 127 healthy individuals that expressed increased trait anxiety 
(HADS ≥ 8) already before the outbreak of the pandemic were tested on state and trait 
anxiety, stress and depression before and four weeks after the outbreak of the pandemic in 
the Netherlands. Online questionnaires were administered between April 16 and April 23, 
2020. 
Results: We observed an increase in state anxiety (STAI) during the pandemic but no change 
in depression. Yet, trait anxiety (STAI) before the pandemic did not predict the increase 
in state anxiety during the pandemic. Further, state anxiety during the pandemic was not 
associated with being in contact with an infected person, having symptoms of Covid-19, 
protective behaviour, or degree of social isolation when controlling for state anxiety 
before the outbreak of the pandemic. However, maladaptive emotion regulation strategies 
measured before the pandemic predicted state anxiety and perceived stress during the 
pandemic, while adaptive strategies had no association with anxiety during the pandemic. 
Conclusion: Reducing learned helplessness and self-blaming to prevent maladaptive 
emotion regulation strategies like giving up and self-devaluation might be more beneficial 
than training adaptive strategies.  
Limitations: Time variation in baseline measurements
Published as:
Brehl, A. K., Schene, A., Kohn, N., & Fernández, G. (2021). Maladaptive emotion regulation 
strategies in a vulnerable population predict increased anxiety during the Covid-19 pandemic: 
a pseudo-prospective study. Journal of Affective Disorders Reports, 4, 100113.
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Introduction
The Corona pandemic poses a global stressor on society with potential consequences for the 
mental health and well-being of individuals. Numerous studies reported increased levels of 
stress, anxiety, and depression, following the outbreak of the novel coronavirus (Covid-19) 
and implementation of pandemic-related measures (Fernández et al., 2020; Holmes et 
al., 2020; Korajlija & Jokic-Begic, 2020; Lahav, 2020; Shevlin et al., 2020; Tian et al., 2020; 
C. Wang & Zhao, 2020; Xiong et al., 2020). Likewise, studies on previous virus pandemics 
described a fear of contamination and restricted social contact due to distancing in private 
and professional life as main risk factors for increased anxiety (Blakey & Abramowitz, 2017).
The majority of the healthy population might experience the pandemic and related regulations 
as challenging. Nevertheless, healthy individuals presumably can draw on sufficient mental 
resources to cope with the situation (Fried, 2020). In contrast, the pandemic and related 
consequences might have a more negative impact on vulnerable individuals that already 
express elevated trait anxiety in normal times. Those individuals might experience increased 
stress during the Covid-19 pandemic, which eventually may lead to the clinical manifestation 
of anxiety or depression (Taylor & Asmundson, 2020). First studies on potential effects of 
the pandemic on mental health focused on healthy populations while clinical and subclinical 
groups received substantially less attention (Yao et al., 2020). Further, most studies only 
assessed mental health during the pandemic and were not able to relate results to 
measurements before the outbreak of the pandemic. We investigated anxiety, depression, 
and perceived stress as well as emotion regulation strategies in a vulnerable population of 
healthy individuals with increased trait anxiety. Importantly, the study data were acquired 
before the outbreak of the pandemic in the Netherlands, ensuring a population that had 
already shown vulnerability (but without clinical severity) before the occurrence of the 
pandemic, and thus, our approach enabled a pseudo-prospective study design. 
Emotion regulation plays a crucial role in emotional well-being in healthy individuals. 
Emotion regulation involves cognitive and behavioural processes that influence emotional 
experiences and emotional reactions (Gross, 1998). Those processes comprise a range of 
cognitive and behavioural strategies that have been categorized as adaptive and maladaptive 
strategies based on their effectiveness and the costs they carry along. Maladaptive emotion 
regulation strategies like suppression and avoidance behaviour have been associated with 
higher levels of anxiety, lower well-being and reduced interpersonal functioning (Campbell-
Sills & Barlow, 2007; Craske & Stein, 2016; Gross & John, 2003; Hofmann et al., 2009). 
Increased anxiety might therefore be a by-product of using maladaptive emotion regulation 
strategies. In contrast, reappraisal, which involves the benign or positive reinterpretation of 
an emotional stimulus or situation, is considered as an adaptive emotion regulation strategy 
and has been associated with lower levels of depression, stress, and anxiety (Martin & 
Dahlen, 2005). Yet, emotion regulation skills may be protective at normal times but may fail 
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when being exposed to a serious global and ongoing stressor like the Covid-19 pandemic. 
Further, pandemic-related restrictions might impede adaptive emotion regulation, as people 
are limited in their ability of actively changing their situation. 
As part of an ongoing study, we evaluated adaptive and maladaptive emotion regulation 
skills already before the outbreak of the pandemic and related these to changes in anxiety 
and depression during the pandemic. We aimed to investigate (a) if anxiety and depression 
increased in the early phase of the pandemic, and (b) whether trait anxiety measured before 
the outbreak of the pandemic predict potential increases in anxiety due to the pandemic. 
Further, we explored whether (c) anxiety or stress during the pandemic can be predicted 
based on adaptive or maladaptive emotion regulation strategies individuals preferably 
applied before the outbreak of the pandemic.
Methods
Study population
Between November 2017 and January 2020 subjects were recruited based on an online 
screening, consisting of the Hospital-Anxiety-and-Depression-Scale (HADS, Zigmond & 
Snaith, 1983), demographical data, and screening for MRI-compatibility (conducted on 
www.soscisurvey.de). The screening was advertised on university websites and announced 
in university lectures. The HADS evaluates anxiety and depression and is a valid tool to 
investigate variance of trait anxiety in a healthy population (Breeman et al., 2015). To 
oversample for high trait anxiety, all individuals with elevated scores (≥8) on the HADS anxiety-
subscale (HADS-A) received a study invitation, while individuals with normal scores (HADS-A 
<8) were selected for study participation based on a 25%-probability. Of 2206 subjects that 
completed the screening, 486 potential participants received a study invitation for a study 
on neural biomarkers of anxiety. In case of HADS-A scores > 15, presumably indicating clinical 
levels of anxiety, a structured interview (DSM-IV-based M.I.N.I) (van Vliet & de Beurs, 2007) 
was conducted with the study psychologist (AKB). Of 248 subjects that agreed to participate 
in an fMRI study, one subject was excluded due to a suspected psychiatric diagnosis in order 
to ensure a healthy study population. Further, 13 subjects were excluded because of reduced 
data quality, incidental findings, falling into sleep during the fMRI session, or incomplete 
data collection due to premature termination. Finally, 234 participants (63 males, 171 
females, mean age 22.8 (4.85)) completed the test session including fMRI, physiological 
measurements (skin conductance, heart rate, pupil dilation), and a questionnaire battery 
on anxiety, stress, and personality (results will be reported elsewhere). The majority were 
university students with elevated HADS-A scores; 184 participants had a HADS-A score ≥8 
(47 males, 137 females), and 50 participants had a HADS-A score < 8 (16 males, 34 females). 
This study was approved by the regional ethics committee (commissie mensgebonden 
onderzoek (CMO)) of the Radboudumc in Nijmegen/ The Netherlands (CMO 2017/3588). 
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Four weeks after the pandemic-related regulations came into force in the Netherlands (15th 
of March 2020), all 234 participants that had completed the study were approached again 
for an online follow-up study. Of those, 127 participants (54%) completed the online follow-
up (98 females, mean age: 22.8). This follow-up study was also approved by the CMO of the 
Radboudumc in Nijmegen/ The Netherlands (CMO2014/288).
Follow-up questionnaires
The follow-up study consisted of several questionnaires on anxiety, depression, and 
emotion regulation that were already administered once before the pandemic during the 
original study (see table 1). To measure the change of anxiety and depression during the 
pandemic, the State and Trait Anxiety Index (STAI; Spielberger et al., 1983) and the HADS 
were measured before (original study) and during the pandemic. Adaptive and maladaptive 
emotion regulation strategies were evaluated on the Questionnaire on Emotion Regulation 
in Adults (FEEL-E; Grob & Horowitz, 2015) only before the pandemic. The FEEL-E entails six 
subscales on adaptive strategies (problem-oriented, acceptance, cognitive problem solving, 
re-evaluation, positive mood, forgetting) and six subscales on maladaptive strategies 
(withdrawal, self-devaluation, giving up, rumination, negative thinking, allocating blame). 
Additionally, a questionnaire on the perception of and dealing with the Covid-19 pandemic 
evaluated if participants experienced symptoms that relate to Covid-19, had been in contact 
with a Covid-19 infected person, frequency of checking the news, fear of contamination, 
general health worry, degree of social isolation, protective behaviour, and how appropriate 
regularities and media attention were perceived. Stress was evaluated on a validated 
questionnaire on stress perception only during the pandemic (PSS; Cohen et al., 1983). All 
questionnaires were administered in Dutch (for detailed description of all questionnaires 
see supplementary material).
In the original study participants filled in the questionnaires during a test session at the 
institute, using a cloud-based clinical data platform (Castor Electronic Data Capture, 2019, 
https://castoredc.com). The follow-up questionnaires during the pandemic were conducted 
online using the same platform. Participants received a link to their encrypted record to 
fill in the questionnaires. Participants had a time window of seven days to complete the 
questionnaires (April 16th - April 23rd 2020). During this period, participants were most likely 
not able to continue their work or study normally and experienced a highly restricted social 
life due to the pandemic related regulations in the Netherlands (https://www.government.
nl/topics/coronavirus-covid-19/tackling-new-coronavirus-in-the-netherlands). 
Statistical analysis
To test the change of anxiety and depression levels before (baseline) and after the pandemic 
(pandemic), paired-sample t-tests were calculated. Further, we conducted Bayesian paired 
sample t-tests to estimate the probability of a potential change (or no change) in anxiety or 
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depression during the pandemic. Bayesian statistics provides the probability of how much 
more likely the data are under the null hypothesis compared to the alternative hypothesis 
(Quintana & Williams, 2018). To investigate whether responders and non-responders to the 
follow-up questionnaire during the Covid-19 pandemic differed in their level of anxiety or 
depression an independent samples t-test was calculated. To test whether individuals that 
were highly anxious before the outbreak of the pandemic experienced a larger increase of 
state anxiety during the pandemic, we correlated trait anxiety before the pandemic with 
the difference score in state anxiety. Furthermore, state anxiety during the pandemic was 
correlated with variables of the Covid-19 questionnaires controlling for state anxiety before 
the pandemic. We conducted independent sample t-tests to test whether individuals that 
had Covid-19 like symptoms such as fever, cold or cough, or had been in contact with a 
Covid-19 patient differed in their state anxiety. Descriptive statistics, correlations, and 
t-tests were conducted in SPSS (SPSS Statistics for Windows, 2015). Bayesian statistics were 
conducted in JASP (Version 0.12.2, JASP Team, 2020, https://jasp-stats.org)
Bayesian regression models
In a pseudo-prospective design, we assessed whether the level of anxiety during the 
pandemic was predicted more accurately by (a) emotion regulation strategies (FEEL-E 
subscales) than by (b) the level of anxiety measured before the pandemic. We assumed that 
anxiety levels at baseline have an inherent association with anxiety during the pandemic, 
and therefore are strong predictors of variance in anxiety during the pandemic. Bayesian 
regression models were chosen for statistical analysis as they allow to include such previous 
assumptions as model parameters (regressors) and provide probability of those prior 
parameters to be predictive for a dependent variable (Baldwin & Larson, 2017) as well as 
convenient comparison of models. Bayesian regression models provide the advantage of 
testing a regression model composed of several regressors against a null-model that already 
considers regressors that are expected to affect the dependent variable, such as variation 
of state anxiety at baseline. Thereby effects due to i.e. regression to the mean and related 
correlational biases such as the selection-distortion bias can be ruled out. The null-model 
is composed of regressors that are assumed to have a strong effect on the dependent 
variable. This way the likelihood of a simple null-model relates to simple effects of anxiety 
values in the initial sample. Possible regression effects are compared to a more elaborate 
model that includes additional effects of interest. Bayesian statistics allow to calculate the 
likelihood that a more elaborate regression model explains the data better than the trivial 
null-model. We conducted Bayesian linear regression models to compare the probability 
of different predictive models to the assumed prediction of baseline anxiety on pandemic 
anxiety. Regressors included in the null model were tested against the alternative regressor 
models containing combinations of additional regressors. We included anxiety scores 
measured before the pandemic and the time interval between the baseline and follow-up 
measure in the null models, assuming that those had a predictive effect towards anxiety 
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during the pandemic. By including anxiety scores measured before the pandemic in the null 
model we consider state variation at baseline and therefore correct for potential regression 
towards the mean and additional correlation biases (i.e. selection-distortion effect). As the 
time interval between baseline measure and pandemic measure was in some of the early 
participants over a period of 2.5 years and therefore highly variable between individuals, 
it was included as a regressor in the null model. Comparing the null model to alternative 
models including adaptive and maladaptive emotion regulation strategies allowed to 
determine the probability of whether a certain emotion regulation strategy or combinations 
of strategies predicted anxiety during the pandemic above and beyond anxiety before the 
outbreak of the pandemic. 
Bayesian regression models were only conducted for scales that indicated a change when 
comparing baseline to pandemic measures. Finally, four Bayesian regression models were 
conducted to determine the probability of (A) adaptive emotion regulation strategies and 
(B) maladaptive emotion regulation strategies to predict (a) state anxiety (STAI-S) or (b) trait 
anxiety (HADS-A) more accurately than anxiety at baseline only (null model). For validation 
purposes, the analysis was repeated with another dependent variable (perceived stress). 
Therefore, two additional Bayesian regression models were conducted to determine the 
probability of (A) adaptive emotion regulation strategies and (B) maladaptive emotion 
regulation strategies to predict perceived stress (PSS) during the pandemic more accurately 
than state anxiety (STAI-S) at baseline only (null model). 
In all analyses, a Bayes factor BFM > 3 indicates moderate to strong evidence of the model 
to explain variance in the dependent variable (Wagenmakers et al., 2018). The Bayes factor 
BF10 estimates the evidence for the alternative model in comparison to the null model. Only 
models with moderate to high probability (BFM > 3, BF10 > 3) accounting for at least 10% 
more variance compared to the null model are reported (all other models can be found in 
the supplementary material). 
Results
Overall, 127 of the original participants completed the follow-up measurement during the 
pandemic. An attrition analysis revealed no significant differences between participants and 
dropouts when comparing baseline scores. Participants of the follow-up were not significantly 
different regarding their baseline scores from participants that did not take part in the follow-
up measurement (supplementary material).Table one displays all conducted measurements 
before the outbreak of the Covid-19 pandemic in the Netherlands (baseline) and 32 to 39 
days after the outbreak (follow-up during the pandemic). Baseline measures were conducted 
between 98 and 868 days before the pandemic measure (mean time difference = 590 days, 
sd = 228). A full correlation table is provided in the supplementary material. 
120 CHAPTER 5
Figure one displays the distribution of state and trait anxiety and trait depression at baseline 
and during the pandemic. Paired-sample t-tests indicated a significant increase in state anxiety 
measured on the STAI-S comparing the baseline measure to the follow-up during the pandemic 
t(126)=4.945, p<.001. However, there was a significant decrease in trait anxiety measured on the 
HADS-A during the pandemic compared to the baseline measurement, t(126)=-9.533, p<.001, 
while trait anxiety measured on the STAI-T did not significantly change, t(126)=-.937, p=.351. 
There was also no significant change in depression (HADS-D), t(126)=1.147, p=.253. There was 
no correlation between trait anxiety before the pandemic and increase of state anxiety (baseline 
– follow up), neither for trait anxiety measured on the STAI-T (r =.139, p > .05), nor for trait 
anxiety measured on the HADS-A (r = .082, p > .05). Figure 2 displays the change in anxiety and 
depression comparing the measurement before the pandemic to the measurement taken four 
weeks after the outbreak of the pandemic. Time differences in the baseline measure did not 
affect changes in anxiety or depression during the pandemic (see supplementary material). There 
was no difference between man and women in state anxiety during the pandemic, t(125) = .176, 
p > .05. Also, change in state anxiety during the pandemic relative to the baseline measurement 
was not different comparing women and men, t(125) = 1.895, p > .05. 
Table 1: Questionnaires on anxiety, depression, stress, and emotion regulation strategies applied between 27 and 
2 months before, and 1 month after the Covid-19 outbreak in the Netherlands. The PSS was only included in the 
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Figure 1: Distribution of state anxiety scores on the STAI-S, trait anxiety scores on the STAI-T and HADS-A and trait 
depression scores on the HADS-D before the Covid-19 outbreak and 4 weeks after the Covid-19 outbreak in the 
Netherlands. The colour intensity of bars indicates the severity of anxiety/depression. A HADS-A score ≥8 and STAI 
scores ≥ 39 indicate increased levels of anxiety. A HADS-D score ≥8 indicates increased levels of depression.
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Two-sided Bayesian t-tests were conducted to estimate the evidence for there being no 
change in anxiety and depression during the pandemic. For the measurements on HADS-A 
and STAI-S, Bayesian Factors revealed that the likelihood for no change between the 
baseline and the pandemic measurement was close to zero. Two-sided Bayesian t-tests 
for the HADS-D measurements suggested that depression was 5.3 times more likely not to 
change during the pandemic. The Bayes factor (BF01= 6.221) for the STAI-T measurements 
suggested that trait anxiety was 6.6 times more likely not to change during the pandemic 
(see supplementary material).  
Association between state anxiety and pandemic related variables
General health worry correlated positively with state anxiety during the pandemic (STAI-S) 
when controlling for state anxiety before the pandemic, r = .285 p < .001. In addition, 
worry of contamination correlated positively with state anxiety, r = .257, p < .05. There 
were no significant correlations between state anxiety during the pandemic (STAI-S) and 
any other variables of the Covid-19 questionnaire when controlling for state anxiety before 
the outbreak of the pandemic (supplementary material). Further, there was no significant 
difference in state anxiety measured during the pandemic between participants that were 
currently experiencing symptoms that are associated with Covid-19 or had been in contact 
with a patient that had been tested positively for Covid-19 (supplementary material). 
Figure 2: 
A: Difference scores (baseline minus follow-up) are displayed for anxiety and depression on the HADS (HADS-A and 
HADS-D), and state and trait anxiety on the STAI (STAI-S and STAI-T). A negative value indicates increased anxiety or 
depression during the pandemic, a positive value indicates decreased anxiety or depression during the pandemic 
relative to the baseline measurement. The shape width indicates the distribution of the difference scores. The 
black line within the boxplot defines the median. B: Individual changes in state anxiety at baseline and during the 
pandemic; the red line indicates the cut-off value for increased anxiety (STAI-S ≥ 39), the dot size represents the 
number of participants. C: Individual changes in trait anxiety; the red line indicates the cut-off value for increased 
anxiety (HADS-A ≥ 8), the dot size represents the number of participants.
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Bayesian regression models to predict anxiety during the pandemic based on emotion 
regulation strategies
Bayesian regression models have been conducted for measurements that revealed a change 
when comparing baseline measures and follow-up measures during the pandemic (STAI-S, 
HADS-A). There was no to low evidence for adaptive emotion regulation strategies to predict 
anxiety (STAI-S, HADS-A) during the pandemic more accurately than the null model. The null 
model included only the baseline measure of anxiety and the time difference between the 
baseline and follow-up measurement. For maladaptive strategies, we found strong evidence 
for a model containing ‘withdrawal’ (ß= -.504), ‘self-devaluation’ (ß= .531), and ‘giving up’ 
(ß= .662), accounting for 23% of the variance in state anxiety (STAI-S) during the pandemic, 
(BF10= 13.103), (table 2, for posterior summaries of coefficients and credible interval, see 
supplementary material).  
Testing the probability of maladaptive regulation strategies measured before the pandemic 
to predict trait anxiety (HADS-A) indicated high evidence for the strategies 'withdrawal' 
(ß = -.107) and 'giving up' (ß = .178) to predict trait anxiety during the pandemic (BF10=0.9). 
However, predicting trait anxiety during the pandemic based on the expression of the 
‘withdrawal’ and ‘giving up’ and trait anxiety before the pandemic accounted for only 3.8% 
more variance compared to the null model which included trait anxiety and time difference 
only (supplementary material). 
Table 2: A Bayesian regression model including all subscales of maladaptive emotion regulation measured at 
baseline as regressors of state anxiety (STAI-S) during the pandemic. All models include STAI-S at baseline. The best 
10 models are displayed.
Model Comparison: Maladaptive emotion regulation strategies predicting anxiety 
Models P(M) P(M|data) BF M BF 10 R² 
Null model (incl. STAI-S at baseline, time difference) 0.143 0.120 0.815 1.000 0.136 
withdrawal + self-devaluation + giving up + rumination + 
negative thinking + allocating blame 
0.143 0.152 1.073 1.269 0.243 
withdrawal + self-devaluation + giving up 0.007 0.078 11.816 13.103 0.230 
self-devaluation 0.024 0.067 2.962 3.380 0.174 
withdrawal + self-devaluation + giving up +  
negative thinking + allocating blame 
0.024 0.055 2.398 2.773 0.240 
giving up 0.024 0.049 2.107 2.453 0.170 
withdrawal + self-devaluation + giving up + rumination + 
allocating blame 
0.024 0.048 2.088 2.432 0.238 
withdrawal + self-devaluation + giving up + rumination 0.010 0.048 5.278 6.059 0.235 
withdrawal + self-devaluation + giving up + rumination + 
negative thinking 
0.024 0.045 1.926 2.251 0.236 
withdrawal + self-devaluation + giving up + allocating blame 0.010 0.041 4.400 5.091 0.233 
P(M) = prior model probability, P(M|data) = posterior model probability, BFM = change from prior model odds to 
posterior model odds, BF10 = Bayes factor for each row (model) against the one on top (H1 vs. H0).
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Bayesian regression model to predict perceived stress during the pandemic
For additional validation, a Bayesian regression model was conducted to determine the 
probability of maladaptive emotion regulation strategies to predict perceived stress (PSS) 
during the pandemic while controlling for state anxiety before the pandemic. Perceived stress 
correlated positively with increase in state anxiety on the STAI-S, r = .465, p < .001 (see all 
correlation measures between anxiety measures and stress in the supplementary material). 
As perceived stress is conceptually related to anxiety increase during the pandemic, we 
aimed to use the perceived stress score as a conceptual validation of the prediction of anxiety 
increase during the pandemic. There was strong evidence (BF10=130.569) for a regression 
model containing the strategies ‘self-devaluation’ (ß= .212) and ‘giving up’ (ß= .345) to 
predict perceived stress. The model accounted for 11.8% of the variance in perceived stress 
during the pandemic (table 3, for posterior summaries of coefficients and credible interval, 
see supplementary material), while anxiety at baseline (null model) predicted only 5% of the 
variance in perceived stress during the pandemic.
Discussion
Using a pseudo-prospective design, anxiety, depression, and stress were evaluated in a 
population of healthy individuals oversampled for high trait anxiety (HADS ≥ 7) measured 
before and one month after the outbreak of the Covid-19 pandemic in the Netherlands. On 
a group level, there was strong evidence for increased state anxiety during the pandemic 
compared to the pre-pandemic baseline. There was substantial evidence for no change in 
trait anxiety (STAI) and depression (HADS-D) during the pandemic. However, trait anxiety 
Table 3: A Bayesian regression model including all subscales of maladaptive emotion regulation measured at 
baseline as regressors of perceived stress during the pandemic (PSS). All models include state anxiety (STAI-S) at 
baseline. The best 10 models are displayed.
Model Comparison: Maladaptive emotion regulation strategies predicting perceived stress
Models P(M) P(M|data) BF M BF 10 R² 
Null model (incl. STAI-S at baseline, time difference) 0.143 0.013 0.076 1.000 0.050 
giving up 0.024 0.194 9.846 92.526 0.144 
self-devaluation + giving up 0.010 0.109 12.762 130.569 0.168 
withdrawal + self-devaluation + giving up + rumination + 
negative thinking + allocating blame 
0.143 0.066 0.426 5.284 0.182 
self-devaluation + giving up + allocating blame 0.007 0.047 6.899 75.317 0.177 
withdrawal + self-devaluation + giving up 0.007 0.036 5.182 57.245 0.173 
self-devaluation + giving up + negative thinking 0.007 0.032 4.633 51.380 0.171 
giving up + negative thinking 0.010 0.029 3.121 34.805 0.148 
withdrawal + self-devaluation + giving up + allocating blame 0.010 0.028 3.050 34.035 0.181 
withdrawal + self-devaluation + giving up + rumination + 
allocating blame 
0.024 0.028 1.169 13.245 0.182 
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measured on the HADS decreased. The study population was selected based on increased 
trait anxiety on the HADS and might have regressed to lower levels. Yet, regression towards 
the mean did not fully explain the observed decrease, since testing low anxious subjects 
separately led to the same decrease in trait anxiety. Trait anxiety before the outbreak of 
Covid-19 did not correlate with increases in state anxiety during the pandemic, indicating 
that healthy but highly anxious individuals did not experience more severe increases in state 
anxiety than individuals with normal trait anxiety. Manifestation of maladaptive emotion 
regulation strategies evaluated before the outbreak of the pandemic predicted the increase 
in state anxiety measured during the pandemic. 
In the scope of the trait vs state concept, trait anxiety is a stable characteristic that is less 
affected by spontaneous threatening events, while state anxiety is transitory and might 
vary with the occurrence of a threatening event (Spielberger et al., 1983). As we found a 
significant decrease in trait anxiety on the HADS during the pandemic but an increase in 
state anxiety, it might be debatable whether the trait vs state distinction holds at times of a 
global stressor like a pandemic as individuals are exposed to a stressful context over a long 
and unforeseeable period. Simultaneously, many constant daily stressors we encounter at 
normal times, like for example work pressure or social comparison are diminished during the 
pandemic due to pandemic-related regulations enforcing social distancing. As the majority 
of participants were university students and Dutch Universities were closed when the 
Covid-19 follow up measurement was conducted, those potential usual daily stressors might 
have been reduced at that time.  Hence, a decrease in trait anxiety during the pandemic 
may be explained by a reduction of daily stressor due to pandemic-related regulations 
while state anxiety might increase as the responses were given in direct relation to the 
acute stressor of the pandemic. Since the STAI did not indicate changes in trait anxiety, it 
cannot be ruled out that decreases in trait anxiety on the HADS occur due to methodological 
differences between the STAI and HADS. The HADS is a short screening instrument of seven 
items that might be less applicable in the context of the pandemic and therefore leading to 
contradictory results (see single item regression analysis in the supplementary material). 
Numerous studies measured anxiety and stress after the outbreak of Covid-19. A recent 
study applying the HADS in Turkey reported higher than normal levels of trait anxiety and 
depression in a healthy population (Özdin & Özdin, 2020).  However, there was no baseline 
measurement supporting that heightened anxiety and depression were related to the 
pandemic. Higher than normal anxiety and depression levels were also reported after the 
outbreak of Covid-19 in Italy measured on the DASS-21. Heightened anxiety and depression 
levels were associated with experiencing stressful situations and having medical problems. 
Further, having an infected family member increased anxiety levels (Mazza et al., 2020). 
Controlling for state anxiety before the pandemic, we were not able to replicate those 
results in the Netherlands. There was no association between state anxiety during the 
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pandemic and being in contact with a Covid-19 infected person or experiencing symptoms 
oneself. Since our population mainly consisted of university students, those differences 
might be less representative for the general population. Although the study population was 
selected based on elevated trait anxiety, the Covid-19 pandemic might have affected this 
group less severely than a general (older) population. Furthermore, the progression of the 
pandemic was less severe in the Netherlands and therefore might have represented a less 
intense threat. In summary, controlling for anxiety and depression before the outbreak of 
the pandemic, there was an increase in state anxiety related to worry of contamination and 
worry about general health but no increase in anxiety was associated with being in contact 
with a patient or experiencing symptoms one selves. 
Instead of high trait anxiety, maladaptive emotion regulation strategies predicted state 
anxiety during the pandemic. There was a high likelihood of ‘giving up’, ‘self-devaluation’, 
and ‘withdrawal’ in combination with state anxiety before the pandemic explaining 21% 
of the variance in state anxiety during the pandemic. Importantly, anxiety during the 
pandemic was predicted more accurately when taking into account the expression of those 
maladaptive emotion regulation strategies in addition to state anxiety before the pandemic 
instead of basing the prediction solely on state anxiety before the pandemic. 
The scale ‘giving up’ entails items like “I anyways can do nothing about my anxiety” or “ I 
don’t want to do anything anymore”  and may reflect the expression of learned helplessness 
(Abramson et al., 1978).  Learned helplessness has been associated with the progression of 
anxiety disorders (Mineka & Zinbarg, 2006). Individuals that tend to perceive problems as 
being beyond their control might experience more severe increases in anxiety when being 
exposed to a global stressor like the pandemic. Uncontrollable stress has been associated 
with subclinical anxiety and depression (Havranek et al., 2016). The threat from Covid-19 to 
the individual and the social network is an uncontrollable stressor. This might amplify the 
experience of helplessness in individuals that already have a high tendency to give up in the 
presence of a stressor. 
Further, the maladaptive strategy ‘self-devaluation’ predicted increased state anxiety during 
the pandemic. The FEEL-E scale ‘self-devaluation’ reflects the tendency of self-attribution, 
indicating that the experience of anxiety might be evaluated as a personal weakness. Pandemic-
related regulations that enforce social distancing might enhance this inherent tendency of 
self-devaluation as exchange with others experiencing similar feelings might be limited. Using 
another outcome measure evaluating perceived stress levels (PSS) corroborated those results. 
The regulation strategies ‘giving up’ and ‘self-devaluation’ were also the best predictors of 
perceived stress during the pandemic, explaining 11.8% of the variance. 
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While ‘giving up’ and ‘self-devaluation’ increased state anxiety during the pandemic, the 
regulation strategy ‘social withdrawal’ was associated with lower anxiety levels during the 
pandemic. Avoidance behaviour like social withdrawal is a common symptom across anxiety 
disorders (Craske & Stein, 2016). While at normal times, social withdrawal is considered as a 
maladaptive regulation strategy, social withdrawal efficiently reduced state anxiety during 
the pandemic, leading to the consideration whether strategies that are usually considered as 
maladaptive might be appropriate and efficient in times that require social distancing. Individuals 
that cope with anxiety by withdrawing themselves might suffer less from regulations that request 
social distancing and thereby can reduce their anxiety effectively. This interpretation is supported 
by the negatively predictive value of withdrawal in the model. A tendency for withdrawal as an 
emotion regulation strategy buffered against an increase in anxiety.
Adaptive emotion regulation strategies, in contrast, had no predictive value regarding state 
anxiety during the pandemic. Adaptive regulation strategies that involve active involvement 
to change an anxiety-evoking situation might not be feasible in the context of a pandemic. 
However, in a German cohort, adaptive emotion regulation strategies (including acceptance, 
refocus on planning, positive refocusing, positive appraisal, and putting into perspective) 
moderated the correlation between feeling well informed about the pandemic and anxiety 
to become infected, while maladaptive emotion regulation strategies did not affect this 
association in a healthy study population  (Jungmann & Witthöft, 2020). 
Our results implicate that reducing maladaptive emotion regulation strategies in vulnerable 
groups in the first place might prevent increased anxiety in response to an uncontrollable 
stressor.  Reducing maladaptive strategies might be more effective than training adaptive 
strategies as those may not always be feasible in the context of an uncontrollable stressor 
like a pandemic. In particular, reducing learned helplessness by strengthening self-efficiency 
might be beneficial. These implications are based on the observed relation between 
emotion regulation strategies and variances in state anxiety due to a global stressor like 
the pandemic in healthy but highly anxious individuals. Reducing maladaptive emotion 
regulation strategies might prevent acute anxiety in response to stress. However, in clinical 
populations, trait anxiety (STAI-T) rather than state anxiety (STAI-S) is a strong indicator for 
clinical depression and anxiety disorders (Knowles & Olatunji, 2020). Concerning clinical 
practice, trait anxiety might therefore be a more transferable measure.
To detect pandemic-related changes in mental states, there is a need for studies that include 
measurements before the outbreak of a pandemic to provide matched baseline values. As 
current standardized measures might change their meaning in the context of a pandemic 
due to changes in interpretation, validated measures on mental states like anxiety and 
depression in the context of a pandemic are required to reliably evaluate mental states and 
relate those to the occurrence of the pandemic. 
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Conclusion
In a vulnerable population of healthy individuals with elevated trait anxiety, state anxiety 
increased after the outbreak of Covid-19 in the Netherlands. However, heightened trait 
anxiety before the pandemic did not lead to a more severe increase in state anxiety during 
the pandemic. Maladaptive emotion regulation strategies predicted the increase in state 
anxiety. It remains challenging to relate changes in anxiety, stress, and depression to the 
global stressor of the pandemic, as pandemic-related regulations may simultaneously lead 
to a reduction of daily stressors in the social and professional life. Therefore, measurements 
without comparison to a baseline before the outbreak of the pandemic must be interpreted 
with caution. 
Limitations
The study population consisted of young and healthy individuals that might experience the 
pandemic as less frightening as they have a lower risk of a severe progression of Covid-19 
than older individuals or individuals with pre-existing health conditions. Further, the 
pandemic might have represented a less intense threat to this study population compared to 
study populations in areas that have been affected more severely by the pandemic than the 
Netherlands. Baseline measurements have been conducted over a time span of 2.5 years, 
which might have induced additional variance. However, time differences did not correlate 
with changes in anxiety or depression and were considered in the regression models.
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1. Questions on pandemic-related factors
As there is no standardized questionnaire on the experience of the pandemic, we applied 
a list of questions on potential causes of anxiety related to the pandemic. To assess the 
association between state anxiety and pandemic-related variables we applied the following 
questions on pandemic related factors (answered on a 5-point scale):
1. Do you think the media attention is appropriate?
2. How frequently do you check the news?
3. How worried are you of becoming infected?
4. How worried are you about your general health condition?
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5. Do you think the government has the situation under control?
6. Do you think the pandemic related regulations are appropriate?
7. With how many people are you sharing a household during the pandemic?
8. Did your eating habits change? (1 = more healthy, 5 = very unhealthy)
9. What do you do to protect yourself from becoming infected? (list of protective 
behaviours)
1.1 Correlations between change in state anxiety and pandemic-related factors
Worry of contamination and worry about general health was correlated with state anxiety 
during the pandemic. 
1.2 Independent samples t-tests: Having symptoms or being in contact with a patient
Participants that had symptoms of a cold did not report higher increases in state anxiety 
during the pandemic than participants that did not have a cold, t(125) = 1.046, p  > .05, also 
participants that had a cough did not report higher increases in state anxiety than participant 
without a cough, t(125)= 1.59, p > .05. Overall, 18 participants had been in contact with a 
patient that was tested positive for Covid-19. Participants that had been in contact with a 
confirmed patient did not experience a higher increase in state anxiety than participants 
that had no contact to patients, t(125)= .212, p > .05. 
2. Bayesian t-tests: Anxiety and depression before and during the pandemic
Suppl. Table 2: Bayesian Paired samples t-Tests for comparing anxiety and depression on the HADS and STAI 
before the pandemic (baseline) and during the pandemic.
BF₀₁ error %
HADS-A baseline - HADS-A pandemic 2.537e -14 3.901e -19
HADS-D baseline - HADS-D pandemic 5.343 1.252e -4
STAI-S baseline - STAI-S pandemic 1.775e -4 4.326e -11
STAI-T baseline - STAI-T pandemic 6.610 1.606e -4
Suppl. Table 1: Correlations of change in state anxiety (STAI-S at baseline – STAI-S during the pandemic) with 
pandemic related factors. *significant at the p < .05 level, Marked in grey: correlation survived Bonferroni correction 
controlling for 9 correlations.





















r .146 -.138 .257 .285 -.168 .066 .041 -.213 -.124
p .105 .124 .004* .001* .061 .462 .653 .017* .167
df 123 123 123 123 123 123 123 123 123
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3. Bayesian regression models: Posterior summaries of coefficients
Suppl. Figure 1: Prior and posterior distribution (based on the dataset). The posterior distribution is shifted to the 
left for positive and shifted to the right for negative effect sizes. The grey dot marks the 0.0 effect size. If the dot 
on the prior distribution is higher than the one on the posterior distribution, then the Bayes factor supports the 
alternative hypothesis. The value for BF01 suggests the probability of the alternative hypothesis. BF01 suggests the 
probability of the null hypothesis (BF01).  The pie chart shows the proportion of evidence for the H1 (red) and H0 
(white) hypothesis. Median effect sizes are shown with 95% credible intervals (CI).
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3.1 Model comparison: Maladaptive emotion regulation strategies predicting anxiety
3.2 Model comparison: Maladaptive emotion regulation strategies predicting perceived stress
Suppl. Table 3: Posterior summaries of coefficients; the credible interval indicates 95% credibility for the strategies 
withdrawal, self-devaluation, and giving up to explain variance in state anxiety during the pandemic.
95% Credible Interval
Coefficient Mean SD P(incl) P(incl|data) BF inclusion Lower Upper 
Intercept 44.000 0.772 1.000 1.000 1.000 42.575 45.648 
STAI-S at baseline 0.300 0.103 1.000 1.000 1.000 0.102 0.509 
withdrawal -0.246 0.257 0.500 0.604 1.523 -0.732 0.004 
self-devaluation 0.352 0.280 0.500 0.728 2.676 0.000 0.842 
giving up 0.369 0.320 0.500 0.694 2.267 -0.005 0.951 
rumination -0.075 0.198 0.500 0.381 0.615 -0.595 0.274 
negative thinking -0.039 0.128 0.500 0.371 0.590 -0.414 0.156 
allocating blame 0.069 0.159 0.500 0.399 0.664 -0.124 0.564 
time difference -0.002 0.003 1.000 1.000 1.000 -0.008 0.004 
Suppl. Table 4: Posterior summaries of coefficients. The credible interval indicates 95% credibility for the strategies 
‘self-devaluation’ and ‘giving up’ explaining variance in perceived stress during the pandemic.
95% Credible Interval
Coefficient Mean SD P(incl) P(incl|data) BF inclusion Lower Upper 
Intercept 20.724 0.442 1.000 1.000 1.000 19.805 21.514 
STAI-S at baseline 0.015 0.056 1.000 1.000 1.000 -0.096 0.114 
withdrawal -0.018 0.073 0.500 0.328 0.488 -0.203 0.127 
self-devaluation 0.134 0.141 0.500 0.609 1.554 0.000 0.422 
giving up 0.285 0.150 0.500 0.901 9.082 0.000 0.513 
rumination 0.017 0.092 0.500 0.304 0.438 -0.204 0.249 
negative thinking 0.009 0.060 0.500 0.316 0.462 -0.127 0.180 
allocating blame 0.040 0.089 0.500 0.372 0.591 -0.056 0.307 
time difference 0.003 0.002 1.000 1.000 1.000 -4.585e -4 0.007 
Suppl. Figure 2: Posterior distributions of the regressors withdrawal, self evaluation, and giving up, CI = credible 
interval, the blue line indicates the median and cut-off value when to reject the H0 (null model). 
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4. Bayesian regression models 
4.1 Predicting state anxiety based on adaptive emotion regulation strategies
Adaptive emotion regulation strategies did not explain more variance in state anxiety during 
the pandemic than state anxiety measured before the pandemic.
Suppl. Figure 3: Posterior distributions of the regressors ‘self-devaluation’ and ‘giving up’, CI = credible interval, the 
blue line indicates the median and cut-off value when to reject the H0 (null model).
Suppl. Table 5: Bayesian regression model including all subscales of adaptive emotion regulation measured at 
baseline as regressors of state anxiety (STAI-S) during the pandemic. All models include STAI-S at baseline and time 
between baseline measure and pandemic measure.
Model Comparison: Maladaptive emotion regulation strategies predicting perceived stress
Models P(M) P(M|data) BF M BF 10 R² 
Null model (incl. STAI-S, time) 0.143 0.302 2.599 1.000 0.136 
cognitive problem solving 0.024 0.140 6.660 2.774 0.171 
forgetting 0.024 0.060 2.596 1.182 0.159 
problem-oriented 0.024 0.056 2.452 1.120 0.158 
positive mood 0.024 0.051 2.182 1.003 0.156 
acceptance 0.024 0.037 1.589 0.741 0.152 
cognitive problem solving + forgetting 0.010 0.029 3.106 1.439 0.180 
reappraisal 0.024 0.024 1.010 0.477 0.145 
cognitive problem solving + positive mood 0.010 0.023 2.394 1.117 0.177 
cognitive problem solving + reappraisal 0.010 0.019 1.962 0.919 0.174 
P(M) = prior model probability, P(M|data) = posterior model probability, BFM = change from prior model odds to 
posterior model odds, BF10 = Bayes factor for each row (model) against the one on top (H1 vs. H0) 
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4.2 Predicting trait anxiety during the pandemic based on adaptive emotion regulation 
strategies
A model containing adaptive emotion regulation strategies in addition to trait anxiety at 
baseline did not explain more variance in trait anxiety during the pandemic compared to a 
model containing trait anxiety at baseline only. The model comparison was conducted for 
trait anxiety measured on the HADS-A (table 6). 
Suppl. Table 6: Bayesian regression model including all subscales of adaptive emotion regulation measured at 
baseline as regressors of trait anxiety (HADS-A) during the pandemic. All models include HADS-A at baseline and 
time between baseline measure and pandemic measure.
Model Comparison: Adaptive emotion regulation strategies predicting trait anxiety (HADS-A)
Models P(M) P(M|data) BF M BF 10 R² 
null model (incl. HADS-A at baseline, time) 0.143 0.670 12.199 1.000 0.169 
positive mood 0.024 0.053 2.297 0.475 0.179 
forgetting 0.024 0.042 1.776 0.372 0.175 
cognitive problem solving 0.024 0.032 1.357 0.287 0.172 
acceptance 0.024 0.030 1.280 0.271 0.171 
problem-oriented 0.024 0.029 1.216 0.258 0.170 
reappraisal 0.024 0.028 1.166 0.248 0.170 
reappraisal + positive mood 0.010 0.007 0.687 0.147 0.180 
problem-oriented + positive mood 0.010 0.006 0.667 0.143 0.180 
positive mood + forgetting 0.010 0.006 0.658 0.141 0.180 
P(M) = prior model probability, P(M|data) = posterior model probability, BFM = change from prior model odds to 
posterior model odds, BF10 = Bayes factor for each row (model) against the one on top (H1 vs. H0).
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4.3 Predicting trait anxiety during the pandemic based on maladaptive emotion 
regulation strategies 
A model containing maladaptive emotion regulation strategies in addition to trait anxiety at 
baseline did not explain more variance in trait anxiety during the pandemic compared to a 
model containing trait anxiety at baseline only. The model comparison was conducted for 
trait anxiety measured on the HADS-A (table 7).
Suppl. Table 7: Bayesian regression model including all subscales of maladaptive emotion regulation measured 
at baseline as regressors of trait anxiety (HADS-A) during the pandemic. All models include the HADS-A screening 
score and time between baseline measure and pandemic measure.
Model Comparison: Maladaptive emotion regulation strategies predicting trait anxiety (HADS-A)
Models P(M) P(M|data) BF M BF 10 R² 
null model (incl. HADS-A, time) 0.143 0.526 6.653 1.000 0.169 
giving up 0.024 0.073 3.227 0.833 0.187 
allocating blame 0.024 0.054 2.328 0.613 0.183 
withdrawal + giving up 0.010 0.032 3.388 0.900 0.207 
negative thinking 0.024 0.029 1.235 0.334 0.174 
withdrawal 0.024 0.023 0.976 0.265 0.171 
rumination 0.024 0.023 0.973 0.264 0.170 
self-devaluation 0.024 0.023 0.950 0.258 0.170 
withdrawal + self-devaluation + giving up + rumination + 
negative thinking + allocating blame 
0.143 0.013 0.080 0.025 0.218 
giving up + allocating blame 0.010 0.012 1.269 0.344 0.193 
P(M) = prior model probability, P(M|data) = posterior model probability, BFM = change from prior model odds to 
posterior model odds, BF10 = Bayes factor for each row (model) against the one on top (H1 vs. H0).
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4.4 Predicting perceived stress based on adaptive emotion regulation strategies
A model containing adaptive emotion regulation strategies in addition to state anxiety at 
baseline did not explain more variance in perceived stress during the pandemic compared 
to a model containing state anxiety at baseline only (table 8).
5. HADS
5.1 Comparing anxiety and depression before and during the pandemic
There was a significant decrease in trait anxiety measured on the HADS-A during the 
pandemic compared to the baseline measurement, t(126)=-9.533, p<.001. There was no 
change in trait depression (HADS-D), t(126)=1.147, p= .253.
5.2 Does trait anxiety before the pandemic predict increase in state anxiety during the 
pandemic? 
There was no relation between measurements on the HADS and increase in state anxiety 
measured on the STAI-S. Trait anxiety before the pandemic did not correlate with increase 
of state anxiety (baseline – follow up) for trait anxiety measured on the HADS-A (r = .082, 
p > .05). There was also no correlation between trait depression before the pandemic and 
increase of state anxiety (r = .072, p > .05).
Suppl. Table 8: Bayesian regression model including all subscales of adaptive emotion regulation measured at 
baseline as regressors of perceived stress (PSS) during the pandemic. All models include STAI-S at baseline and time 
between baseline measure and pandemic measure.
Model Comparison: Adaptive emotion regulation strategies predicting perceived stress (PSS)
Models P(M) P(M|data) BF M BF 10 R² 
null model (incl. STAI-S at baseline, time) 0.143 0.378 3.639 1.000 0.050 
cognitive problem solving 0.024 0.095 4.293 1.506 0.078 
acceptance 0.024 0.083 3.709 1.318 0.075 
problem-oriented 0.024 0.040 1.702 0.633 0.063 
positive mood 0.024 0.037 1.574 0.588 0.061 
forgetting 0.024 0.033 1.392 0.522 0.059 
acceptance + cognitive problem solving 0.010 0.021 2.194 0.821 0.086 
reappraisal 0.024 0.021 0.859 0.326 0.051 
cognitive problem solving + forgetting 0.010 0.014 1.512 0.569 0.079 
cognitive problem solving + positive mood 0.010 0.014 1.497 0.564 0.079 
P(M) = prior model probability, P(M|data) = posterior model probability, BFM = change from prior model odds to 
posterior model odds, BF10 = Bayes factor for each row (model) against the one on top (H1 vs. H0).
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5.3 Multiple linear regression model to test the predictive value of the single HADS items 
A multiple linear regression model was conducted for both subscales of the HADS, including 
all single items of a scale to as regressors of the sum score of the scale. For the HADS-A 
scale, item 1 (“I feel tense or wound up”) did not predict the HADS-A sum score. All other 
items added statistically significantly to the prediction, F(7,121) = 1706,929, p < .001, R2 = 
.99 (table 9). For the HADS-D scale, all items added significantly to the prediction of the 
HADS-D sum score, R2 = 1.00 (table 10). However, item 10 (“I don’t have lost interest in my 
outer appearance”) was the strongest predictor for the HADS-D sum score. Since pandemic 
related regulations required to stay at home as much as possible it is up for discussion if loss 
in outer appearance might point towards increased depression or is rather a by-product of 
staying at home significantly more than usual. 








Model B std. error Beta t sig. lower bound upper bound
(Constant) -.045 .083 -.545 .587 -.210 .120
Item 1 .059 .051 .013 1.146 .254 -.043 .160
Item 3 1.008 .043 .264 23.367 .000 .923 1.093
Item 5 .973 .046 .244 21.231 .000 .882 1.064
Item 7 1.008 .041 .257 24.310 .000 .926 1.090
Item 9 .991 .040 .268 24.610 .000 .912 1.071
Item 11 1.006 .034 .296 29.774 .000 .939 1.073
Item 13 1.038 .055 .231 19.021 .000 .930 1.147








Model B std. error Beta t sig. lower bound upper bound
(Constant) 2.554e-15 .000 .000 1.000 .000 .000
Item 2 1.000 .000 .205 77505046.60 .000 1.000 1.000
Item 4 1.000 .000 .188 72938513.60 .000 1.000 1.000
Item 6 1.000 .000 .198 87846006.69 .000 1.000 1.000
Item 8 1.000 .000 .231 107281715.91 .000 1.000 1.000
Item 10 1.000 .000 .250 126554983.87 .000 1.000 1.000
Item 12 1.000 .000 .244 104942971.99 .000 1.000 1.000
Item 14 1.000 .000 .230 99876669.652 .000 1.000 1.000
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6. Time effects
Baseline measurements were conducted between December 2017 and February 2020. 
There was no correlation between the time span between the baseline measurement and 
the change in anxiety and depression. 
7. Attrition analysis
Overall, 54% of the participants that took part in the original study also completed the follow 
up measurement during the pandemic. To test whether there was a systematic difference 
between participants that took part in the follow up and participants that did not take part in 
the follow up participators and non-participators were compared on their scores.  Participators 
and non-participators did not significantly differ in anxiety or depression measured at baseline.
Suppl. Table 11: Correlations between the time span (days between baseline measurement and follow-up measurement 









Time difference between baseline 
and pandemic measure
r .075 -.034 -.021 .050
p .402 .706 .813 .576
Suppl. Table 12: T-tests for equality of means. For HADS-A and HADS-D equal variance has been assumed. Levene's 
test indicated unequal variances for both scales of the STAI; STAI-S (F = 9.22, p = .003), STAI -T (F = 5.75, p = .017). 
Degrees of freedom were adjusted.
group N mean sd t df p
HADS-A
participated 127 9.14 3.328
-0.654 243 0.513
not participated 118 9.43 3.620
HADS-D
participated 126 5.11 3.208
-0.786 242 0.433
not participated 118 5.44 3.342
STAI-S
participated 127 39.56 8.254
-0.8 212.488 0.424
not participated 115 40.56 10.814
STAI-T
participated 127 43.55 9.932
-0.166 219.243 0.868
not participated 115 43.79 12.297
8. Description of all applied questionnaires
HADS: The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) consist of two 
scales (7 items each) evaluating anxiety and depression and is a valid tool to investigate 
variance of anxiety in a healthy population (Bocéréan & Dupret, 2014; Breeman et al., 2015). 
All items are rated on a 4-point scale (0 to 3). A HADS-A/D score above seven is considered 
as an indicator for moderate anxiety/ depression symptoms. A score of more than or equal 
to 11 is defined as a definitive case of anxiety or depression (Breeman et al., 2015).
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STAI: The State Trait Anxiety Inventory (Spielberger et al., 1983) consists of 40 items, 
measuring symptoms of anxiety. The questionnaire distinguishes between permanent trait 
and fluctuating state components of anxiety. For evaluating state anxiety, 20 items have to 
be completed referring to the current situation. To assess trait anxiety, the same 20 items 
are completed again with the instruction to refer to the last week.  All items are rated on a 
4-point scale (almost never to almost always). Higher scores indicate greater anxiety.
FEEL-E: (Vragenlijst over emotieregulatie bij volwassenen, (Grob & Horowitz, 2015) consist of 
72 questions evaluating adaptive and maladaptive emotion regulation strategies when dealing 
with anger, anxiety, or sadness. Evaluated adaptive strategies include problem oriented acting, 
acceptance, problem solving, re-evaluation (reappraisal), lighten the mood, and forgetting 
(oblivion). Evaluated maladaptive strategies are withdrawal, self-devaluation (degrading and 
blaming oneself) giving up, negative thinking (catastrophic thinking), and allocating blame 
(blaming others).  
PSS: The Perceived Stress Scale (Cohen et al., 1983) consist of 10 items evaluating the 
current level of experienced stress. All items are rated on a 5-point scale (0 = never to 
4 = very often). Items are answered with the instruction to refer to the last month.
Suppl. Table 13: Correlation table for all anxiety, depression, and stress scales measured at baseline and during the 
pandemic. (Note: The perceived stress scale (PSS) was only measured during the pandemic).
baseline follow up measurement pandemic






r .552** .536** .678** .412** .222* .377** .409** .320**
p .000 .000 .000 .000 .012 .000 .000 .000
HADS-D
r .552** .536** .657** .311** .457** .386** .488** .272**
p .000 .000 .000 .000 .000 .000 .000 .002
STAI-S
r .536** .536** .632** .251** .180* .361** .360** .153
p .000 .000 .000 .004 .043 .000 .000 .086
STAI-T
r .678** .657** .632** .412** .330** .400** .599** .280**














r .412** .311** .251** .412** .558** .738** .672** .626**
p .000 .000 .004 .000 .000 .000 .000 .000
HADS-D
r .222* .457** .180* .330** .558** .622** .605** .623**
p .012 .000 .043 .000 .000 .000 .000 .000
STAI-S
r .377** .386** .361** .400** .738** .622** .762** .625**
p .000 .000 .000 .000 .000 .000 .000 .000
STAI-T
r .409** .488** .360** .599** .672** .605** .762** .546**
p .000 .000 .000 .000 .000 .000 .000 .000
PSS
r .320** .272** .153 .280** .626** .623** .625** .546**
p .000 .002 .086 .001 .000 .000 .000 .000
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Suppl. Table 14: Correlation table for emotion regulation strategies (FEEL-E) measured at baseline and all anxiety, 
depression, and stress scales, measured at baseline and during the pandemic. Corrected significant correlations are 
marked in grey (Bonferroni corrected for 30 correlations: Bonferroni correction was applied separately for adaptive 
and maladaptive strategy, correcting for 6 strategies x 5 different measures).
baseline follow up measurement pandemic















r -.183* -.134 -.074 -.294** -.101 -.145 -.174 -.318** -.126
p .040 .133 .407 .001 .260 .105 .051 .000 .158
acceptance
r -.270** -.220* -.104 -.373** -.146 -.214* -.175* -.334** -.138




r -.016 -.074 .097 -.080 -.054 -.122 -.146 -.210* -.163
p .857 .408 .278 .373 .546 .173 .101 .018 .068
re-evaluation
r .021 .046 .136 .008 .001 -.033 -.054 -.100 .012
p .816 .606 .129 .931 .995 .713 .547 .263 .898
lighten the 
mood
r -.215* -.329** -.228** -.304** -.184* -.253** -.226* -.327** -.128
p .015 .000 .010 .001 .038 .004 .011 .000 .151
forgetting
r -.090 -.124 -.056 -.161 -.113 -.203* -.181* -.266** -.077
















r .228** .271** .199* .309** .062 .128 .065 .175* .201*
p .010 .002 .025 .000 .489 .150 .471 .049 .024
self-
devaluation
r .386** .342** .194* .410** .183* .205* .265** .283** .253**
p .000 .000 .029 .000 .039 .021 .003 .001 .004
giving up
r .402** .349** .347** .526** .287** .270** .298** .395** .340**
p .000 .000 .000 .000 .001 .002 .001 .000 .000
rumination
r .257** .111 .224* .272** .074 -.027 .081 .061 .107
p .004 .215 .011 .002 .405 .761 .364 .497 .233
negative 
thinking
r .297** .277** .241** .341** .186* .107 .142 .215* .185*
p .001 .002 .006 .000 .036 .231 .112 .015 .037
allocating 
blame
r .151 .091 .255** .170 .176* .103 .156 .198* .179*
p .091 .310 .004 .055 .048 .251 .080 .026 .044
Suppl. Table 15: Correlations of perceived stress measured during the pandemic (PSS) with changes in anxiety and 
depression between baseline and follow up. The difference scores were calculated by subtracting the baseline score 












r .465** .278** .268** .369**
p .000 .002 .002 .000
N 127 127 127 127
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Summary of main findings
This work investigated individual differences in the neurobiological mechanisms underlying 
anxiety. Different streams of research have highlighted amygdala hypersensitivity, decreased 
prefrontal control and high locus coeruleus drive as neurobiological correlates of the anxious 
phenotype. So far, these constructs have coexisted without the attempt for conceptual 
integration. In chapter two we proposed a comprehensive biomarker model combining 
amygdala hypersensitivity, decreased prefrontal control and high locus coeruleus drive in 
a dynamic interplay. This work suggests that different neurobiological profiles can evoke 
the same phenotype and lays out the theoretical framework for a clustering-based analysis 
approach that allows capturing different neurobiological profiles within a highly anxious 
population. In chapter three we applied the biomarker model in a population of healthy 
but highly anxious individuals. Clustering individuals based on their neural activation profile 
during three cognitive tasks that provoked emotion processing, emotion regulation and 
salience processing revealed three distinct subgroups that differed in their neural activation 
profiles. The activation profile of two of those subgroups expressed characteristics that 
aligned with two of the biomarkers proposed in the model. Group 1 was characterized by 
overall reduced prefrontal engagement. Moreover, subgroup 1 reported less regulatory 
success when evaluating their emotional state after the attempt of regulating negative 
emotions. Presumably, decreased prefrontal control was the most pronounced mechanism 
underlying anxiety in group 1. In contrast, group 3 expressed the highest PFC engagement 
and amygdala activation during the emotion regulation task as well as the highest PFC 
activation during the salience task relative to the other two groups. This pattern is associated 
with increased locus coeruleus activation, as noradrenaline release from the locus coeruleus 
would elevate neural activation in prefrontal regions and the amygdala. The neural 
profile of the second group was not entirely in line with activation patterns that would be 
expected with manifested amygdala hypersensitivity. The presented clustering solution was 
validated on an independent physiological parameter. Group-dependent patterns in pupil 
dilation when manipulating the stress level indicated that the three detected subgroups 
indeed captured three distinct biological profiles that not only differed on a neural level 
but also on a physiological parameter. However, the three groups did not differ in terms 
of symptomatology. We demonstrated that three distinct biological profiles are associated 
with phenotypes that cannot be distinguished on symptom level.
In chapter four we investigated neural activation and functional connectivity during an 
emotion regulation task in highly anxious individuals. On a behavioural level, anxiety traits 
did not affect emotion regulation efficiency. Yet, emotion regulation was associated with 
ventrolateral prefrontal cortex (VLPFC) activation, which increased with anxiety. Moreover, 
the VLPFC was negatively coupled to the dorsomedial PFC (DMPFC) and middle temporal 
gyrus (MTG) during emotion regulation, suggesting that the DMPFC and MTG have a 
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regulatory effect onto the VLPFC. In addition, stronger functional VLPFC-DMPFC connectivity 
was associated with lower anxiety traits. Taken together, increased VLPFC activation and 
coupling to areas involved in regulatory processes might be the neural basis of compensatory 
emotion regulation in highly anxious individuals. 
Chapter five presented a pseudo-prospective study on anxiety during the Covid-19 pandemic 
and predictive effects of emotion regulation strategies that had been established before the 
outbreak of the pandemic. We observed an increase in state anxiety (STAI-S) during the 
pandemic. However, trait anxiety (STAI-T) measured before the pandemic did not predict 
the increase in state anxiety during the pandemic. Hence, individuals that scored high on 
anxiety before the pandemic did not necessarily experience a stronger increase in anxiety 
during the first wave of the pandemic. Instead, maladaptive emotion regulation strategies 
measured before the pandemic were a reliable predictor of state anxiety and perceived 
stress during the pandemic. Specifically maladaptive emotion regulation strategies that 
indicate learned helplessness and self-blaming led to higher state anxiety during the 
pandemic. In contrast, social withdrawal, which is usually considered as a maladaptive 
strategy was associated with lower state anxiety during the pandemic eventually reflecting 
the capacity of an individual to cope with social isolation. This work revealed the importance 
of efficient emotion regulation strategies in stressful times and points out that the quality of 
emotion regulation might have a stronger impact on state anxiety and perceived stress than 
inherent anxiety traits.
Integration of findings and clinical relevance
The challenge of biological heterogeneity within clinical categories
The first part of this thesis presented a biomarker model to classify highly anxious 
individuals based on their individual neurobiological profile. The model integrates amygdala 
hypersensitivity, decreased prefrontal control and increased locus coeruleus drive; three 
neural mechanisms that have been related to anxiety but have never been considered in 
conjunction. Our results support previous research proposing decreased prefrontal control 
and increased locus coeruleus drive as potential neural correlates of anxiety. Yet, this 
work goes beyond testing single mechanism-symptom associations by demonstrating an 
analysis approach that allows identifying the distribution of different mechanisms within a 
population of individuals that express the same anxious phenotype. Moreover, our analysis 
approach defines how strongly different mechanisms (biomarkers) are manifested in the 
individual and detects the most prominent biomarker in a given individual. Previous studies 
have mostly focused on detecting one single neural mechanism associated with anxiety, and 
thereby accepted the risk of compromising inter-subject variability. 
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Up to this day, psychiatry follows a symptom-based approach. Patients in psychiatry are 
diagnosed based on symptoms without taking into account individual variation in the 
neurobiological correlates causing a symptomatology. Moreover, the same treatment 
is assigned to patients falling into the same clinical category although patients might 
highly differ regarding their neurobiological profile leading to their symptoms. Taking the 
example of anxiety disorders, cognitive behavioural therapy (CBT) is the standard treatment 
recommendation. Yet, with response rates around 50%, treatment trajectories often involve 
trial and error (Bandelow et al., 2014; Loerinc et al., 2015).  According to the European 
study of the epidemiology of mental disorders (ESEMeD), 19.6% of patients that reached 
out for treatment received psychotherapy, while 30.8% got medication, and 26.5% received 
a combined treatment (Alonso et al., 2007; Bandelow et al., 2017).  Choosing the right 
medical treatment for a patient with an anxiety disorder has been challenging due to the 
high variety of available medical agents that all target different neurotransmitter systems 
and neurobiological processes. To name but a few, state-of-the-art anxiolytic drugs target 
the serotonergic or GABAergic system (benzodiazepines). Since the early 1990s, selective 
serotonin (5-HT) reuptake inhibitors (SSRIs) are the first-line drug treatment for anxiety 
disorders (Bandelow et al., 2017). More recent pharmacological developments are based on 
modulating glutamatergic neurotransmission, activation of the neurosteroid aloradine which 
alters neural excitability, or agents that have been shown to enhance extinction learning 
and have been applied to support the effectiveness of exposure-based therapy (Sartori 
& Singewald, 2019). This brief and by far not complete overview illustrates the variety of 
agents and more importantly the diverse biological mechanisms targeted by state-of-the-
art treatments. The fact, that all these agents have anxiolytic effects in some but not all 
patients, despite their different working mechanisms supports the assumption that diverse 
underlying neurobiological profiles evoke the same anxious phenotype. Hence, suboptimal 
treatment effects as they have been described for diverse drugs might not only be attributed 
to side effects, risk for dependence, lack of commitment, or symptoms of withdrawal but 
may also indicate a high neurobiological heterogeneity among patients that express the same 
symptomatology. As a result, some patients might benefit more from a specific medication, 
in case the agent ‘coincidently’ targeted the right mechanism in that individual patient. 
However, as research has not provided satisfying biomarker models for mental disorders yet 
and thus there is no common practice to probe the neurobiological origin of disease in the 
individual patient, medical treatment is prescribed without a biological indication but rather 
based on symptoms and individual experience of the practitioner. Hence, psychiatry is in 
need of biomarker-based tests that allow detecting the biological mechanism underlying 
the patient’s symptoms in order to tailor psychotherapeutic or medication to the individual.
Due to high biological heterogeneity among patients within the same diagnostic category 
and the overall complexity of mental disorders, research on the development of biomarkers 
in psychiatry is still in its infancy. Personalized medicine or precision medicine is a burgeoning 
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concept that follows an integrative approach, taking into account inter-individual differences 
regarding environmental factors, genetics, biological correlates, and lifestyle (Baune, 
2019, p.1; Collins & Varmus, 2015). This holistic perspective slowly emerges in psychiatry, 
questioning the traditional symptom-based disease classification. Yet, the complex nature of 
mental disorders poses a great challenge in this regard. Mental disorders involve a dynamic 
interplay of behavioural, genetic, physiological, cognitive, and environmental factors. To 
capture this multidimensional heterogeneity, psychiatry is in need for tools and models from 
different disciplines. To tackle neurobiological heterogeneity and develop comprehensive 
biomarker models for mental disorders, psychiatry requires the synergy between psychiatric 
practice and neuroscientific research. Neuroscience reveals neurobiological mechanisms 
related to symptomatology and treatment effects, and might provide insights towards a 
more targeted manipulation of brain structures that underlie certain symptoms or mental 
processes (Månsson et al., 2021). 
Data-driven stratification in psychiatry
Over the last decade, a growing body of research has applied computational approaches to 
stratify clinical populations of a certain diagnostic category into biologically homogenous 
subgroups. Yet, the field faces three major issues that have diminished the development 
of biological models based on stratification. First, although we are in need for biological 
mappings of mental disorders, the vast majority of studies has stratified clinical populations 
based on symptoms and psychometric variables rather than biological parameters by 
applying k-means clustering, hierarchical clustering, or finite mixture models (Marquand 
et al., 2016). Second, despite the high similarity of computational models that are currently 
used for stratification purposes, prior selection of model parameters (like i.e. pre-defining 
the number of clusters) strongly affects the model outcome and thus contributes to highly 
divergent results despite applying similar algorithms (Marquand et al., 2016). Validation of 
cluster solutions yielded by stratification approaches constitutes a third concern. Oftentimes, 
subgroups do not differ regarding their clinical profile. Therefore, external validation 
on independent parameters is an important practise to conclude whether the detected 
subgroups have any relevance towards explaining heterogeneity. Subsequent analysis of 
external parameters that had not been included in the clustering procedure is an accepted 
quality assessment for cluster-robustness. However, many stratification studies miss an 
external validation on independent parameters. A common but less reliable approach has 
been to train a classifier and apply it to the same dataset to detect the same subgroups. The 
inherent circularity of this approach leads to reduced reproducibility. Performing a cross-
validation by repeatedly splitting the data into training and testing sets and applying the 
classifier that was first trained on the training set to a testing set is an accepted alternative 
to test cluster-robustness (Etzel et al., 2009).
GENERAL DISCUSSION 149
6
Moreover, stratification studies differ regarding their inclusion criteria. While some studies 
only include patients, others include patients and healthy controls, with the idea that 
latter ones might form a biologically distinct subgroup. Other studies select participants 
based on specific symptoms rather than diagnosis. Considering the high comorbidity and 
transdiagnostic nature of numerous psychological symptoms, it is up to debate whether 
stratification studies should include subjects based on their diagnosis or based on specific 
symptoms. As we intend to develop biological models that might not entirely align with the 
symptom-based categories established in clinical practise, but rather go beyond categorical 
boarders, the diagnostic label might be secondary in this regard. However, to make this 
decision, the purpose of a biomarker needs to be defined. The Biomarkers Definition 
Working Group proposes the following definition of a biomarker: 
“A biomarker is a characteristic that is objectively measured and evaluated as an 
indicator of normal biological processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention.” (Biomarkers Definitions Working Group, 
2001)
However, in psychiatry, biomarkers have been rather evaluated with regard to the traditional 
categorical diagnostic system. Based on the consensus report of the World Federation of 
Societies of Biological Psychiatry (WFSBP) and the World Federation of ADHD, biomarkers 
need to provide a sensitivity >80%, a specificity >80%, and must be reliable, reproducible, 
inexpensive, non-invasive, and easy to use (Thome et al., 2012). According to these criteria, 
reliable biomarkers rather serve as diagnostic tools that allow identifying clinical cases 
pursuant to the current symptom-based clinical manual. Thus, the purpose of a biomarker 
needs to be defined in order to select the appropriate population for stratification. 
Are we searching for biological correlates of mental symptoms that might however be 
transdiagnostic and not align with a DSM-V or ICD-10 diagnosis, or do we adhere to the 
established categorical system aiming to find biomarkers that detect cases within a clinical 
category?
Either way, regardless of whether we develop reliable biological models of a transdiagnostic 
symptom or a circumscribed mental disorder we need to base stratification on quantifiable 
biological parameters rather than symptoms. Yet, the selection of those constitutes a 
major challenge. A review on stratification studies in psychiatry reported that up to date, 
the majority of stratification studies clustered individuals based on symptoms rather than 
biological parameters. Moreover, studies that applied biological parameter for stratification, 
mainly included neuroimaging data (Marquand et al., 2016). To select biological parameters 
that might be a meaningful read-out, we require comprehensive theoretical frameworks 
that provide a biological rational of a disorder are required. 
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Considering the brain as a network system, inter-individual variations will be reflected in 
the complex interplay of regions rather than manifest in activation levels of a circumscribed 
brain area. A small number of studies has made some efforts towards that end, selecting 
biological markers based on prior theoretical frameworks. Subgroups of patients with 
attention deficit hyperactivity disorder (ADHD) have been identified by stratifying individual 
based on resting state functional connectivity in brain regions that have been associated 
with reward, and based on functional connectivity in a frontal-parietal network, as later 
one had previously been shown to be altered in ADHD (Costa Dias et al., 2015; Gates et 
al., 2014). Study results highly varied and are barely comparable due to the divergence in 
selected stratification parameters. In terms of anxiety disorders, the number of stratification 
studies based on biological parameters is highly limited. White matter connectivity has been 
used as a biological parameter for stratification of patients with generalized anxiety disorder 
and depression. Increased limbic connectivity during resting state was associated with 
higher levels of depression and increased attentional bias towards threat (Bijsterbosch et 
al., 2018). Applying neuroimaging parameters for stratification, these studies demonstrate 
an approach that requires a priori defined regions of interests or biological mechanisms. 
Selecting meaningful biological parameters requires working hypotheses on quantifiable 
mechanisms underlying a particular pathology. Yet, this poses a major challenge, as so far, 
psychiatric research has only revealed a small number of potential biomarkers for mental 
disorders and a systematic search for more candidates is needed (Abi-Dargham & Horga, 
2016).  The concept of limited emotion regulation provides such potential candidate.
Emotion regulation:  A transdiagnostic biomarker 
Dysfunctional emotion regulation is a transdiagnostic phenomenon that has been related 
to anxiety disorders, depression and bipolar disorder (Davidson et al., 2002; Gruber et al., 
2012; Mennin et al., 2009), while effective emotion regulation has been linked to resilience 
and reduced the risk for developing an anxiety disorder or depression (Min et al., 2013). The 
biological basis of emotion regulation has been well studied. Neuroimaging studies have 
identified a set of brain regions that has been established as emotion regulation network 
(Kohn et al., 2014; Ochsner et al., 2012). As the neurobiological mechanisms underlying 
emotion regulation are fairly well understood, emotion regulation is a suitable candidate 
for stratification.  A recent study stratified patients with euthymic bipolar 1 disorder based 
on their neural activation in the emotion regulation network and identified two subgroups 
that differed in amygdala activation and VLPFC involvement during an emotion regulation 
task (Njau et al., 2020). Subsequent analysis revealed that the two groups differed regarding 
the number of hospitalizations and first onset of manic episodes. Such study designs make a 
leap forward towards defining biologically distinct subgroups within a clinical category. Yet, 
stratification based on one biological mechanism might be too simplified. In case of anxiety 
disorders, previous research has proposed a variety of biological mechanisms that might lead 
to symptoms of anxiety. Moreover, taking the example of emotion regulation as a biomarker 
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for anxiety, studies have yielded different results. While some studies reported reduced 
involvement of the prefrontal emotion regulation network to be associated with anxiety 
disorders, others demonstrated increased PFC recruitment during emotion regulation in 
anxious populations and patients with PTSD (Campbell-Sills et al., 2011; Nicholson et al., 
2017; Wang et al., 2018). The results of chapter four supported the latter. Although anxiety 
did not affect the subjective regulatory success of emotion regulation, on a neural level, 
anxiety in a highly anxious population was associated with increased VLPFC recruitment 
during emotional reappraisal. This discrepancy in the literature might indicate that reduced 
prefrontal control might be a biological mechanism in some but not all individuals that 
express elevated anxiety levels. Furthermore, considering the transdiagnostic nature of 
deviant emotion regulation, stratification based on one biological mechanism might be 
insufficient for diagnostic purposes in clinical practice. 
Multidimensional biomarker models
In chapter three, we combined several biomarkers of anxiety in a stratification study. 
Instead of clustering participants in terms of one biological concept like emotion regulation, 
we developed an integrative biomarker model that allowed stratification based on twelve 
dimensions (neural activation levels during the experimental and control conditions of three 
different cognitive tasks that tap into three previously established neural mechanisms of 
anxiety). Such a multidimensional stratification model provides a more complete picture and 
allows the identification of more complex biological interdependencies underlying mental 
disorders. Yet, this remains a balancing act, since enhancing the number of dimensions 
punishes the overall model reliability. Our model is based on the assumption that all 
symptoms of anxiety are evoked by amygdala activity. Taking the amygdala as a reference 
point, we focussed on regulatory neural networks that would affect amygdala activity and 
reviewed prior research on these networks and their association with pathological anxiety 
(chapter two). The presented model offers an integrative perspective on the biological 
origins of anxiety but is far from providing an all-embracing framework. Other concepts 
that have not been considered in this model have been suggested as neural biomarkers 
for anxiety.  To provide a glance on cognitive concepts that have been grounded in neural 
mechanisms and are associated with anxiety, a few prominent candidates that would be 
suitable for biomarker stratification should be named.
Patients with anxiety disorders and PTSD oftentimes express poor discrimination between 
resembling stimuli. In PTSD, stimuli that bear resemblance to the original traumatic stimulus 
evoke symptoms of fear and panic. This phenomenon of overgeneralization has been linked 
to structural and functional alteration in the hippocampus and was proposed as a neural 
biomarker for PTSD (Jovanovic et al., 2012; Kheirbek et al., 2012). Moreover, impaired 
extinction learning has been demonstrated to be a predictor for treatment outcome of 
exposure-based interventions in children with obsessive-compulsive disorder (Geller et al., 
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2019). Fear extinction defines the process of eliminating the fear response to a conditioned 
stimulus in the absence of an aversive stimulus and has been associated with activation in 
the dorsal anterior cingulate and anterior insular cortices, regions that are involved in threat 
appraisal (Fullana et al., 2018). Hence, neural activation underlying extinction learning might 
identify biological subgroups of anxious individuals and support the prediction of treatment 
outcome. Meyer et al. (Meyer, 2016) proposed error-related negativity as a biomarker for 
anxiety disorders. Error-related negativity comprises the neural signal evoked by negative 
affect and anticipation of pain and punishment and can be defined as an index for sensitivity 
to threat. On a neural level, error-related negativity has been linked to activation in the 
anterior midcingulate cortex (Shackman et al., 2011). Error-related negativity has been 
suggested as a transdiagnostic biomarker for mood disorders and has been demonstrated 
to prospectively predict the onset of a mood disorder (Meyer, 2016).
Limitations
The following section discusses methodological constraints of the presented work. The 
study population and selection of measurements included in the biomarker model led to 
limitations that should be taken into consideration regarding the overall interpretation of 
the results and derivation of potential clinical indications. 
All presented analyses are based on a study population of healthy but highly anxious 
individuals. Although we oversampled for elevated anxiety traits and established sufficient 
statistical power by testing a large population (n = 217), it is up to debate whether such a 
population allows for conclusions that can be transferred to clinical populations. Stratification 
approaches require large samples. Considering the challenges of recruiting patients with 
anxiety disorders for an fMRI study, an oversampling for high anxiety traits in a healthy 
population allowed a feasible compromise. With regard to the continuum hypothesis of 
psychiatric symptoms, we expected to capture a subclinical population that would express 
a similar but less severe symptomatology and therefore concluded that their underlying 
neural profiles would also bear resemblance to neural biomarkers in clinical populations. 
Yet, the results of chapter four indicate compensatory neural mechanisms that enabled 
participants to reach efficient emotion regulation despite elevated anxiety traits. We might 
have selected an anxious but resilient population that might be not representative for clinical 
populations that lack these resources. Hence, to formulate clinical implications the model 
tested in chapter three would need to be validated in clinical samples with pathological 
anxiety.
Secondly, the quantification of locus coeruleus drive could have been optimized. To 
operationalize the three proposed biomarkers of anxiety we measured neural activation 
during three cognitive tasks that taped into the three mechanisms. We did not implement 
GENERAL DISCUSSION 153
6
a structural scan that would identify the locus coeruleus, which established the limitation 
of only having an indirect measure of locus coeruleus activation. A more direct measure of 
locus coeruleus activation could have been obtained by applying neuromelanin-sensitive 
T1-weighted approaches (Liu et al., 2017). The current design measures activation in 
the amygdala and emotion regulation network during a task that has previously been 
demonstrated to manipulate locus coeruleus activation and thus only allows for indirect 
conclusions in terms of locus coeruleus involvement.  The validation on an independent 
physiological measure (pupil dilation) allowed assessing the reliability of the model. A 
validation based on the outcome of an intervention that had targeted one of the three 
mechanisms would have allowed for stronger clinical implications regarding biomarker-
based treatment selection. As discussed in the preceding section, many other biological 
parameters are worth considering as potential biomarkers of anxiety. We contributed 
a stratification model that is purely based on neuroimaging data and therefore might be 
incomplete. Moreover, in chapter three we only identified two mechanisms that were in 
line with the theoretical framework presented in chapter two. Thus, other mechanisms that 
could not be detected with our design might have contributed to the anxious phenotype 
of this population. The aforementioned limitations restrain the overall reliability of our 
biomarker model and its potential clinical implications.
The follow-up study conducted during the Covid-19 pandemic (chapter five) was based on 
a pseudo-prospective design as the study was implemented after baseline measurements 
had already been taken.  We were able to predict state anxiety and perceived stress based 
on maladaptive emotion regulation strategies that had been evaluated before the outbreak 
of the pandemic. Hence, the question remains how stable such strategies are over time and 
whether participants had applied these strategies also to deal with emotional challenges 
that they experienced due to the pandemic. Furthermore, we implemented the follow-up 
during the first wave of the pandemic. The duration of the pandemic might have had an 
effect on mental health. Mental constraints might have been much more severe during the 
second and third wave. Moreover, by then, infection rates increased drastically, pandemic-
regulation were tightened and the seasonal effect of the winter period presumably further 
increased the risk for anxiety, stress, and depression. Moreover, the risk of infection might 
have been less threatening to our study population compared to the general population. The 
study population was mainly composed of healthy young students and is not representative 
for high-risk groups that faced a severe health threat during the pandemic. Nevertheless, 
young adults might have been stronger mentally affected by pandemic-related regulations 
that restricted social interaction than the actual risk of an infection. 
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Future directions
Although psychiatric practise still follows a symptom-based approach, a new perspective 
is emerging. The US National Institute of Mental Health (NIMH) formulated the research 
domain criteria approach for investigating mental disorders (RDoC), a modification of the 
traditional symptom-based classification system that proposes to map biological, cognitive, 
and genetic factors to a mental disease. The RDoC approach supports the development 
of neuroimaging biomarkers that would allow to define psychiatric disorders based on 
dimensions of observable behaviour and neurobiological measures (Abi-Dargham & Horga, 
2016). 
Personalized medicine has already become clinical practice in various medical domains and 
has revolutionized treatment strategies. For instance, the discovery of reliable biomarkers 
in oncology that allow to predict cellular and molecular mechanisms that drive tumour 
progression has led to treatment selection based on the biological profile of the individual 
patient (Kalia, 2015). Such integrative models that represent the complex interplay of various 
neural correlates to capture the entire neurobiological profile underlying mental disorders 
are still missing. Yet, large-scale research projects that aim at identifying multiple biomarkers 
in psychiatry are emerging. The ENIGMA consortium initiated worldwide collaborations in 
order to combine patient datasets in genetics, neurology and psychiatry into data bases that 
would allow analyses of high statistical power. For instance, the ENIGMA anxiety working 
group established to integrate over 100 study samples including imaging and genetic data of 
patients with diverse anxiety disorders (Bas-Hoogendam et al., 2020). Further efforts have 
been accomplished with regard to autism spectrum disorders. The EU-AIMS Longitudinal 
European Autism Project (LEAP) applies stratification analyses based on longitudinal data 




on symptomatology, comorbidities, neurocognitive performance, structural and functional 
neuroimaging data, biochemical markers and genetic information in over 800 participants in 
order to define predictive biomarkers regarding treatment effects (Loth et al., 2017).   Such 
initiatives provide the statistical power and required multidimensionality in order to deliver 
a scientific ground for the development of reliable biological tests for diagnostic purposes 
and predictive biomarkers to support treatment-selection. 
Moreover, a trend in neuroimaging research aiming to identify therapy induced neural 
alterations has burgeoned (La Buissonniere-Ariza et al., 2021; Norman et al., 2020; Ritchey 
et al., 2011; Straube et al., 2006). Insights on biological effects of therapeutic treatment is a 
necessary precondition for biomarker-based treatment selection. Adapting treatment to the 
neurobiological predisposition of a patient might be the future road towards personalized 
treatment in psychiatry and increased treatment response rates. 
Concluding Remarks
Psychiatry has recognized individuality in terms of behaviour but neglected heterogeneity 
in biological parameters of mental disorders. This thesis demonstrated that symptoms 
of anxiety are associated with distinct neural correlates and contributed an exemplary 
framework on how to capture biological heterogeneity among anxious individuals. Our 
findings support two previously proposed neural correlates of anxiety. We detected 
subgroups of anxious individuals expressing decreased prefrontal control or increased locus 
coeruleus drive as their primary neural correlate of anxiety. While this work only considered 
neural correlates, physiological, genetic, neurobiological, and behavioral factors need to 
be integrated to reach a comprehensive understanding of the anxious phenotype and its 
various biological origins. Interdisciplinary research aimed at understanding the diversity of 
biological mechanisms evoking anxiety will provide biological reference points for treatment 
selection and forms the necessary foundation for biomarker-guided treatment in psychiatry.
The second part of this thesis revealed neural correlates reflecting the protective effect of 
efficient emotion regulation in highly anxious individuals. Investigating emotion regulation 
strategies in highly anxious individuals during the Covid-19 pandemic, we detected that 
maladaptive emotion regulation strategies were a strong predictor of anxiety and perceived 
stress during the pandemic. These findings underline the potential of interventions targeting 
emotion regulation in healthy and clinical populations to relieve the burden of anxiety.
“Whoever has learned to be anxious in the right way has learned the ultimate.”
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Nederlandse Samenvatting
Symptomen van angst zijn een veelvoorkomend fenomeen binnen de gezonde populatie en 
een kenmerk van veel psychiatrische diagnosen. Classificatiesystemen voor psychiatrische 
stoornissen zoals de ICD-10 en de DSM-5 definiëren angst op het symptoomniveau en 
categoriseren angststoornissen gebaseerd op cognitieve, emotionele, fysiologische en 
gedragssymptomen.  In de huidige klinische praktijk worden de onderliggende fysiologische 
en neurobiologische mechanismen en interindividuele verschillen in de neurobiologische 
predispositie van een patiënt niet meegenomen in zowel de diagnostiek als behandeling. Enkel 
een focus op symptoomniveau, is één van de oorzaken voor een beperkte therapiesucces 
van standaard angstbehandelingen. Echter, er is op dit moment nog geen neurobiologisch 
verklaringsmodel dat een betrouwbare basis voor een meer neurobiologisch gefundeerde 
diagnostiek en behandeling zou kunnen bieden. 
Eerder onderzoek stelt verschillende neurobiologische mechanismen (biomarkers) voor, die 
allemaal naar dezelfde zichtbare symptomen van angst leiden. Tot zover hebben studies vooral 
op zichzelf staande mechanismen onderzocht maar zelden meerdere mechanismen tegelijk 
bekeken. Het is echter aannemelijk dat een samenspel van verschillende mechanismen tot een 
angststoornis leidt, waarbij binnen individuele patiënten de mechanismen variëren in intensiteit. 
Dit soort neurobiologische heterogeniteit kan met groep gebaseerde statistiekmodellen niet 
gedetecteerd worden. Dit roept de vraag op in hoeverre neurobiologische heterogeniteit 
binnen de onderzoekspopulatie resultaten van psychiatrisch behandelstudies beïnvloeden 
of effecten verhullen die binnen een neurobiologisch homogene subpopulatie wel zichtbaar 
zouden worden.
Deel I: Neuronale biomarkers van angstsymptomen
Dit proefschrift onderzoekt drie neurobiologische angstmechanismen en stelt een analyse-
strategie voor om neuronale heterogeniteit binnen een populatie vast te stellen.
In hoofdstuk 2 wordt een biomarker-model voorgesteld waarbinnen drie neurologische 
mechanismen van angst worden geïntegreerd: amygdala hypersensitiviteit, een verlaagde 
prefrontale controle en een verhoogde noradrenaline-uitstoot van de locus coeruleus 
(een structuur in de hersenstam die noradrenaline produceert).  Symptomen van angst 
worden opgeroepen door neuronale activiteit van de amygdala. Patiënten met een 
angststoornis hebben een verhoogd activiteitsniveau van de amygdala. Dit kan een gevolg 
zijn van hypersensitiviteit van de neuronen binnen de amygdala. Anderzijds, kan er ook 
een verhoogde noradrenaline-toevoer van de locus coeruleus naar de amygdala tot een 
verhoogde neuronale activiteit leiden, terwijl er geen hypersensitiviteit van de amygdala 
bestaat. Verder kan een beperkt inhibitoir (dempend) effect van prefrontale netwerken 




netwerken vormt de neuronale basis van emotieregulatie. Tijdens het onder controle 
houden van emotionele reacties, worden inhibitoire prefrontale netwerken geactiveerd. 
Verhoogde amygdala-activiteit wordt door de dempende prefrontale verbindingen geremd. 
Als dit prefrontale mechanisme weinig actief is, ontvangt de amygdala continu te weinig 
dempende signalen en het activiteitsniveau blijft daardoor voortdurend verhoogd. 
In hoofdstuk 3 is het hierboven voorgestelde biomarker-model in een subklinische 
populatie van gezonde, maar hoog angstige, deelnemers getoetst. Hiervoor werden een 
MRI en meerdere fysiologische metingen bij 217 deelnemers uitgevoerd. Gebaseerd op de 
functionele MRI-data is er een clusteranalyse uitgevoerd om homogene subgroepen van 
individuele deelnemers met een hoge overeenstemming in hun neuronale activiteitenprofiel 
te bepalen. Het gebruikte algoritme onderscheidde drie groepen binnen de populatie. 
Retrospectief hebben we de activiteitenprofielen van de drie subgroepen vergleken met de 
activiteitenprofielen die bij de drie biomarkers (amygdala hypersensitiviteit, verhoogde locus 
coeruleus of verlaagde prefrontale activiteit) te verwachten zijn. Twee groepen hadden een 
duidelijke overeenstemming met respectievelijk het te verwachtende activiteitenprofiel bij 
verhoogde locus coeruleus activiteit en het activiteitenprofiel bij de verlaagde prefrontale 
activiteit, terwijl er geen duidelijke indicatie was voor amygdala hypersensitiviteit binnen de 
populatie. De resultaten zijn gevalideerd met behulp van de fysiologische data. Hieruit bleek 
dat de subgroepen die op basis van neuronale activiteit gevormd waren, ook verschillende 
fysiologische profielen toonden tijdens het induceren van stress. Vervolgonderzoek in 
klinische populaties zou kunnen bevestigen of therapievormen die rekening houden met 
de dominante biomarker van een individuele patiënt tot een hoger behandelsucces leiden. 
Hierbij zou eerst het neurobiologische profiel van een patiënt gedefinieerd moet worden 
om vervolgens de behandeling op zijn of haar profiel af te stemmen. 
Deel II: Emotieregulatie
Het tweede deel van dit proefschrift richt zich op emotieregulatie in een hoogangstige 
populatie. Hoofdstuk 4 beschrijft een MRI-studie waarin de neuronale mechanismen van 
emotieregulatie bij gezonde, maar hoog angstige, proefpersonen onderzocht is. Tijdens 
de MRI-meting kregen deelnemers afbeeldingen met een negatieve emotionele lading te 
zien en moesten ze er óf gewoon naar kijken óf ze werden gevraagd om er een ‘positieve 
draai’ aan te geven en zo de emotionele impact te verminderen. Uit de resultaten bleek dat 
verhoogde angst was geassocieerd met activiteit in de ventrolaterale prefrontale cortex, 
een hersengebied dat uit eerder onderzoek betrokken blijkt te zijn in het verwerken van 
emotie. Verder bleek uit een connectiviteitsanalyse dat de mediotemporale gyrus en 
de dorsomediale prefrontale cortex een regulerend effect hadden op de ventrolaterale 
prefrontale cortex. Hoe sterker deze connectiviteit was, hoe lager was het angstniveau van 
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de deelnemers. Regulerende netwerken zorgen voor een effectieve regulatie van emoties 
en helpen dus de angst onder controle te houden.
Hoofdstuk 5 is tijdens de eerste golf van de Covid-19 pandemie ontstaan. Verschillende studies 
omschreven een forse toename van mentale klachten als gevolg van de pandemie en de door 
de Corona-maatregelen ontstane beperkingen in het openbare leven. In dit hoofdstuk wilden 
we het effect van de Covid-19 pandemie onderzoeken bij mensen die al voor de uitbraak 
een verhoogd angstniveau hadden. Daarom vroegen we alle deelnemers van de biomarker-
studie uit hoofdstuk 3 vanaf het uitbreken van de pandemie (april 2020) om een keer per 
maand hun mentale gezondheid, stress, gezondheidsklachten en sociale gevolgen in verband 
met de pandemie te beoordelen. De verwachting dat hoog angstige mensen meer last van 
de sociale gevolgen van de pandemie zouden hebben, en eventueel zelfs een pathologisch 
angstniveau zouden bereikten, werd niet bevestigd. Het angstniveau voor de pandemie was 
geen voorspeller voor het beleven van angst en stress tijdens de pandemie. Belangrijker 
waren efficiënte emotieregulatie-strategieën, die al voor de pandemie ingezet werden. De 
vaardigheid tot een efficiënte emotieregulatie bleek een betere voorspeller voor het beleven 
van angst en stress tijdens de pandemie dan het algemene angstniveau. Verhoogde angst is 
dus niet noodzakelijkerwijs een risico voor het ontwikkelen van een angststoornis wanneer 
er een globale stressfactor optreedt, zolang iemand in staat is effectieve emotieregulatie-
strategieën in te zetten.
Conclusie
De resultaten van dit proefschrift laten zien dat angstsymptomen gebaseerd zijn op 
verschillende neuronale mechanismen. Het in ogenschouw nemen van neurobiologische 
factoren en interindividuele biologische verschillen past bij de trend om binnen psychiatrische 
diagnostiek en behandeling de therapiekeuze af te stemmen op het biologische profiel 
van de patiënt. De bevindingen leveren een bijdrage aan de op neurobiologie gebaseerde 
diagnostiek en behandeling van angststoornissen. Toekomstige behandelstudies in klinische 
populaties kunnen op basis van dit werk onderzoeken of een biomarker het behandelsucces 
kan voorspellen en of de behandeling hierdoor beter afgestemd kan worden op de patiënt. 
Een gebrekkige emotieregulatie is een fenomeen van talrijke psychiatrische stoornissen. 
Voorgaande studies hebben neuronale activiteit tijdens emotieregulatie vooral in gezonde 
populaties onderzocht. Onze studie levert een bijdrage aan het begrip van neuronale 
processen tijdens emotieregulatie bij verhoogde angst. Naast de neuronale basis van 
emotieregulatie, hebben we ook de emotieregulatiestrategieën bij hoog angstige personen 
in een acute stresssituatie (de Covid-19 pandemie) onderzocht. De mate waarin personen 
hun emoties konden reguleren, voorspelde het ervaren van angst en stress tijdens de 
Covid-19 pandemie. Dit onderschrijft de beschermende waarde van een adequate inzet 
van emotieregulatiestrategieën. Verhoogde angst hoeft niet noodzakelijkerwijs tot een 




Angstsymptome sind ein weitverbreitetes Phänomen in der gesunden Bevölkerung 
und Bestandteil zahlreicher psychiatrischer Diagnosen. Diagnosemanuale (ICD-10, 
DSM-5) definieren Angst auf der Symptomebene, und kategorisieren Angststörungen 
basierend auf kognitiven, emotionalen, physiologischen und Verhaltenssymptomen. 
Aktuelle psychiatrische Behandlungspraxis begrenzt sich dabei vornehmlich auf einen 
beschreibend-beobachtenden Modus mit wenig Berücksichtigung der zu Grunde liegenden 
physiologischen und neurobiologischen Mechanismen sowie interindividuellen Differenzen 
in neurobiologischen Prädispositionen. Die Reduktion auf Symptomebene ist eine mögliche 
Ursache für begrenzten Therapieerfolg von Standardbehandlungen. Bislang fehlt es jedoch 
an neurobiologischen Erklärungsmodellen und Messmethoden, die eine zuverlässige 
Grundlagen für eine neurobiologisch fundierte Diagnostik und Behandlung bieten könnten.
Tier- und Humanforschung stellt verschiedene neurobiologische Mechanismen (Biomarker) zur 
Diskussion, die trotz ihrer biologischen Diversität zu identischer äußerlicher Symptomatik von 
Angst führen. Bislang haben Studien überwiegend einzelne neurobiologische Mechanismen 
unter die Lupe genommen, jedoch selten mehrere Mechanismen im Zusammenhang 
betrachtet. Es ist anzunehmen, dass das Zusammenspiel verschiedener Mechanismen zur 
Angstsymptomatik führt. Einzelne Mechanismen können dabei interindividuell unterschiedlich 
stark ausgeprägt sein. Derartige neurobiologische Heterogenität kann mit Modellen der 
herkömmlichen gruppenbasierten Statistik nur schwer erfasst werden. Somit stellt sich die 
Frage inwieweit neurobiologische Heterogenität innerhalb der Studienpopulationen die 
Ergebnisse psychiatrischer Behandlungsstudien verzerrt oder potentielle Behandlungseffekte, 
die nur in neurobiologisch homogenen Subpopulationen auftreten würden, verdeckt.
Teil I: Neuronale Biomarker von Angstsymptomen
Die vorliegende Arbeit untersucht drei neurobiologische Mechanismen und stellt einen 
Analyseansatz vor, der es ermöglicht neurobiologische Heterogenität innerhalb einer 
Population zu erfassen. 
In Kapitel 2 wurde ein Biomarker-Model konzipiert, das drei neurologische Mechanismen 
von Angst integriert; Amygdala Hypersensitivität, verringerte präfrontale Kontrolle und 
erhöhte Noradrenalin Ausstoß des Locus coeruleus. Angstsymptome basieren in erster Linie 
auf neuronaler Aktivität in der Amygdala. Patienten mit Angststörungen weisen ein erhöhtes 
Aktivitätslevel der Amygdala auf. Dieses kann Folge einer Hypersensitivität der Neurone in 
der Amygdala sein. Andererseits kann jedoch auch erhöhte Noradrenalinprojektion vom 
LC zur Amygdala zu erhöhter neuronaler Aktivität führen, während die Amygdala keine 
neurobiologischen Abweichungen bezüglich ihrer Sensitivität aufweist. 
DEUTSCHE ZUSAMMENFASSUNG
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Die Amygdala ist eingebettet in ein Netzwerk mit präfrontalen Arealen, die die Amygdalaaktivität 
runterregulieren. Eine eingeschränkte inhibitorische (hemmende) Wirkung präfrontaler 
Netzwerke kann ein weiterer Auslöser von erhöhter Amygdalaaktivität sein. Auf kognitiver Ebene 
entsprechen diese Prozesse der Emotionsregulation. Beim Versuch seine Emotionen unter 
Kontrolle zu halten, werden inhibtorische präfrontale Netzwerke aktiviert. Amygdalaaktiviät wird 
dann durch hemmende präfrontale Signale gebremst. Ist dieses Netzwerk zu wenig ausgeprägt, 
erhält die Amygdala kontinuierlich zu geringe inhibitorische Signale und das Aktivitätsniveau 
ist dauerhaft erhöht. In Kapitel 2 wurden diese drei Mechanismen in ein Biomarker-Model 
integriert.
In Kapitel 3 wurde das zuvor vorgestellte Biomarker-Model anhand einer hoch ängstlichen 
(subklinischen) Population getestet. Dazu wurde an 217 Studienteilnehmern eine MRI 
(Magnet-Resonance-Imaging) Messung, mehrere physiologische Messungen und Fragebögen 
abgenommen. Basierend auf den funktionellen (aktivitätsmessenden) MRI-Daten wurde 
eine Clusteranalyse durchgeführt, um homogene Subpopulationen zu bestimmen, die eine 
hohe Übereinstimmung in ihrem neuronalen Aktivitätsprofil aufzeigten. Der angewandte 
Algorithmus differenzierte drei Subgruppen innerhalb der Population.  Retrospektiv wurden 
die Aktivitätsprofile dieser drei Subgruppen mit den Aktivitätsprofilen verglichen die unter 
Ausprägung der drei Biomarker (Amygdala Hypersensitivität, erhöhte LC oder verringerte 
präfrontale Aktivität) zu erwarten wären. Zwei Gruppen zeigten deutliche Übereinstimmung 
mit den Aktivitätsprofilen bei erhöhter LC Aktivität oder verringerte präfrontaler 
Aktivität, während keine deutliche Indikation für Amygdala Hypersensitivität in dieser 
Population festgestellt werden konnte. Die Resultate der Clusteranalyse wurden anhand 
der physiologischen Messdaten validiert. Subgruppen, die auf Grund ihrer neuronalen 
Aktivität geformt wurden, unterschieden sich auch hinsichtlich ihres physiologischen Profils 
während einer experimentellen Stressinduktion. Therapieansätze, die den dominierenden 
Biomarker eines Patienten berücksichtigen und gezielt behandeln, würden vermutlich zu 
effektiverem Behandlungserfolg führen. Eine Testung dieser Hypothese erfordert eine 
Behandlungsstudie, die zunächst das neurobiologische Profil eines Patienten definiert und 
dann die Vorhersagekraft des neurobiologischen Profils auf den Behandlungserfolg testet.
Teil II: Emotionsregulation 
Der zweite Teil dieser Arbeit widmet sich der genaueren Betrachtung von Emotionsregulation 
in hochängstlichen Individuen. Kapitel 4 beschreibt eine MRI-Studie, in der die neuronalen 
Mechanismen der Emotionsregulation an gesunden jedoch hoch ängstlichen Probanden 
untersucht wurden. Während einer MRI-Aufnahme wurden den Probanden Fotos mit 
negativen emotionalen Inhalten präsentiert und die Probanden wurden aufgefordert 




sehen um eventuell ausgelöste emotionale Reaktionen weitestgehend zu unterdrücken. 
Erhöhte Ängstlichkeit ging mit verstärkter Aktivität im ventrolateralen präfrontalen Kortex 
(PFC) einher, ein Hirnareal, das aus früheren Untersuchungen bereits mit neuronalen 
Prozessen während der Verarbeitung von Emotionen assoziiert wurde. Erhöhte Angst steht 
demnach mit erhöhter Aktivität des ventrolateralen PFC und somit einer intensivierten 
Emotionsverarbeitung in Verbindung. Desweiteren zeigte eine Konnektivitätsanalyse dass 
zwei weitere präfrontale Areale (der mediotemporalen Gyrus und der dorsomedialen 
PFC) einen regulativen Effekt auf den ventrolateralen PFC ausübten während Probanden 
versuchten ihre Emotionen zu kontrollieren. Mit steigender funktionaler Konnektivität (= 
gleichzeitige Aktivität) zu diesen beiden Arealen nahm die Aktivität des ventrolateralen PFC 
ab. Je stärker diese Konnektivität ausgeprägt war, umso geringer waren auch die Angstwerte 
der Probanden. Auch bei erhöhter Angst scheinen regulative Netzwerke demnach eine 
effektive Emotionsregulation zu ermöglichen in dem eine intensivierte Emotionsverarbeitung 
(ventrolaterale PFC Aktivität) durch regulative präfrontale Areale runterreguliert wird.
Kapitel 5 dieser Thesis ist während der Covid-19 Pandemie entstanden. Studien 
berichteten eine erhebliche mentale Belastung als Folge der Pandemie und den damit 
zusammenhängenden Maßnahmen zur Kontaktreduzierung. Bisher hatten wir unsere 
Pandemie lediglich in einer Laborsituation untersucht. Die Pandemie ermöglichte den Effekt 
von hoher Stressbelastung auf Menschen zu untersuchen, die bereits vor der Pandemie 
hohe Angstwerte aufwiesen. Dazu befragten wir alle Probanden der Biomarkerstudie aus 
Kapitel 3 ab vier Wochen nach dem Ausbruch der Pandemie in den Niederlanden (April 
2020) monatlich nach ihrer mentalen Gesundheit, ihrem Stressempfinden und nach 
gesundheitlichen und sozialen Belastungen auf Grund der Pandemie. Die Prognose, dass 
hochängstliche Menschen besonders unter der Pandemie leiden und eventuell pathologische 
Angstlevel erreichen würden, ließ sich nicht bestätigen. Ängstlichkeit vor der Pandemie 
war kein Prädiktor für Angst und Stresserleben während der Pandemie. Entscheidender 
waren vielmehr effiziente Emotionsregulationsstrategien, die bereits vor der Pandemie 
etabliert worden waren. Die Fähigkeit zu effizienter Emotionsregulation scheint somit eine 
stärkere Vorhersagekraft zu haben bezüglich der durch die Pandemie ausgelösten Angst 
und Stress als die allgemeine Ängstlichkeit einer Person. Erhöhte Ängstlichkeit stellt somit 
nicht zwangsläufig ein Risiko für eine Erkrankung an Angststörungen dar sobald ernste und 
langfristige äußere Stressfaktoren (wie beispielsweise eine Pandemie) auftreten, solange 
effiziente Regulationsstrategien im Umgang mit Stress und Belastung etabliert wurden.
Fazit
Die Ergebnisse dieser Arbeit zeigen, dass Angstsymptome auf verschiedenen neuronalen 
Mechanismen basieren. Die Einbeziehung neurobiologischer Faktoren und Berücksichtigung 
interindividueller biologischer Unterschiede stellen einen neuen Trend innerhalb der 
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psychiatrischen Diagnostik und Behandlung dar.  Die hier vorgestellten Ergebnisse liefern 
einen Beitrag zur neurobiologisch fundierten Diagnostik und Behandlungspraxis von 
Angststörungen. Weiterführende Behandlungsstudien in klinischen Populationen können 
auf Basis dieser Arbeit untersuchen ob ein Biomarker den Behandlungserfolg einer Therapie 
vorhersagt und ob eine Therapie die auf das biologische Profil des Patienten abgestimmt ist 
zu besseren Behandlungsergebnissen führt. 
Schwierigkeiten bei der Regulation von Emotionen sind ein Phänomen zahlreicher 
psychiatrischer Störungen. Bisherige Studien haben neuronale Aktivität und Konnektivität 
während der Emotionsregulation vor allem in gesunden Populationen betrachtet. 
Unsere Studie liefert einen Beitrag zum Verständnis von neuronalen Prozessen während 
der Emotionsregulation bei hoher Ängstlichkeit. Neben neuronalen Grundlagen der 
Emotionsregulation wurden auch Emotionsregulationsstrategien bei hochängstlichen 
Probanden in einer akuten Stresssituation (Covid-19 Pandemie) untersucht. Die 
Vorhersagekraft von Emotionsregulationskompetenz in Bezug auf Angst und Stresserleben 
während der Covid-19 Pandemie unterstreicht die protektive Bedeutung von adäquater 
Emotionsregulation. Erhöhte Ängstlichkeit ist demnach nicht zwingend als Risikofaktor für die 
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the research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the 
best and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni show 
a continuation in academia with postdoc positions at top institutes worldwide, e.g. Stanford 
University, University of Oxford, University of Cambridge, UCL London, MPI Leipzig, Hanyang 
University in South Korea, NTNU Norway, University of Illinois, North Western University, 
Northeastern University in Boston, ETH Zürich, University of Vienna etc.. Positions outside 
academia spread among the following sectors: specialists in a medical environment, mainly 
in genetics, geriatrics, psychiatry and neurology. Specialists in a psychological environment, 
e.g. as specialist in neuropsychology, psychological diagnostics or therapy. Positions in higher 
education as coordinators or lecturers. A smaller percentage enters business as research 
consultants, analysts or head of research and development. Fewer graduates stay in a 
research environment as lab coordinators, technical support or policy advisors. Upcoming 
possibilities are positions in the IT sector and management position in pharmaceutical 
industry. In general, the PhDs graduates almost invariably continue with high-quality 
positions that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses, please visit:
http://www.ru.nl/donders/graduate-school/phd/
